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Abstract		
DNA	 replication	 initiation	 is	 strictly	 controlled	 to	 maintain	 chromosome	 copy	 number.	
Over-	 or	 under-replication	 of	 an	 organism's	 genome	 is	 detrimental	 to	 survival,	 thus	
initiation	events	are	tightly	regulated	to	ensure	only	one	round	of	DNA	replication	occurs	
per	cell	cycle.	In	prokaryotes,	DNA	replication	commences	when	a	protein	initiator,	DnaA,	
forms	a	helical	filament	at	the	origin	of	replication,	oriC,	inducing	localised	DNA	unwinding	
and	 the	 recruitment	 of	 the	 replication	 machinery.	 The	 work	 described	 here	 sought	 to	
elucidate	how	DNA	replication	initiation	is	regulated	in	the	Gram-positive	model	organism	
Bacillus	subtilis.	In	particular,	this	work	aimed	to	offer	insight	into	the	mechanisms	of	two	
negative	 regulators	 of	 DNA	 replication	 initiation,	 SirA	 and	 YabA;	 proteins	 that	 play	
significant	roles	 in	regulating	replication	initiation	in	sporulating	and	vegetatively	growing	
cells,	respectively.	 	Both	SirA	and	YabA	interact	directly	with	the	initiator	DnaA,	and	YabA	
has	 additionally	 been	 shown	 to	 interact	 with	 the	 DNA	 polymerase	 β-clamp,	 DnaN	 (an	
essential	component	of	the	replication	machinery).		
Detailed	here	are	structural	and	biophysical	studies	of	SirA	and	YabA.	This	includes	the	X-
ray	 crystal	 structure	 of	 SirA	 bound	 to	 the	 N-terminal	 domain	 of	 DnaA	 in	 an	 inhibitory	
complex,	 and	 characterisation	of	 the	 SirA-DnaADI	 interface	using	 an	 in	 vitro	 assay.	When	
coupled	with	in	vivo	localisation	studies	carried	out	by	our	collaborators,	the	work	on	SirA	
suggests	a	mechanism	for	 its	 inhibition	of	DNA	replication.	 	 	Also	detailed	are	biophysical	
studies	used	to	characterise	the	architecture	of	YabA,	guided	by	the	use	of	in	silico	models,	
and	 the	X-ray	 crystal	 structure	of	 YabA's	N-terminal	 domain.	 These	 results	 are	discussed	
alongside	 structural	 and	 mutational	 studies	 of	 YabA	 carried	 out	 by	 our	 collaborators;	
collectively	the	results	delineate	the	full-length	structure	of	YabA	and	offer	insight	into	its	
interactions	with	DnaA	and	DnaN.		
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Chapter	1 :	Introduction	
1.1:	DNA	Replication		
For	all	organisms,	replication	of	genomic	DNA	is	a	complex	task.	The	scale	of	the	genome,	
even	in	a	bacterial	cell	(at	1-10	Mbp1),	already	presents	a	considerable	challenge	-	the	cell	
must	 be	 able	 to	 replicate	 its	 DNA	 very	 quickly,	 but	 also	 highly	 accurately	 to	 ensure	 the	
correct	passage	of	 information	 from	one	generation	 to	 the	next.	 	 In	order	 to	 initiate	 the	
replication	 process,	 a	 nucleoprotein	 complex	 must	 form	 on	 DNA	 and	 localised	 DNA	
unwinding	must	occur	 to	 allow	 the	 loading	of	 a	 processive	DNA	helicase.	 	A	 large	multi-
component	molecular	machine	known	as	the	replisome	must	then	be	assembled,	and	this	
molecular	machine	carries	out	the	replication	of	the	DNA	-	using	different	mechanisms	to	
replicate	 each	 stand	 of	 DNA	 due	 to	 their	 different	 polarities.	 Furthermore,	 the	 need	 to	
coordinate	DNA	replication	with	cell	cycle,	ensuring	the	genome	is	replicated	once	per	cell	
division,	adds	an	additional	level	of	complexity	to	the	process.	Below,	these	processes	will	
be	discussed	 in	detail,	with	particular	emphasis	on	how	DNA	replication	 is	regulated.	The	
exact	proteins	and	regulatory	mechanisms	involved	in	DNA	replication	vary,	both	between	
and	within	each	domain	of	life.	Although	a	number	of	parallels	can	be	drawn	between	the	
domains,	 this	 introduction	 will	 focus	 only	 on	 the	 replication	 of	 DNA	 in	 prokaryotes	 and	
differences	observed	within	this	domain.		
	
1.2:	Semi-conserved	Replication	
Prokaryotic	 DNA	 replication	 occurs	 from	 a	 single	 origin	 of	 replication	 and	 involves	 the	
progressive	 separation	 of	 the	 two	 parental	 strands	 of	 DNA	with	 concurrent	 synthesis	 of	
new	 DNA	 strands	 complementary	 to	 each	 of	 the	 parental	 strands	 (i.e.	 each	 replicated	
strand	uses	one	parental	strand	as	a	template).	This	results	in	two	double-stranded	semi-
conservatively	 replicated	 daughter	 chromosomes.	 	 Replicating	 chromosomes	 have	 been	
described	 to	 have	 replication	 'eyes'	 or	 'bubbles'	 where	 the	 branch	 points	 of	 these	
structures	are	the	 locations	of	 'replication	 forks'	 -	 i.e.	where	new	strand	synthesis	occurs	
(Fig.	1.1,	A).	Strand	synthesis	is	usually	bidirectional	(contains	two	replication	forks)	but	can	
be	unidirectional2.		
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1.3:	Semi-discontinuous	Replication	
New	strands	of	DNA	are	synthesised	by	the	action	of	DNA	polymerase,	which	extends	DNA	
strands	in	a	5'	to	3'	direction.	This	means	that	as	both	strands	of	the	DNA	double	helix	are	
replicated	 simultaneously	 at	 the	 replication	 fork,	 they	 require	 different	 mechanisms	 of	
synthesis	to	allow	the	DNA	polymerase	to	travel	in	only	a	5'	to	3'	direction	(Fig.	1.1,	B).	The	
strand	which	extends	with	the	replication	fork	in	the	5'	to	3'	direction	will	be	continuously	
synthesised	with	replication	fork	movement	-	this	strand	is	known	as	the	"leading	strand".	
However,	the	strand	extending	in	the	3'	to	5'	direction	is	synthesised	as	a	series	of	5'	to	3'	
segments	 (containing	 around	 1000-2000	 bps	 each)	 known	 as	 Okazaki	 fragments.	 This	 is	
known	as	 the	"lagging	strand";	 these	 lagging	strand	 fragments	are	 later	covalently	 linked	
by	the	enzyme	DNA	ligase.	This	process	of	leading	and	lagging	strand	synthesis	is	given	the	
term	'semi-discontinuous	replication'	because	only	one	strand	is	replicated	continuously2.			
	
	
	
Figure	1.1:	Bidirectional	and	semi-discontinuous	DNA	replication:	A)	Replication	‘eye’	or	‘bubble’;	
yellow	 circles	 indicate	 the	 location	 of	 oriC,	 green	 circles	 indicate	 the	 replication	 forks	 during	
bidirectional	 replication	and	the	red	circle	shows	the	point	of	 replication	 termination.	Taken	 from	
Robinson	 et	 al.	Current	 Drug	 Targets	 13,	 352–372	 (2012).	B)	 Semi-discontinuous	 DNA	 replication	
diverging	from	the	replication	origin	 (yellow	circles	 indicate	 location	of	oriC);	all	DNA	polymerases	
synthesise	 DNA	 in	 a	 5’à	 3’	 direction.	 Leading	 strand	 synthesis	 (red)	 occurs	 continuously	 whilst	
lagging	strands	(green)	are	synthesised	as	a	series	of	Okazaki	fragments.		
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1.4:	Phases	of	DNA	Replication	
The	 process	 of	 DNA	 replication	 can	 be	 separated	 into	 3	 distinct	 phases:	 initiation,	
elongation	and	termination.	During	the	initiation	phase,	a	nucleoprotein	complex	induces	
localised	DNA	unwinding	and	facilitates	helicase	loading	at	the	origin	of	replication.	In	the	
elongation	phase,	the	replication	machinery	assembles	and	lagging	and	leading	strands	are	
prossessively	synthesised	by	DNA	polymerase	to	form	new	strands	of	DNA.	Finally,	during	
termination,	 DNA	 polymerisation	 is	 halted	 at	 a	 specific	 termination	 site.	 A	 number	 of	
proteins	are	required	to	collectively	orchestrate	each	replication	phase2.	The	role	of	these	
proteins	and	the	events	of	each	stage	will	be	described	in	some	detail	below.	Much	of	our	
current	 understanding	of	 the	DNA	 replication	process	 in	 bacteria	 has	been	derived	 from	
work	carried	out	in	E.	coli	(model	organism	for	Gram-negative	bacteria).	This	knowledge	is	
thought	to	be	directly	transferable	to	other	bacterial	species	given	the	high	conservation	of	
DNA	 replication	 proteins	 (e.g.	 DnaA,	 DnaB-like	 helicase	 etc.)3.	 However	 differences	
between	 species	 have	 been	 observed,	 and	 these	 will	 be	 discussed	 where	 relevant	 (and	
known).	 In	 particular,	 differences	 observed	 in	 B.	 subtilis	 (a	 model	 organism	 for	 Gram-
positive	bacteria)	will	be	presented	as	these	are	pertinent	to	this	study.		
	
1.5:	Initiation	of	DNA	Replication	
1.5.1:	DNA	Replication	Initiation	in	E.	coli	
DNA	 replication	 is	 initiated	 by	 the	 binding	 of	 a	 protein	 initiator,	 DnaA,	 to	 the	 origin	 of	
replication,	oriC.	DnaA	 forms	 a	 right-handed	helical	 oligomer	on	 the	DNA4,5	 by	 binding	 a	
series	 of	 recognition	 sites	 within	 the	 origin	 termed	 DnaA-boxes6.	 The	 formation	 of	 this	
oligomer	 induces	 a	 localised	 unwinding	 of	 DNA	 within	 the	 origin	 at	 an	 AT-rich	 region	
termed	the	DUE	(for	‘DNA	Unwinding	Element’)7,8.	DnaA	then	plays	a	role	in	recruiting	the	
prossessive	DNA	helicase,	DnaB,9	which	 is	 loaded	onto	the	unwound	ssDNA	by	a	helicase	
loader,	 DnaC10.	 DnaB	 subsequently	 recruits	 the	 primase,	 DnaG,	 and	 the	 polymerase	 β-
clamp	DnaN,	which	will	 recruit	other	 components	of	 the	 replication	machinery	 ready	 for	
strand	synthesis11.	
DnaA	is	 is	a	member	of	the	AAA+	ATPase	family	(ATPases	associated	with	diverse	cellular	
activities),	able	to	bind	and	hydrolyse	ATP,	it	exists	in	the	cell	as	both	an	ATP-	and	an	ADP-
bound	form12.	However,	DnaA-ATP	is	considered	to	be	the	‘active’	form	of	the	protein	as	
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this	 is	 required	 for	 oligomerisation	 at	 the	 origin13,14,	 triggering	 DNA	 unwinding	 and	
ultimately,	assembly	of	the	replisome.		
The	DnaA-boxes	within	 the	 origin	 of	 replication	 vary	 in	 their	 affinity	 for	DnaA,	 based	on	
their	 similarity	 to	a	consensus	binding	sequence	and	on	 the	adenosine	nucleotide	bound	
state	 of	 DnaA15,16.	 The	 DnaA-boxes	 at	 the	 origin	 can	 be	 either	 ‘strong’	 or	 ‘weak’;	where	
strong	boxes	bind	both	DnaA-ATP	and	DnaA-ADP	with	equal	affinity	and	‘weak’	boxes	have	
a	 much	 greater	 affinity	 for	 DnaA-ATP	 (over	 DnaA-ADP)17.	 In	 order	 for	 the	 helical	 DnaA	
oligomer	 to	 form	at	 the	origin	and	 induce	DNA	unwinding,	both	strong-	and	weak-	DnaA	
boxes	need	to	bind	DnaA18,19.	In	the	E.	coli	origin	(Fig.	1.2),	DnaA-boxes	are	distributed	such	
that	the	3	strong	boxes	 lie	at	the	extreme	ends	of	the	origin	and	 in	the	centre.	As	DnaA-
ATP	recruitment	to	the	origin	has	been	shown	to	be	co-operative,	these	‘strong’-boxes	are	
thought	 to	 form	 anchoring	 points	 from	 which	 the	 DnaA	 oligomer	 can	 grow18,20.	 In	 this	
model,	 DnaA-ATP	 is	 recruited	 to	weak-sites	 via	 co-operative	 interactions	with	 DnaA-ATP	
molecules	already	bound	to	neighbouring	sites20.		
	
Figure	 1.2:	 DNA	 replication	 initiation	 at	oriC	 A)	 The	E.	 coli	 origin	 of	 replication	 (oriC)	 contains	 a	
series	of	DnaA-boxes	with	differing	affinity	for	DnaA	(R-boxes	have	the	consensus	sequence,	I	and	C	
boxes	 contain	 mismatches),	 a	 DNA	 unwinding	 element	 (DUE)	 and	 binding	 sites	 for	 accessory	
proteins	(IHF/Fis).	Figure	A	adapted	from	Leonard	and	Grimwade,	Front.	Microbiol.	6	1-13	(2015).	B)	
DnaA	recognises	binding	sites	on	oriC,	forming	a	nucleoprotein	complex	which	induces	unwinding	at	
the	DUE.	 The	DNA	helicase	and	other	 components	of	 the	 replication	machinery	are	 subsequently	
recruited.	Figure	B	adapted	from	Mott	and	Berger,	Nat.	Rev.	Microbiol.	5	343-354	(2007).	
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When	the	oligomer	has	formed	at	the	origin,	localised	strand	unwinding	occurs	at	the	DUE	
(Fig	 1.3).	 Based	 on	 structural	work	 carried	 out	with	Aquifex	 aeolicus	 DnaA,	 unwinding	 is	
thought	to	be	directly	mediated	by	the	DnaA-oligomer,	which	introduces	positive	writhe	in	
the	bound	DNA4;	compensatory	negative	writhe	at	the	DUE	could	subsequently	cause	DNA	
unwinding5,21.	Unwound	DNA	is	then	stabilised	by	binding	to	DnaA	at	a	ssDNA	binding	site	
in	its	ATPase	domain22,23.		
	
Figure	 1.3:	 Model	 of	 DNA	 replication	 initiation	 at	 oriC:	 DnaA-ATP	 forms	 a	 right-handed	 helical	
oligomer	 at	 oriC	 introducing	 positive	 writhe	 in	 the	 bound	 DNA.	 Compensatory	 negative	 writhe	
destabilises	 the	 DUE	 causing	 DNA	 unwinding.	 The	 DnaA	 ATPase	 domain	 binds	 to	 single-stranded	
DNA,	stabilising	the	unwound	DUE.	Figure	adapted	from	from	Mott	and	Berger,	Nat.	Rev.	Microbiol.	
5	343-354	(2007).		
	
Following	the	unwinding	of	the	DUE,	a	homohexameric	DNA	helicase,	DnaB,	is	loaded	onto	
single	 stranded	 DNA	 at	 the	 replication	 origin	 by	 the	 action	 of	 a	 helicase	 loader	 protein,	
DnaC.	 Loading	 of	 the	 helicase	 onto	 ssDNA	 is	 understood	 to	 occur	 via	 a	 ring-breaking	
mechanism	whereby	DnaC	 forms	 a	 spiral	 oligomer	which	 remodels	 the	 homo-hexameric	
DnaB	 ring,	 to	 produce	 a	 break	 in	 the	 ring	 which	 is	 large	 enough	 to	 allow	 loading	 onto	
ssDNA24.	 The	 DnaB-DnaC	 complex	 is	 recruited	 to	 the	 origin	 by	 DnaA.	 An	 interaction	
between	the	N-terminal	domain	of	DnaA	and	the	helicase,	DnaB9,25,26	 is	thought	to	create	
the	correct	orientation	for	 loading	of	DnaB	onto	the	bottom	strand,	whilst	an	 interaction	
between	 the	 AAA+	 domains	 of	 DnaA	 and	DnaC	 is	 thought	 to	 recruit	 the	 complex	 in	 the	
correct	orientation	for	DnaB	loading	on	the	upper	strand	(Fig.	1.4).24,27	An	interaction	with	
the	 N-terminal	 domain	 of	 DnaB	 subsequently	 recruits	 the	 primase,	 DnaG.	 Active	 primer	
formation	then	appears	 to	 induce	the	dissociation	of	DnaC,	a	step	which	 is	necessary	 for	
21	
	
DnaB	to	 function	as	an	active	helicase.	Release	of	DnaC	appears	 to	be	dependant	on	the	
ATPase	 activity	 of	 DnaC	 and	 is	 suggested	 to	 be	 induced	 by	 a	 confromational	 change	 in	
DnaB	 during	 primer	 formation28	 (DnaG	 interacts	 with	 the	 N-terminal	 domain	 of	 DnaB,	
whilst	DnaC	interacts	with	the	C-terminal	domain)29.		
The	 loading	of	 the	helicase	 is	also	 important	 for	 the	 recruitment	of	 the	DNA	polymerase	
clamp,	DnaN.	The	clamp	will,	in	turn,	recruit	the	DNA	polymerase,	ready	for	elongation29,30.			
	
Figure	1.4:	DnaC	loads	DnaB	via	a	ring	breaking	mechanism:		The	initiator	DnaA	forms	a	
helical	oligomer	during	initiation	which	associates	with	the	upper	strand	of	DNA.	Following	
unwinding	of	the	DUE,	interactions	between	DnaA	and	DnaB	or	DnaC	in	the	DnaC-DnaB	
complex		are	thought	to	correctly	orientate	DnaB	for	loading	onto	the	bottom	and	top	
strands	of	DNA,	respectively.	Figure	taken	from	Mott	et	al.	Cell	135,	623-34	(2008).					
	
1.5.2:	DNA	Replication	Initiation	in	Bacillus	
Despite	 the	 high	 conservation	 of	 replication	 initiation	 proteins	 between	 bacterial	
organisms,	significant	differences	between	bacterial	origins	have	been	observed31,	as	well	
as	differences	in	the	accessory	proteins	involved	in	initiation3.	Bacillus	subtilis,	 like	E.	coli,	
utilises	the	initiation	proteins	DnaA,	a	DnaB-like	helicase	known	as	DnaC,	a	helicase	loader,	
DnaI,	 and	 a	 primase,	 DnaG32.	 B.	 subtilis	 DnaA	 has	 also	 been	 shown	 to	 form	 helical	
oligomers	 on	 both	 double	 and	 single	 stranded	 DNA33	 and	 requires	 DnaA-ATP	 for	 co-
operative	 binding	 to	 the	 origin34.	 Bacillus	 anthracis	 DnaA	 displays	 an	 ATP-dependent	
variable	affinity	 for	DnaA-box	sequences35.	Together	these	 findings	suggest	Bacillus	DnaA	
functions	 at	oriC	 in	 a	 similar	manner	 to	E.	 coli	 DnaA.	However,	 in	 contrast	 to	 the	 single	
origin	found	in	E.	coli,		B.	subtilis	has	a	bipartite	origin	whereby	DnaA	boxes	are	located	on	
either	side	of	the	dnaA	gene	(see	section	1.9).		B.	subtilis	 initiation	also	requires	the	roles	
of	 two	 additional	 essential	 proteins,	 DnaD	 and	 DnaB32,36,	 both	 of	 which	 exhibit	 DNA	
remodelling	properties37	 and	bind	 to	 the	origin	upstream	of	helicase	 loading38;	 their	 role	
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and	architecture	is	discussed	below	in	section	1.11.	For	clarity,	essential	components	of	the	
B.	subtilis	DNA	replication	machinery	and	their	E.	coli	equivalents	are	listed	below	in	Table	
1.1.		
Table	1.1:	The	essential	DNA	replication	initiation	machinery	of	B.	subtilis	and	E.	coli	
Role	in	DNA	Replication	Initiation	 B.subtilis	 E.	coli	
Initiator	 DnaA	 DnaA	
Helicase	 DnaC	 DnaB	
DNA	Remodelling	 DnaB,	DnaD	 			_	
Helicase	Loader	 DnaI	 DnaC	
Primase	 DnaG	 DnaG	
	
Helicase	 loading	 in	B.	 subtilis	 is	 thought	 to	occur	 via	 an	 alternative	mechanism	 to	E.	 coli		
known	 as	 ring	 assembly30.	 In	 this	 model,	 DnaI	 facilitates	 the	 assembly	 of	 DnaC	 onto	
ssDNA39,40.	 This	 is	 supported	 by	 the	 fact	 that,	 in	 the	 presence	 of	 DnaI,	 hexameric	 DnaC	
shows	no	helicase	or	translocase	activity	whilst	monomeric	DnaC	shows	both	helicase	and	
translocase	activities39.	The	helicase	loader	DnaI,	like	E.	coli's	loader	protein,	contains	an	N-
terminal	helicase	interaction	domain	and	a	C-terminal	AAA+	domain41.	The	ATPase	activity	
of	 DnaI's	 C-terminal	 domain	 is	 stimulated	 in	 the	 presence	 of	 ssDNA,	 but	 only	 in	 the	
absence	of	DnaI's	N-terminal	domain.	Thus,	it	seems	that	binding	of	the	N-terminal	domain	
of	 DnaI	 to	 the	 helicase	 DnaC	 reveals	 a	 cryptic	 ssDNA	 binding	 site	 on	 the	 C-terminal	
domain40.	 It	 is	 thought	 that	 this	 can	 then	 stimulate	helicase	 loading	onto	 ssDNA	and	 the	
ATPase	activity	of	 the	C-terminal	domain	may	stimulate	the	release	of	DnaI	once	 loading	
has	occured40.		
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1.6:	The	Elongation	Phase		
During	 the	 elongation	 phase	 of	 DNA	 replication,	 DNA	 is	 processively	 synthesised	 by	 the	
action	of	a	large	multi-subunit	complex	known	as	the	replisome	(Fig.	1.4,	A).	This	consists	
of	three	DNA	polymerase	complexes,	the	helicase	(homohexamer),	primase	(assumed	from	
structural	studies	to	comprise	of	3	subunits42),	three	processivity	clamps,	DnaN	(only	two	
of	 which	 are	 associated	 with	 the	 core	 replisome)	 and	 a	 pentameric	 clamp	 loader	
complex43.		
In	E.	 coli,	 following	 initiation	 recruitment	of	 the	primase,	DnaG,	occurs	via	an	 interaction	
with	 the	helicase	DnaB;	 this	causes	 the	helicase	 loader,	DnaC,	 to	dissociate.	A	short	RNA	
primer	 is	 synthesised	by	DnaG,	 and	 the	processivity	 clamp	DnaN	 is	 loaded	by	 the	 clamp	
loader	complex,	followed	by	DNA	pol	III.	These	RNA	fragments	are	extended	by	DNA	pol	III,	
but	later	replaced	with	DNA	by	DNA	polymerase	I	and	fused	with	adjacent	DNA	fragments	
by	DNA	ligase2,44,45.		
	
Figure	1.5:	Replisome	components	in	E.	coli	and	B.	subtilis:	A)	Schematic	representation	of	the	E.	
coli	 replisome	 showing	 locations	 of	 the	 helicase,	 primase,	 DnaA	 pol	 III,	 the-β	 clamp	 and	 clamp	
loader	 (τ3δδ’)	 at	 the	 replication	 fork.	 	 B)	 Schematic	 representation	 of	 the	 B.	 subtilis	 replisome	
showing	locations	of	the	helicase,	primase,	DnaA	pol	III,	the-β	clamp	and	clamp	loader	(τ3δδ’)	at	the	
replication	 fork.	 In	 (i)	DnaE	 is	 shown	extending	 the	 initial	RNA	primer	with	DNA	and	 in	 (ii)	PolC	 is	
shown	extending	that	DNA	further	along	the	Okazaki	fragment.	Figure	adapted	from	Robinson	et	al.	
Current	Drug	Targets	13,	352–372	(2012).	
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The	 helicase	 forms	 a	 homohexameric	 ring	which	 is	 understood	 to	 sit	 at	 the	 head	 of	 the	
replication	 fork	 on	 the	 lagging	 strand	 of	 the	 template	 DNA.	 	 The	 helicase	 mechanically	
separates	dsDNA	by	translocating	along	the	lagging	strand	template	–	a	process	driven	by	
ATP-hydrolysis.		Separated	DNA	strands	are	coated	in	single-stranded	binding	protein,	SSB,	
which	 prevents	 strands	 from	 re-annealing	 and	 offers	 protection	 of	 the	 ssDNA	 from	
nucleases2,44,45.		
The	primase,	DnaG,	contains	 three	 functional	domains;	an	N-terminal	Zn-binding	domain	
(ZBD),	a	central	RNA	polymerase	domain	(RPD)	and	a	C-terminal	helicase	binding	domain.	
Three	DnaG	molecules	 associate	with	 the	N-terminal	 domain	 of	 the	 helicase,	 positioned	
such	 that	 the	 primase	 captures	 ssDNA	which	 has	 been	 newly	 unwound	 by	 the	 helicase,	
ready	 for	 primer	 formation46.	 The	 primase	 contains	 a	 ssDNA	 binding	 groove	 which	 is	
thought	 to	 interact	 non-specifically	with	 ssDNA,	 allowing	 the	 primase	 to	 track	 along	 the	
ssDNA	and	orientate	it	correctly	for	entry	into	the	active	site	in	the	RPD	(where	primers	are	
synthesised	 from	 available	 rNTPs);	 this	 also	 allows	 extrusion	 of	 the	 newly	 synthsised	
primer	 on	 the	 outside	 of	 the	 DnaB-DnaG	 complex,	 ready	 for	 handoff	 to	 SSB	 and	 DNA	
polymerase46.	Whilst	the	RPD	contains	the	catalytic	site	for	RNA	primer	synthesis,	the	ZBD	
is	 responsible	 for	 modulating	 the	 activity	 of	 the	 RPD.	 Interestingly,	 the	 ZBD	 does	 not	
regulate	 the	 activity	 of	 the	RPD	 intramolecularly	 on	 the	 same	DnaG	molecule	 in	 cis,	 but	
rather,	regulates	the	RPD	of	an	adjacent	primase	in	trans47.	A	RPD	and	ZBD	from	separate	
molecules	 recognise	 a	 single	 ssDNA	 template	 to	 intitate	 primer	 synethesis	 at	 specific	
trinuceotide	 regognition	 sites;	 with	 the	 ZBD	 increasing	 the	 catalytic	 activity	 of	 the	 trans	
RPD,	but	also	restricting	processivity	and	primer	length47.	
Strand	extension	of	the	primer	is	carried	out	by	DNA	pol	III,	which	has	a	subunit	structure	
of	αεθ	(where	α	is	the	catalytic	subunit,	ε	is	responsible	for	its	proofreading	function	and	θ	
is	a	non-essential	subunit	thought	to	stimulate	the	activity	of	ε).	It	extends	the	primer	with	
the	 assistance	 of	 the	 processivity	 clamp,	 DnaN	 (also	 known	 as	 the	 β-clamp).	 DnaN	 is	
thought	 to	 sit	 directly	 behind	DNA	pol	 III,	 and	 forms	 a	 closed	 ring	 structure	on	 the	DNA	
which	 is	 formed	of	a	homodimer	of	C-shaped	monomers.	When	binding	dsDNA,	DnaN	 is	
thought	to	minimize	its	interactions	by	binding	across	the	major	and	minor	grooves	of	DNA	
(and	not	within	the	DNA	groove),	allowing	the	protein	to	essentially	slide	along	the	DNA.	
The	β-clamp	allows	the	polymerase	to	synthesise	up	to	1000	bases	a	second2,44,45.	
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Each	 new	 lagging	 strand	 requires	 the	 loading	 of	 a	 new	 β-clamp;	 thus	 the	 clamp	 loader	
complex	forms	part	of	the	replisome	machinery.	The	clamp	loader	is	a	pentameric	complex	
of	 τ3δδ’.	 The	 τ	 subunit,	 the	 product	 of	 the	 gene	DnaX,	 forms	 interactions	with	 both	 the	
DNA	helicase	and	DNA	polymerase	III	–	this	 is	thought	to	play	an	architectural	role	at	the	
replisome	and	couple	DNA	unwinding	with	DNA	extension2,44,45.	
Elongation	in	B.	subtilis	occurs	by	a	similar	mechanism;	however	it	uses	two	different	(but	
related)	DNA	polymerases,	 PolC	 and	DnaE	 for	DNA	 synthesis	 (Fig.	 1.4,	 B).	 (DnaE	 is	more	
closely	related	to	E.	coli	DNA	pol	III	than	PolC)48.		Both	polymerases	have	been	shown	to	be	
essential	 for	 lagging	 strand	 synthesis,	 whilst	 only	 PolC	 is	 required	 for	 leading	 strand	
synthesis49.	 Both	 polymerases	 are	 able	 to	 extend	DNA	primers,	 but	 only	DnaE	 is	 able	 to	
extend	RNA	primers	produced	by	primase,	DnaG49.	During	 the	handover	of	RNA	primers,	
DnaE	 appears	 to	 form	 a	 ternary	 complex	 with	 DnaG	 and	 the	 helicase,	 DnaC50.	 In	
reconstituted	in	vitro	assays,	DnaC	acts	to	stimulate	the	activity	of	DnaG,	and	DnaE	is	able	
to	extend	very	short	primers	of	only	2	or	4	nulecotides	produced	by	DnaG;	the	abunance	of	
which	 are	 increased	 by	 the	 presence	 of	 DnaC.	 Both	 DnaC	 and	 DnaG	 were	 shown	 to	
increase	 the	 fidelity	 of	 DnaE,	 in	 a	 nucelotide-dependant	 manner50.	 DnaE	 is	 thought	 to	
subsequently	 pass	 strand	 synthesis	 over	 to	 PolC,	 which	 is	 more	 procesive49.	 This	 is	
analogous	 to	a	 system	 in	eukaryotes	where	 the	DNA	polymerase	α	extends	RNA	primers	
with	DNA,	before	the	lagging	strand	polymerase	δ	continues	DNA	synthesis44.		
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1.7:	Termination	of	DNA	replication		
1.7.1:	Termination	of	DNA	replication	in	E.	coli	
The	termination	of	DNA	replication	occurs	at	the	replication	terminus	–	a	locus	positioned	
directly	opposite	oriC.	In	E.	coli,	this	region	is	flanked	on	either	side	by	five	non-palindromic	
23-bp	 sites,	 TerA-J,	 which	 bind	 the	 monomeric	 protein	 Tus	 (Terminator	 utilisation	
substance)51–53.	 The	 orientation	 of	 these	 Ter	 sites	 dictates	 whether	 or	 not	 a	 travelling	
replication	 fork	 is	 able	 to	 pass	 the	 site	 or	 is	 halted	 in	 DNA	 replication51,53.	 Thus,	 a	
replication	 fork	 can	 bypass	 a	 Ter	 site	 unimpeded	 when	 travelling	 in	 the	 permissive	
direction,	but	 is	blocked	when	travelling	 in	 the	non-permissive	direction.	For	example,	 in	
Fig.	1.5,	A,	a	replication	fork	travelling	clockwise	would	bypass	TerH,	TerI,	TerE,	TerD	and	
TerA,	but	would	be	halted	at	TerC	 (or	failing	that,	at	TerB,	TerF,	TerG	or	TerJ).	Tus	 is	a	36	
kDa	 protein	 which	 specifically	 binds	 Ter	 sites	 in	 an	 asymmetric	 manner54	 (Fig.	 1.5,	 B);	
collision	 with	 DnaB	 (E.	 coli	 helicase)	 causes	 Tus	 to	 rapidly	 dissociate	 in	 the	 permissive	
direction,	 however	 in	 the	 non-permissive	 direction	 Tus-Ter	 forms	 a	 roadblock	 which	
prevents	the	translocation	of	DnaB	(and	thus	the	replication	fork)55.	Tus	is	has	been	shown	
to	function	like	a	‘molecular	mousetrap’	at	Ter;	the	trap	is	set	by	asymmetric	binding	of	Tus	
to	 dsDNA	 in	 the	 non-permissive	 orientation,	 and	 subsequent	 strand	 unwinding	 by	 the	
oncoming	machinery	‘triggers’	the	trap	causing	a	specific	cytosine	base	at	position	6	of	the	
Ter	site	to	flip	into	a	binding	site	on	Tus,	forming	a	‘locked’	Tus-Ter	complex	(Figure	1.5,	B)	
and	 thus	 formation	 of	 a	 roadblock	 which	 prevents	 the	 progression	 of	 the	 replication	
fork55,56.		
	
Figure	 1.6:	 Ter	 sites	 on	 the	 E.	 coli	 chromosome	 and	 the	 Tus-Ter	 complex:	 A)	 Location	 and	
orientation	of	Ter	sites	in	E.	coli:	permissive	face	shown	in	blue,	non-permissive	face	shown	in	red.	
Figure	adapted	from	Berghuis	et	al.	Nat.	Chem.	Biol.	11	579-585	(2015).	B)	Structure	of	the	Tus-Ter	
complex	showing	permissive	face	(left)	and	non-permissive	face	(right).	On	the	non-permissive	face	
a	 specific	 cytosine	base	 flips	 into	 Tus	when	dsDNA	 is	 unwound	by	 the	oncoming	 replication	 fork,	
creating	a	‘locked’	complex.	
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1.7.2:	Termination	of	Replication	in	B.	subtilis	
Replication	termination	in	B.	subtilis	also	occurs	by	a	polar	mechanism	in	which	the	Ter	site	
can	 be	 approached	 from	 a	 ‘permissive’	 or	 ‘non-permissive’	 direction.	 In	 this	 case,	 the	
binding	of	two	homodimers	of	the	replication	termination	protein	(RTP)	at	‘A’	and	‘B’	sites	
within	the	Ter	region	are	required	to	arrest	replication	(Figure	1.6,	A)57,58.	The	approach	of	
the	 replication	 machinery	 from	 the	 ‘B’	 site	 results	 in	 termination	 of	 replication	 (non-
permissive	 direction)	 whilst	 approach	 from	 the	 ‘A’	 site	 allows	 replication	 to	 continue	
(permissive	direction).	The	crystal	structure	of	a	single	dimer	bound	to	the	native	 ‘B’	site	
has	been	 shown	 to	display	 asymmetry	 in	 the	 ‘wing’	 region	of	 the	winged-helix	 domain59	
(Figure	 1.6,	 B);	 the	 protomer	 which	 would	 lie	 adjacent	 to	 the	 A-site	 shows	 a	 ‘wing-up’	
conformation,	 whilst	 the	 other	 protomer	 displays	 a	 ‘wing	 down’	 conformation,	 making	
different	 contacts	 with	 the	 dsDNA.	 This	 asymmetry	 alone	may	 provide	 a	 mechanism	 to	
allow	 ‘permissive’	 and	 ‘non-permissive’	 directions.	However,	 binding	of	 the	A	 site	 is	 also	
required	to	block	replication	fork	progression	and	binding	to	the	A-site	has	been	shown	to	
be	co-operative	following	B-site	binding60,	thus	the	molecular	mechanism	RTP	uses	to	block	
replication	progression	in	B.	subtilis	remains	unknown.		Although	the	molecular	details	of	
E.	coli	and	B.	subtilis	replication	termination	mechanisms	vary,	they	appear	to	have	evolved	
conceptually	similar	mechanisms	for	terminating	replication	in	a	direction	specific	manner.		
	
Figure	1.7:	RTP	binds	as	a	dimer	to	A	and	B	sites	in	B.	subtilis	replication	terminus	:	A)	Schematic	
image	of	two	RTP	dimers	binding	at	the	A	and	B	sites	of	the	terminus	region.	B)	Structure	of	an	RTP	
dimer	 bound	 to	 dsDNA	with	 the	 sequence	 of	 a	 B-site	 region;	 one	molecule	 displays	 a	 ‘wing	 up’	
conformation	(adjacent	to	the	A	site)	and	the	other	a	‘wing	down’	conformation.		
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1.8:	Regulation	of	DNA	Replication	
DNA	 replication	 is	 tightly	 regulated	 to	 ensure	 that	 it	 occurs	 in	 an	 accurate	 and	 timely	
manner,	only	once	per	cell	 cycle.	Over-	or	under-replication	of	 the	organism's	genome	 is	
detrimental	 to	 the	 organism's	 survival.	 Under-replication	 leads	 to	 cells	 which	 may	 be	
missing	vital	genetic	information,	whilst	over-replication	can	lead	to	wasted	resources	and	
dysregulation	of	other	cellular	processes.	The	regulation	of	DNA	replication	occurs	mainly	
at	 the	 initiation	 phase,	 during	 or	 prior	 to	 the	 recruitment	 of	 the	 replication	 machinery	
(once	elongation	commences	it	will	progress	in	a	largely	uncontrolled	manner).	Regulatory	
mechanisms	 typically	 affect	 the	 ability	 of	 DnaA	 to	 form	 a	 nucleoprotein	 complex	 at	 the	
replication	origin.	Thus,	an	understanding	of	replication	origins	and	the	proteins	involved	in	
replication	 initiation	 is	 important	 for	 understanding	 regulatory	 mechanisms	 of	 DNA	
replication;	these	will	first	be	covered	in	more	detail	below.		
	
1.9:	Replication	Origins	
Regulation	 of	 DNA	 replication	 often	 involves	 the	 prevention	 of	 DnaA	 or	 other	 initiation	
proteins	 from	 binding	 the	 origin	 (i.e.	 prevention	 of	 orisome	 formation)61,62.	 Thus,	
understanding	 of	 replication	 origins	 is	 of	 significance	 to	 our	 understanding	 of	 how	
replication	 is	 regulated31.	 Despite	 this,	 our	 knowledge	 of	 replication	 origins	 is	 relatively	
limited.	 The	 replication	 origins	 of	 many	 species	 have	 been	 predicted	 by	 computational	
programs,	however	only	a	few	of	these	have	been	functionally	confirmed	in	vivo;	of	these,	
the	origins	vary	significantly	in	length,	sequence	and	organisation	(e.g.	number	and	spacing	
of	 DnaA-boxes	 and	 the	 location	 of	 unwinding	 elements)31,63.	 Conserved	 features	 of	
replication	origins	 include	 the	presence	of	DnaA-box	 clusters,	 a	DNA	unwinding	 element	
(DUE)	and	locations	for	the	binding	of	regulatory	proteins31.	
The	location	of	the	replication	origin	and	its	gene	context	is	well	conserved	across	bacterial	
species,	with	most	 flanked	 by	 (or	 containing)	 the	dnaA	 gene32,64.	 The	 genes	 surrounding	
oriC	and	dnaA	are	typically	also	well	conserved	with	oriC	residing	in	one	or	two	intergenic	
regions32.	Origins	are	described	as	either	continuous	or	bipartite	depending	on	whether	all	
of	their	functional	elements	are	found	within	one	or	two	intergenic	regions.	For	example,	
the	 origins	 of	 B.	 subtilis	 and	H.	 pylori	 (Fig.	 1.7)	 are	 bipartate,	 containing	 two	 DnaA-box	
clusters,	 separated	by	 the	dnaA	 gene65,66.	E.	 coli	 is	 representative	of	a	 continuous	origin,	
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but	 unusually,	 the	 E.	 coli	 origin	 has	 undergone	 a	 major	 rearrangement	 resulting	 in	 a	
translocation	 of	 the	 origin	 44	 kb	 away	 from	 the	dnaA	 gene	 (and	 surrounding	 context)64.	
This	suggests	that	B.	subtilis	may	provide	a	better	model	for	bacterial	replication	origins	in	
general;	 representing	 a	 more	 primordial	 origin	 with	 conserved	 gene	 context32.	 The	
bipartate	 origin	 structure	 in	 B.	 subtilis	 has	 been	 shown	 to	 be	 important	 for	 proper	
replication	 initiation,	 however,	 the	 region	 could	 be	 shortened	 considerably65.	 Notably,	
during	replication	initiation,	B.	subtilis	 forms	looped	structures	which	are	thought	to	be	a	
consequence	of	the	bipartite	nature	of	its	origin67.	
	
Figure	1.8:	The	bipartite	replication	origins	of	B.	subtilis	and	H.	pylori:	In	these	origins,	two	clusters	
of	DnaA-boxes	are	separated	by	the	dnaA	gene	and	the	DUE	lies	at	the	end	of	one	of	the	DnaA-box	
clusters.	Figure	adapted	from	Wolanski	et	al.	Front.	Microbiol.	5	1-14	(2015).	
	
One	 conserved	 feature	 of	 replication	 origins	 is	 the	 existence	 of	 a	 series	 of	 recognition	
sequences	(or	‘affinity	boxes’)	for	DnaA;	although	the	number	and	spacing	of	DnaA-boxes	
varies	between	organisms	and	in	some	more	distantly	related	species	DnaA-box	consensus	
binding	 sequences	 are	 different31.	 In	 organisms	 where	 they	 have	 been	 characterised,	
DnaA-boxes	are	9	base	pair	elements,	with	the	exception	of	a	12	base	pair	box	identified	in	
Thermotoga	 maritima31.	 All	 boxes	 share	 a	 conserved	 core	 sequence,	 and	 most	 deviate	
from	the	E.	coli	consensus	by	only	one	or	two	bases31	(NB:	B.	subtilis	and	E.	coli	share	the	
same	consensus	box	sequence	of	5’-TTATCCACA-3’12).		
DnaA-box	 spacing	 and	 orientation	 have	 been	 shown	 to	 be	 important	 for	 replication	
initiation	 in	 E.coli62	 (e.g.	 altering	 box-spacing	 by	 part	 of	 a	 helical	 DNA	 turn	 is	 highly	
detrimental	 to	 initiation,	 whilst	 altering	 by	 a	 single	 turn	 is	 without	 effect68).	 DnaA-box	
spacing	preferences	have	also	been	observed	for	other	bacteria	(e.g.	preferring	two	closely	
spaced	boxes	over	a	single	box)63,69.	The	affinity	of	DnaA	for	DnaA-boxes	within	the	origin	
may	vary,	as	is	seen	in	E.	coli	and	C.	crescentus18.	In	E.	coli	the	presence	of	high-	and	low-	
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affinity	boxes	 is	an	essential	 feature	for	orisome	formation18,20.	 It	 is	not	known	if	this	 is	a	
conserved	mechanism	for	orisome	formation	across	other	bacterial	species.		
Another	 conserved	 feature	 of	 replication	 origins	 is	 the	 presence	 of	 DNA	 unwinding	
elements.	 These	 are	 AT-rich	 sequences	 which	 typically	 contain	 13-nucleotide	 repeat	
sequences70.	 These	 regions	 are	 noticeably	 AT-rich	 compared	 to	 neighbouring	 sequences,	
giving	 them	reduced	thermo-stability.	DUEs	are	always	 located	up-	or	down-	stream	of	a	
DnaA	 box	 cluster	 and	 proper	 spacing	 between	 the	 DUE	 and	 its	 neighbouring	 DnaA-box	
cluster	is	essential	for	DNA	unwinding70.		
Although	bacterial	origins	differ	in	their	composition,	all	origins	harbour	sequences	which	
direct	the	formation	of	replication	complexes,	DNA	unwinding	and	regulatory	activities	 in	
their	own	species.	Cognate	DnaA	proteins	and	replication	origins	have	likely	co-evolved	to	
optimise	 their	 interactions,	 creating	 genus	 and	 species	 specific	 instructions	 for	 the	
initiation	of	DNA	replication31.		
	
1.10:	DnaA:	Structure	and	Function			
The	 DNA	 replication	 initiator	 protein,	 DnaA,	 is	 responsible	 for	 the	 recognition	 of	 DnaA-
boxes	 at	 the	 replication	 origin,	 forming	 a	 nucleoprotein	 complex	 whereby	 a	 helical	
oligomer	 of	 DnaA	 self-associates	 and	 induces	 a	 localised	 unwinding	 at	 the	 origin	 DUE,	
which	leads	to	the	recruitment	of	the	DNA	helicase	and	further	replication	machinery.	
DnaA	 is	 a	member	 of	 the	AAA+	ATPase	 family,	 containing	 four	 distinct	 domains71,72	 (Fig.	
1.8,	 A).	 The	 N-terminal	 domain	 I	 is	 an	 ‘interaction	 domain'	 which	 has	 been	 shown	 to	
interact	with	various	protein	regulators	of	DnaA	across	different	organisms	and	is	thought	
to	play	a	role	in	the	self-assembly	of	DnaA	at	the	origin.	In	E.	coli,	it	also	interacts	with	the	
helicase,	 DnaB.	 Domain	 II	 is	 a	 poorly	 conserved	 flexible	 linker	 of	 variable	 length,	 whilst	
domain	III	contains	Walker	A	and	B	type	ATPase	motifs	capable	of	binding	and	hydrolysing	
ATP.	 Domain	 III	 also	 plays	 a	 role	 in	 self-interaction/oligomer	 formation	 and	 in	 ssDNA	
binding.	 The	 C-terminal	 domain	 IV	 is	 a	 dsDNA	 binding	 domain	 which	 is	 responsible	 for	
DnaA-box	 recognition	 at	 the	 origin.	 Since	 its	 discovery,	 DnaA	 has	 been	 the	 subject	 of	
mutational	 and	 structural	 studies	 which	 have	 led	 to	 our	 current	 understanding	 of	 its	
function.	The	outcome	of	these	studies,	focusing	on	each	of	DnaA’s	domains	in	turn,	will	be	
described	below.		
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Figure	1.9:	DnaA	has	four	functional	domains	:	A)	Domain	structure	of	DnaA.	B)	DnaA	Domain	I	has	
a	KH-domain	fold	similar	to	that	found	in	some	ssDNA	binding	proteins.		
	
1.10.1:	DnaA	Domain	I	
DnaA	 Domain	 I	 has	 a	 K	 homology	 (KH)-domain	 fold	 typically	 found	 in	 ssDNA	 binding	
proteins26,73,74	(Fig	1.8,	B).	Domain	I	is	reported	to	play	a	role	in	the	oligomerisation	of	DnaA	
at	oriC	75,76	and	in	E.	coli,	it	interacts	with	the	helicase	DnaB77–79	where	it	is	thought	to	help	
correctly	orientate	the	loading	of	DnaB	at	the	origin.	Domain	I	has	been	recently	termed	an	
‘interaction	 hub’	 because	 in	 addition	 to	 the	 helicase,	 various	 protein	 regulators	 from	
different	 organisms	 have	 been	 shown	 to	 interact	with	 the	 domain.	 These	 include	 E.	 coli	
DiaA80	 and	H.	 pylori	 HobA81	 -	 structural	 homologues	 and	 promoters	 of	 initiation	 in	 their	
respective	organisms	and	two	negative	regulators	of	initiation:	E.	coli	Hda82	and	B.	subtilis	
SirA83	(see	sections	1.13	and	1.14).	DnaA	Domain	I	has	been	shown	to	have	a	weak	affinity	
for	single-stranded	oriC	DNA	but	not	poly(dT)	DNA	suggesting	some	sequence	specificity	to	
its	binding26.	However,	no	ssDNA	binding	role	has	been	shown	for	DnaA	in	vivo.	
	
1.10.2:	DnaA	Domain	II	
NMR	studies	suggest	that	domain	II	 is	unstructured	and	acts	as	a	flexible	tether	between	
domains	 I	 and	 III.	 It	 is	 not	 completely	 dispensable	 for	 DnaA	 function,	 but	 it	 is	 poorly	
conserved	 and	 varies	 significantly	 in	 length	 between	 organisms72.	 One	 study	 in	 E.	 coli	
showed	that	deletions	of	30-36	residues	could	be	made	at	several	positions	along	domain	
II	 (defined	 here	 as	 residues	 79-135)	 without	 loss	 of	 cell	 viability,	 indicating	 that	 21-27	
residues	 is	 the	 minimum	 domain	 II	 length	 needed	 for	 DnaA	 functionality,	 and	 that	 no	
specific	 residues	 are	 required84.	 	 The	authors	did	however	note	 that	deletion	of	 30	base	
pairs	 or	more	 increases	 the	 doubling	 time	 of	 cells	 compared	 to	 wildtype,	 and	 it	 is	 only	
shorter	 deletions	 (17-19	 residues)	 which	 show	 a	 phenotype	 indistinguishable	 from	
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wildtype.	 Consistent	 with	 this	 observation,	 another	 study	 suggests	 that	 domain	 II	 is	
important	 for	 replication	 efficiency,	 as	 spontaneous	mutations	 causing	 a	 deletion	within	
DnaA	domain	II	were	able	to	suppress	a	strain	which	showed	poor	growth	due	to	an	over-
initiation	 phenotype85.	 In	 this	 study,	 E.	 coli	 cells	 lacking	 a	 regulator	 of	 DNA	 replication	
(SeqA)	display	slow	growth	and	small	colony	formation,	as	well	as	severe	over-initiation.	A	
deletion	mutation	within	DnaA	domain	II	restored	near-wildtype	growth	and	DNA	content.	
This	 behaviour	 mimics	 that	 of	 a	 deletion	 mutant	 of	 a	 stimulator	 of	 initiation	 (DiaA),	
suggesting	that	domain	II	is	playing	a	role	in	replication	efficiency85.			
It	seems	likely	that	the	spacer	is	required	to	allow	DnaA	to	adopt	the	correct	conformation	
for	 initiation84;	 this	 would	 naturally	 play	 a	 role	 in	 replication	 efficiency.	 	 Although	 the	
spacer	must	be	21-27	residues	long	in	E.	coli,	this	number	is	likely	to	differ	in	other	species	
where	domain	II	has	a	highly	variable	length.	One	interesting	theory	is	that	domain	II	size	
may	 be	 related	 to	 the	 spacing	 of	 DnaA-boxes	 within	 the	 origin,	 with	 greater	 spacing	
between	DnaA-boxes	 requiring	 a	 longer	 domain	 II	 63.	 If	 this	 is	 the	 case,	 perturbations	 in	
domain	II	size	could	affect	the	oligomerisation	efficiency	of	DnaA	–	and	hence	the	overall	
replication	efficiency.	However,	further	understanding	of	both	the	minimum	domain	II	size	
of	other	species’	DnaA	proteins	and	of	DnaA-box	spacing	at	replication	origins	is	required	
to	draw	any	meaningful	conclusions	about	this	relationship.		
	
1.10.3:	DnaA	Domains	III-IV	
Domain	 IV	of	DnaA	 is	 responsible	 for	 the	 recognition	of	DnaA-boxes	at	 the	origin86.	 In	E.	
coli,	DnaA	has	the	highest	affinity	for	the	9	base	pair	consensus	sequence	5’-TTATNCACA-3’	
87.	An	X-ray	structure	of	domain	IV	bound	to	a	consensus	sequence	DnaA-box	revealed	that	
this	 interaction	 is	mediated	by	a	helix-turn-helix	motif,	which	 interacts	primarily	with	the	
major	groove	of	the	dsDNA.	Additional	contacts	are	also	made	 in	the	minor	groove88	 (Fig	
1.9,	A).		Base	specific	interactions	could	be	observed	at	8	of	the	9	base	pairs	in	the	DnaA-
box;	the	exception	being	the	base	pair	at	position	5,	which	has	no	specific	base	associated	
with	 the	 consensus	 binding	 motif.	 In	 the	 major	 groove,	 residues	 in	 helices	 4	 and	 5	 of	
Domain	IV	make	base	specific	interactions	with	T4,	C6,	A7,	G8*	and	T9*	(where	*	indicates	
a	 base	 on	 the	 3’	 to	 5’	 strand).	 In	 the	minor	 groove,	 a	 specific	 arginine	 residue	 (Arg399)	
makes	several	base-specific	 interactions;	A2*	forms	a	direct	H-bond	with	the	Arg399	side	
chain,	 and	 interactions	 with	 A1*,	 T2	 and	 T3*	 and	 Arg399	 are	 mediated	 via	 water	
molecules.	Many	 interactions	 are	 also	 formed	with	 backbone	 phosphate	 groups	 in	 both	
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major	 and	minor	 grooves88.	 	Mutations	 at	 residues	 involved	 in	 base-specific	 interactions	
result	 in	 loss	 of	 DnaA-box	 binding	 specificity,	 or	 eliminate	 DNA-binding	 completely89.	
Binding	of	domain	IV	introduces	a	local	kink	of	28°	into	the	DNA,	which	may	be	significant	
for	assisting	DNA-unwinding88.		
Domain	III	of	DnaA	contains	two	distinct	structural	regions	which	are	referred	to	as	domain	
IIIa	 and	 IIIb.	 Domain	 IIIa	 has	 an	 αβ-structure	 and	 contributes	 to	 nucleotide	 binding	 via	
Walker	A,	Walker	B	and	sensor	I	sequence	motifs.	Domain	IIIb	has	a	helical	structure	and	
contains	the	sensor	II	motif,	which	is	also	important	in	nucleotide	binding.	This	structure	is	
typical	 of	AAA+	ATPases90,91.	Unusually	however,	 a	 crystal	 structure	of	ATP-	bound	DnaA	
domains	 III-IV	 (using	a	non-hydrolysable	ATP	analogue)	shows	that	DnaA	adopts	an	open	
spiral	 conformation5	 contrary	 to	 the	 planar	 ring	 conformations	 adopted	 by	 many	 AAA+	
family	ATPases90	(Fig.	1.9,	B).		DnaA’s	spiral	conformation	is	a	right-handed	helical	filament,	
the	 formation	 of	 which	 is	 ATP-dependent	 and	 likely	 mimics	 the	 oligomer	 DnaA	 forms	
during	 initiation	 at	 the	 origin4.	 	 Adjacent	 protomers	 interact	 with	 one	 another	 via	 two	
clusters	of	conserved	residues	located	on	either	side	of	the	nucleotide	binding	pocket5.		
Crucially	for	DnaA’s	function,	DnaA-ADP	cannot	form	the	right-handed	oligomer	displayed	
by	DnaA-ATP4,	and	 this	 can	be	accounted	 for	by	a	comparison	of	 their	 structures.	Whilst	
DnaA-ATP	shows	an	open	spiral	conformation5,	DnaA-ADP	appears	to	be	a	monomer92.		A	
small	but	significant	conformational	change	occurs	upon	ATP	binding:	repositioning	of	the	
‘lid’	in	domain	IIIb.	This	appears	to	be	mediated	by	interactions	which	are	formed	between	
the	 sensor	 II	 arginine	 and	 the	 γ-phosphate	 of	 the	 nucleotide.	 This	 opens	 the	 ATPase	
domain	to	allow	a	helix	 from	an	adjacent	promoter	 to	 interact	with	 the	bound	ATP	via	a	
conserved	arginine	residue,	which	seems	to	be	an	important	factor	for	stabilising	the	DnaA	
helical	 filament5.	 	 This	 ‘arginine	 finger’	 interaction	 is	 conserved	 across	 other	 AAA+	
ATPases93.		
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Figure	 1.10:	 DnaA	 domains	 III	 and	 IV:	 DnaA-box	 recognition	 and	 self-oligomerisation:	 A)	DnaA	
Domain	IV	bound	to	a	DnaA-box	motif;	DnaA	makes	base	specific	interactions	with	8	of	the	9	DnaA-
box	 bases.	 B)	 DnaA	 Domains	 III-IV	 bound	 to	 a	 non-hydrolysable	 ATP	 analogue,	 form	 a	 spiral	
structure	which	 is	 thought	 to	mimic	DnaA	oligomerisation	at	 the	origin.	Domain	 III	 is	displayed	 in	
green;	Domain	IV	is	in	light	blue.		
	
Comparison	 of	 the	 Domain	 IV-DnaA-box	 binding	 modes	 and	 the	 domain	 III-IV	 structure	
suggests	that	a	conformational	change	must	occur	at	the	linker	helix	between	domains	III	
and	 IV	 for	 dsDNA	 binding	 to	 be	 compatible	 with	 helical	 filament	 formation88,94.	 	 A	
significant	kink	in	the	linker	helix	is	observed	in	the	ATP-bound	structure	compared	to	the	
ADP	 bound	 form	 (where	 the	 helix	 is	 straight)	 suggesting	 that	 the	 two	 domains	 are	
‘conformationally	 uncoupled’	 and	 must	 rotate	 with	 respect	 to	 one	 another	 to	 allow	
filament	formation	at	the	origin5.		
A	structure	showing	DnaA	domain	III’s	ssDNA-binding	mode	(also	ATP-bound)	displays	the	
same	 spiral	 conformation	 as	 that	 seen	 for	 ATP-bound	 DnaA23	 (Fig	 1.10,	 A).	 In	 this	 case,	
each	 DnaA	 protomer	 binds	 3	 nucleotides,	 making	 many	 interactions	 with	 the	 DNA	
phosphodiester	 backbone.	 Each	 nucleotide	 triplet	 displays	 a	 normal	 B-form	 DNA	
conformation,	 but	 the	 triplets	 are	 separated	 by	 gaps	 of	 approximately	 10	 Å	 creating	 an	
overall	extended	form	of	DNA23	(Fig.	1.10,	B).	This	strand	extension	was	been	shown	to	be	
ATP	 dependent	 in	 solution	 and	 is	 highly	 reminiscent	 of	 ssDNA	 binding	 displayed	 by	 the	
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homologous	 recombination	 protein,	 RecA.	 The	 third	 base	 of	 each	 triplet	 is	 rotated	
however,	making	bases	in	the	DnaA-bound	strand	discontiguous;	this	presumably	prevents	
re-annealing	of	the	strand	at	the	origin23	(Fig.	1.10,	C).		DnaA	is	able	to	directly	melt	DNAs	
of	moderate	stability,	enabling	localised	unwinding	at	the	DUE.	It	is	likely	to	be	assisted	in	
unwinding	at	the	origin	by	DNA	remodelling	proteins	(known	to	play	a	role	in	initiation).	It	
is	as	yet	unclear	how	DnaA	co-coordinates	both	double	and	single-stranded	DnaA	binding	
modes	for	nucleoprotein	filament	formation	and	dsDNA	unwinding	at	the	DUE95.			
	
	
Figure	1.11:	ssDNA	binding	by	DnaA	domains	III-IV:	A)	ssDNA-binding	mode	of	DnaA	domains	III-IV.	
Domain	III	mediates	ssDNA	DNA-binding.	Domain	III	is	in	green,	domain	IV	in	light	blue,	and	ssDNA	
in	red.	B)	ssDNA	binding	by	DnaA	stretches	the	strand	into	an	extended	form	compared	to	B-form	
DNA.	 C)	 Diagram	 showing	 how	 bound	 ssDNA	 (yellow)	 would	 pair	 with	 B-form	 DNA	 (red)	 when	
bound	to	DnaA	and	RecA.	DnaA	binds	ssDNA	so	that	triplets	of	bases	are	non-contiguous,	assumed	
to	prevent	re-annealing	of	the	strand	at	the	origin.	(B)	and	(C)	were	adapted	from	Duderstadt	et	al.,	
Nature	478,	209–213	(2011).	
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1.11:	B.	subtilis	Initiation	Proteins	DnaD	and	DnaB	
Besides	DnaA,	DnaC	(equivalent	to	E.	coli	DnaB),	DnaI	and	DnaG,	DNA	replication	initiation	
in	B.	subtilis	requires	the	presence	of	two	additional	essential	proteins,	DnaD	and	DnaB32.	
Both	DnaD	and	DnaB	are	components	of	the	replication	initiation	machinery	at	oriC36	and	
of	 the	 replication	 restart	 machinery	 (DnaA-independent)96.	 Both	 proteins	 exhibit	 DNA	
remodelling	 activities37	 and	 share	 structural	 similarity97.	 B.	 subtilis’	 initiation	 machinery	
assembles	in	a	specific	hierarchical	manner,	with	DnaD	and	DnaB	required	between	DnaA	
binding	 at	 oriC	 and	 the	 loading	 of	 the	 helicase,	 DnaC38.	 DnaD	 is	 recruited	 after	 DnaA,	
forming	 a	 direct	 interaction	 with	 DnaA	 (and	 itself)98.	 DnaD	 is	 in	 turn	 required	 for	 the	
recruitment	of	DnaB,	which	then	recruits	DnaC-DnaI38	and	is	thought	to	function	as	a	dual	
helicase	loader39.		
The	exact	roles	of	DnaD	and	DnaB	in	replication	initiation	remain	somewhat	unclear.	DnaD	
displays	DNA	remodelling	properties,	able	to	untwist	supercoiled	DNA	into	an	open	looped	
form99.		It	forms	tetramers	which	can	assemble	into	large	protein	scaffolds	that	appear	to	
mediate	DNA	 loop	 formation	and	enhance	melting	of	dsDNA100.	Although	 the	N-terminal	
domain	 (DDBH1)	 of	 DnaD	 is	 implicated	 in	 tetramer	 formation101,102	 and	 the	 C-terminal	
domain	(DDBH2)	in	both	double-	and	single-stranded	DNA	binding100,102.	Full-length	protein	
is	 required	 for	 DnaD	 to	 exhibit	 DNA	 remodelling	 activity	 (i.e.	 DNA	 looping	 and	
melting)100,102.	 Furthermore,	 the	 abundance	 of	DnaD	 in	 the	 cell	 (estimated	 at	 3000-5000	
molecules103)	has	 led	to	 the	suggestion	that	DnaD	plays	a	global	 role	 in	DNA	remodelling	
(beyond	that	required	for	DNA	replication	initiation)37.		This	is	supported	by	a	recent	study	
showing	 that	 DNA	 remodelling	 by	 DnaD	 stimulates	 DNA	 repair	 by	Nth	 endonucleases	 in	
response	to	DNA	damage	by	treatment	with	H2O2104.		
It	 is	 generally	 thought	 that	DnaB	acts	 together	with	DnaI	 to	enable	 that	 loading	of	DnaC	
onto	 forked	 DNA39.	 However,	 a	 study	 by	 Ioannou	 et	 al.40	 suggests	 that	 DnaI	 alone	 is	
sufficient	to	load	the	helicase	onto	DNA.	DnaB	is	however	required	to	recruit	DnaC-DnaI	to	
the	 origin38	 and	 has	 been	 shown	 to	 stimulate	 the	 helicase	 and	 translocase	 activities	 of	
DnaC	 in	the	presence	of	DnaI39;	 thus	 it	certainly	assists	with	helicase	function.	 It	has	also	
been	 implicated	 in	 association	 of	 the	 DNA	 replication	 machinery	 with	 the	 cell	
membrane105,106	and	additionally,	has	been	shown	to	laterally	compact	DNA	-	although	it	is	
unknown	how	this	contributes	to	its	function37.		
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Although	DnaD	and	DnaB	show	 little	 sequence	similarity,	analysis	using	a	hidden	markov	
model	 technique	 identified	 two	 shared	 domains	 known	 as	 DDBH1	 and	 DDBH2.	 DnaD	
displays	 a	 DDBH1-DDBH2	 architecture,	 whilst	 DnaB	 has	 a	 DDBH1-DDBH2-DDBH2	
architecture97	 (Fig.	 1.11,	 A).	 	 The	 structure	 of	 the	 DDBH1	 domain	 of	 DnaD	 revealed	 a	
winged	helix	domain	with	two	additional	structural	elements:	an	N-terminal	helix-strand-
helix	 and	 a	 C-terminal	 helix101	 (Fig.	 1.11,	 C).	 The	 β-strand	 of	 the	 helix-strand-helix	 was	
found	 to	 mediate	 interactions	 between	 DnaD	 molecules	 in	 both	 dimer	 and	 tetramer	
interactions	(Fig	1.11,	C).	The	C-terminal	helix	has	been	shown	to	be	important	in	higher-
order	 oligomerisation	 (between	 tetramers)101.	 	 These	 structural	 elements	 appear	 to	 be	
present	 in	DnaB	DDBH197	and	DnaB	has	also	been	shown	to	form	tetramers	mediated	by	
its	N-terminus37,	suggesting	that	DnaB	and	DnaD	share	similar	oligomerisation	properties.		
	
Figure	1.12:	Architecture	of	DnaD	and	DnaB:	A)	Diagram	showing	architecture	of	DnaD	and	DnaB.	
Conserved	DNA	binding	motif	YxxxIxxxW	is	marked	on	the	relevant	DDBH2	domain.	Image	adapted	
from	 Briggs	 et	 al.	 (2012)32.	 B)	 Ribbon	 diagram	 of	 the	 DnaD	 DDBH2	 domain	 from	 Streptococcus	
mutans	(PDB	code:	2ZC2).	Tyrosine,	Isoleucine	and	Tryptophan	residues	of	the	YxxxIxxxW	motif	are	
coloured	by	atom	(carbon	in	green,	nitrogen	in	blue	and	oxygen	in	red).		C)	Ribbon	diagram	of	DnaD	
DDBH1	 domain	 from	 Bacillus	 subtilis	 (PDB	 code:	 2V79)	 showing	 a	 winged	 helix	 with	 additional	
structural	elements;	typlical	winged	helix	architecture	is	shown	in	darker	colours	(blue,	green)	and	
additional	 structural	 elements	 are	 shown	 in	 lighter	 colours.	 I)	 Monomer	 of	 DDBH1;	 II)	 Dimer	 of	
DDBH1	and	III)	Tetramer	of	DDBH1.	Dimer	and	tetramer	interactions	are	mediated	by	the	β-strand	
of	the	additional	helix-strand-helix.		
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The	DDBH2	domain	of	DnaD	has	been	shown	to	be	 involved	 in	DNA-binding	and	 in	DNA-
dependent	 higher-order	 oligomerisation102.	 	 Two	 structures	 deposited	 by	 the	 Midwest	
Center	 for	 Structural	 Genomics	 of	 the	 DDBH2	 domain	 of	 DnaD	 homologues	 from	
Streptococcus	mutans	(PDB	code:	2ZC2)	and	Enterococcus	faecalis	(PDB	code:	2I5U)	show	a	
compact	helical	structure	with	four	 longer	helices	 I-IV	and	a	short	 fifth	helix	 (V)	of	only	4	
residues	(Fig.	1.11,	B).	Although	residues	after	this	point	are	poorly	conserved	across	DnaD	
homologs,	secondary	structure	prediction	and	analysis	of	the	Bacillus	subtilis	DnaD	DDBH2	
domain	 by	 NMR	 suggests	 that	 helix	 V	 is	 longer	 than	 that	 shown	 in	 either	 of	 the	 X-ray	
structures,	 extending	 it	 by	 another	 7	 residues97.	 This	 final	 helix	 (V)	 is	 followed	 by	 a	
disordered	 region	 at	 the	 C-terminus.	 Structural	 elements	 which	 have	 been	 found	 to	 be	
important	 for	 ssDNA	 binding	 are	 a	 YxxxIxxxW	 motif	 residing	 in	 helix	 IV,	 the	 poorly	
conserved	 helix	 V	 and	 the	 C-terminal	 unstructured	 region97.	 These	 structural	 elements	
appear	 to	be	conserved	 in	 the	second	of	 the	DDBH2	domains	of	DnaB97,	which	has	been	
implicated	 in	 both	 ds-	 and	 ss-	 DNA	binding	 and	 in	 higher-order	 oligomerisation107;	 again	
suggesting	that	the	domains	play	similar	roles.		
A	fragment	containing	DnaB	DDBH1-DDBH2	(residues	1-300	without	the	C-terminal	DDBH2	
domain)	mediates	tetramer	formation,	and	is	also	able	to	bind	ssDNA,	suggesting	the	first	
DDBH2	 domain	may	 have	 evolved	 to	 bind	 only	 ssDNA97,107.	 Interestingly,	 the	 function	 of	
DnaB	appears	to	be	mediated	by	proteolysis	from	its	C-terminus	as	truncated	versions	of	
the	protein	are	seen	 in	the	cytosol	during	the	mid-late	growth	phase	(i.e.	not	membrane	
associated).	 Only	 full	 length	 DnaB	 is	 observed	 at	 oriC,	 thus	 proteolysis	 appears	 to	 be	
regulating	DnaB’s	 function.107	 It	 is	unclear	however	whether	 the	truncated	version	of	 the	
protein	has	 its	own	 function,	or	 if	 its	purpose	 is	 solely	 in	 self-regulation.107	Nevertheless,	
the	different	DNA	binding	capabilities	of	the	DDBH2	domains	of	DnaB	may	be	important	in	
differentiating	the	functions	of	the	full-length	and	truncated	versions	of	DnaB.			
It	 has	 been	 previously	 noted	 that	 the	 requirement	 of	 two	 additional	 proteins	 in	Bacillus	
subtilis’	 initiation	 of	 DNA	 replication,	 and	 their	 sequential	 recruitment	 at	 oriC,	 provides	
additional	opportunities	 for	 the	 regulation	of	 replication	 initiation	–	with	opportunity	 for	
regulators	to	inhibit	protein-protein	interactions	at	each	stage	of	initition38.	Recent	studies	
suggest	that	DnaD	itself	may	indeed	play	a	role	in	regulating	DNA	replication	initiation	as	it	
has	 been	 found	 to	 affect	 the	 formation	 of	 the	 DnaA	 filament	 at	 oriC.108,109	 (see	 section	
1.14.3).	
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1.12:	Regulation	of	DNA	Replication	Initiation	
It	 has	 long	 been	 recognised	 that	 DNA	 replication	 initiation	 is	 coupled	 to	 the	 cell	 cycle,	
ensuring	 that	 the	 frequency	 of	 genome	 duplication	 coordinates	with	 the	 rate	 of	 cellular	
growth110.	In	rapidly	dividing	cells,	DNA	replication	increases	in	frequency	to	support	rapid	
growth110.	 Although	 the	 link	 between	 replication	 rate	 and	 cell	 cycle	 is	 well	 recognised,	
nutrient	mediated	regulatory	control	 is	not	well	understood111.	 It	was	previously	 thought	
that	 the	 cellular	 concentration	 of	 DnaA	 acted	 as	 a	 limiting	 factor	 for	 the	 rate	 of	 DNA	
replication	 initiation112,113.	 However,	 recent	 studies	 in	 both	 B.	 subtilis	 and	 E.	 coli	 have	
suggested	 that	 increasing	 DnaA	 concentration	 alone	 is	 not	 enough	 to	 trigger	 DNA	
replication	 initiation113,114.	 Nutrient	 mediated	 growth	 rate	 regulation	 was	 found	 to	 be	
dependent	 on	 both	 DnaA	 and	 oriC	 in	 B.	 subtilis114	 and	 there	 appear	 to	 be	 multiple	
regulatory	mechanisms	for	coupling	growth	rate	with	replication;	links	with	central	carbon	
metabolism,	respiration,	fatty	acid	synthesis,	phospholipid	synthesis	and	protein	synthesis	
were	all	reported114.			
	
1.12.1:	DnaA	Acts	as	a	Transcription	Factor	
DnaA	 is	 known	 to	 act	 as	 a	 transcription	 regulator	 in	 E.	 coli115,	 B.	 subtilis116	 and	 C.	
cresentus117.	 It	has	been	shown	to	act	 in	the	auto-regulation	of	the	dnaA	gene	promoter,	
reducing	 expression	 of	 DnaA	 when	 it	 is	 highly	 abundant	 in	 the	 cell118.	 It	 has	 also	 been	
shown	to	regulate	the	expression	of	many	other	genes	in	E.	coli	and	B.	subtilis115,116	and	a	
study	 into	 B.	 subtilis	 transcription	 regulation	 suggested	 that	 many	 DnaA-binding	 sites	
utilised	 for	 transcription	 regulation	 in	 B.	 subtilis	 are	 conserved	 in	 other	 organisms116.	
Furthermore,	 transcription	 regulation	 in	 B.	 subtilis	 responds	 to	 replication	 status	 to	
maintain	 cell	 viability	 (i.e.	 perturbations	 in	 replication	elongation	or	 initiation	 resulted	 in	
transcription	 regulation	 to	 inhibit	 cell	 division	 and	 maintain	 cell	 integrity)116,119.	 This	
provides	 the	 cell	 with	 a	mechanism	 to	 couple	 DNA	 replication	 and	 the	 cell	 cycle.	 DnaA	
transcription	mediated	coupling	of	replication	with	the	cell	cycle	has	also	been	observed	in	
C.	cresentus117,120.	These	mechanisms	are	currently	poorly	understood,	but	are	likely	to	play	
an	important	role	in	the	coupling	of	DNA	replication	to	the	cell	cycle.		
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1.12.2:	Species	Specific	DNA	Replication	Regulation			
A	 range	 of	 protein	 regulators	 and	 cis-acting	 DNA	 elements	 have	 been	 identified	 across	
various	 organisms	 which	 regulate	 the	 timing	 and	 frequency	 of	 DNA	 replication	
initiation95,121.	 However,	 all	 of	 the	 identified	 regulators	 are	 genus	 or	 species	 specific	 and	
the	 same	 regulators	 are	 only	 observed	 in	 very	 closely	 related	 bacteria.	 Notably,	 Gram-
negative	and	Gram-positive	bacteria	appear	 to	employ	 separate	 systems	of	 regulation	of	
replication	 initiation,	with	 the	model	organisms	E.	 coli	 and	B.	 subtilis	 providing	our	most	
thorough	understanding	of	the	control	of	replication	initiation	in	Gram-negative	and	Gram-
positive	bacteria,	respectively122.	Both	organisms	use	a	range	of	protein	regulators	and	cis-
acting	DNA	elements	that	have	no	known	homolog	in	the	other	species.	A	comprehensive	
overview	of	these	mechanisms	is	detailed	below.		
	
1.13:	Regulation:	E.	coli	
1.13.1:	Regulatory	Inactivation	of	DnaA	(RIDA)		
In	 E.	 coli,	 the	 concentration	 of	 available	 ‘initiation-active’	 DnaA-ATP	 is	 considered	 an	
important	limiting	factor	in	the	initiation	of	DNA	replication	from	oriC123,	thus	regulation	of	
the	 available	 DnaA-ATP	 can	 be	 employed	 to	 control	 initiation	 events.	 The	 ‘regulatory	
inactivation	of	DnaA’	 is	 a	 term	given	 to	 the	process	of	 converting	 ‘active’	DnaA-ATP	 into	
‘inactive’	 DnaA-ADP	 by	 ATP	 hydrolysis.	 	 Hydrolysis	 is	 promoted	 by	 the	 protein	 Hda,	 and	
requires	a	complex	between	DnaA,	Hda	and	the	DNA-bound	polymerase	β-clamp,	DnaN124–
126.	 In	 this	 way,	 the	 regulation	 appears	 to	 couple	 initiation	 and	 elongation	 of	 DNA	
replication,	as	ATP	hydrolysis	is	activated	following	the	start	of	DNA	synthesis125.		
Hda	is	homologous	to	DnaA	domain	III,	with	a	48%	sequence	similarity	between	the	AAA+	
ATPase	 domains125.	 Hda	 binds	 DnaN	 via	 an	 N-terminal	 clamp	 binding	 motif	 (sequence	
QL[SP]LPL)127,	 whilst	 Hda:DnaA	 interactions	 are	 mediated	 via	 their	 respective	 ATPase	
domains128.	Strains	carrying	a	hda	deletion,	and	inactivated	Hda	mutants	or	DnaA	mutants	
unable	 to	 hydrolyse	 ATP,	 exhibit	 overinitiation	 of	 DNA	 replication	 and	 growth	
inhibition13,123,124,129.	 Hda	 mediated	 hydrolysis	 of	 DnaA-ATP	 to	 DnaA-ADP	 requires	 ADP-
bound	Hda130	which	 has	 been	 shown	 to	 be	monomeric.	 In	 contrast,	 apo-Hda	 appears	 to	
form	 homomultimers	 (mainly	 homodimers)130.	 Together	 this	 suggests	 that	 Hda’s	
oligomeriation	 state	 plays	 a	 role	 in	 its	 ability	 to	 promote	 DnaA-ATP	 hydrolysis130.	 A	
structural	study	of	Hda	also	showed	the	formation	of	dimers	(where	Hda	is	bound	to	the	
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nucleotide	CDP).	However	because	the	DnaN	binding	motif	is	buried	in	this	conformation,	
it	is	assumed	to	be	an	inactive	form	of	the	protein131.		
Mutations	 in	 both	 Hda	 and	 DnaA	 suggest	 that	 the	 proteins	 interact	 via	 their	 respective	
AAA+	domains,	with	Hda’s	arginine	 finger	 residue	playing	an	 important	 role	 in	DnaA-ATP	
hydrolysis128,132.	 	Models	 of	 the	DnaA-Hda	 interaction	 suggest	 that	 it	may	 form	 a	 similar	
interaction	to	that	seen	between	molecules	of	DnaA131,132,	however	Hda	may	make	fewer	
contacts	 with	 DnaA	 than	 DnaA	 protomers132.	 	 Hda’s	 interaction	 with	 the	 β-clamp	 is	
important	for	Hda-DnaA	binding,	suggesting	that	the	β-clamp	may	adjust	the	conformation	
of	 the	Hda-DnaA	 interaction	 to	 promote	ATP	hydrolysis132.	 	 Recently	 interactions	 of	Hda	
with	DnaA	domains	I	and	IV	have	also	been	shown	to	be	important	for	RIDA	as	mutations	
at	specific	DnaA	Domain	I	and	IV	residues	leads	to	higher	cellular	concentrations	of	DnaA-
ATP	 than	 seen	 in	 wildtype	 cells82,133.	 The	 Hda-DnaA	 model	 suggests	 domain	 IV	 makes	
contacts	with	Hda	at	a	nucleotide	interaction	surface	towards	the	C-terminus	of	Hda133.	It	
has	therefore	been	proposed	that	DnaA	domain	I	interacts	with	the	N-terminal	portion	of	
Hda’s	ATPase	domain,	 to	 stabilise	 the	DnaA-Hda	 interaction	 from	both	 sides82(Fig.	 1.12).	
Further	 understanding	 of	 the	 interactions	 between	 Hda,	 DnaA	 and	 the	 β-clamp	 are	
required	to	fully	elucidate	Hda’s	molecular	mechanism.	
	
Figure	1.13:	Schematic	representation	of	the	interaction	of	Hda	with	DnaA	and	the	β-clamp:Hda	
makes	contacts	with	Domains	I,	III	and	IV	of	DnaA,	and	the	DNA-bound	β-clamp	during	RIDA.	Image	
taken	from	Su’etsugu,	et	al.,	Environ.	Microbiol.	15,	3183–95	(2013).	
	
1.13.2:	IHF	and	Fis	
The	DNA-bending	proteins	IHF	and	Fis	are	thought	to	play	important	roles	in	regulating	the	
binding	of	DnaA	at	 the	origin	of	 replication134.	 Further	 to	 this,	 they	have	been	 shown	 to	
play	 roles	 in	 the	 binding	 of	DnaA	 to	 two	 cis-acting	 regulatory	 sites	 on	 the	 chromosome,	
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datA	 and	 DARS135,136	 (See	 below).	 Loss	 of	 IHF	 disrupts	 synchronous	 DNA	 replication.	
Curiously,	 Fis	 has	 been	 reported	 to	 play	 both	 inhibitory	 and	 stimulatory	 roles	 in	 DNA	
replication	initiation137–139.		
Both	 proteins	 are	 able	 to	 bind	 oriC	 and	 have	 been	 shown	 to	 act	 in	 an	 antagonistic	
manner134,140.	Binding	of	 IHF	to	a	specific	site	 in	the	E.	coli	 replication	origin	(see	Fig.	1.2)	
promotes	 binding	 of	 DnaA	 at	 DnaA-boxes	 within	 the	 origin141,	 contributing	 to	 DnaA	
oligomer	 formation.	 Fis	 has	 been	 reported	 to	 inhibit	DNA	 unwinding	 at	oriC	 by	 blocking	
binding	of	both	DnaA	and	IHF134.	Increasing	concentrations	of	DnaA	were	found	to	relieve	
Fis	inhibition,	and	IHF	was	found	to	redistribute	DnaA	molecules	at	oriC134,141.		
IHF	 binds	 to	 the	 origin	 between	DnaA-boxes	 R1	 and	R5	 during	 replication	 initiation	 (Fig.	
1.2),	causing	a	bend	in	the	DNA;	this	DNA	bending	has	been	proposed	to	bring	the	R1	and	
R5	DnaA-boxes	into	close	proximity	with	one	another,	allowing	them	to	extend	the	helical	
DnaA	oligomer20.	Strains	with	a	deletion	of	either	of	the	high-affinity	DnaA-boxes,	R1	or	R4,	
at	 the	 ends	 of	 oriC	 (Fig.	 1.2),	 required	 both	 Fis	 and	 IHF	 for	 initiation;	 leading	 to	 the	
suggestion	 that	 the	 DNA	 bending	 exhibited	 by	 both	 proteins	 creates	 the	 correct	
conformation	 for	 an	 initiation	 complex20	 which	 is	 proposed	 to	 form	 a	 loop	 structure	
stabilised	by	DnaA	molecules	on	high	affinity	DnaA	boxes	R1,	R2	and	R4	(Fig	1.13,	A).	Thus	
the	authors	suggest	that	Fis	and	IHF	help	to	mimic	this	conformation	in	the	absence	of	the	
R1	 or	 R4	 boxes	 (Fig.	 1.	 13,	 B)	 but	 that	 simultaneous	 binding	 of	 Fis	 and	 IHF	may	 not	 be	
possible	 in	 the	 normal	 initiation	 complex	 –	 providing	 a	 mechanism	 for	 the	 dynamic	
behaviour	of	Fis	and	IHF20.			
	
Figure	1.14:	Schematic	representation	of	the	initiation	complex:	A)	DnaA	binding	at	DnaA-boxes	
R1,	R2	and	R4	on	the	E.	coli	replication	origin	are	proposed	to	form	a	looped	DNA	structure.	B)	
Binding	of	both	IHF	and	Fis	may	act	to	mimic	the	looping	of	DNA	at	oriC	in	strains	lacking	the	R4	(or	
R1)	DnaA-box.	Figure	taken	from	Kaur	et	al.,	Mol.	Microbiol.	91,	1148–1163	(2014).	
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1.13.3:	datA	
datA	 is	a	chromosomal	locus	in	E.	coli	around	~1	kb	in	length,	located	at	94.7	minutes	on	
the	 chromosome142.	 It	 contains	 five	 DnaA-boxes	 and	 exhibits	 a	 high	 affinity	 for	 DnaA	
molecules.	It	acts	as	a	negative	regulator	of	DNA	replication	initiation;	deletion	of	datA	or	
mutations	in	DnaA-boxes	within	datA	cause	overinitiation	of	DNA	replication142–144.	datA	is	
unique	 in	 this	 behaviour	 as	 other	 chromosomal	DnaA-box	 sites	 (other	 than	 those	within	
oriC)	do	not	affect	replication	 initiation	events144.	Binding	of	 IHF	to	datA	promotes	DnaA-
binding	 and	 is	 essential	 for	 the	 regulatory	 action	 of	 datA	 145.	 	 datA	 has	 mainly	 been	
suggested	 to	 act	 as	 a	 sink	 for	DnaA	molecules,	 titrating	 them	away	 from	 the	 replication	
origin142–145,	 however	 a	 recent	 study	 has	 revealed	 that	 datA	 promotes	 the	 hydrolysis	 of	
DnaA-ATP	to	DnaA-ADP	136.	This	mechanism	is	dependent	on	both	IHF	binding	to	datA	and	
the	DnaA	arginine	finger	residue	(Arg285)	suggesting	that	datA	promotes	the	formation	of	
a	nucleoprotein	complex,	somewhat	reminiscent	of	oriC,	and	stimulates	the	hydrolysis	of	
DnaA-ATP	 at	 this	 site136.	 	 The	 binding	 of	 IHF	was	 shown	 to	 take	 place	 immediately	 after	
initiation,	providing	a	mechanism	for	the	timing	of	datA	mediated	DnaA-ATP	hydroylsis136.		
	
1.13.4:	DARS	
Two	 loci	 in	 E.	 coli,	 termed	 DARS1	 and	 DARS2	 for	 ‘DnaA	 reactivating	 site’	 1	 and	 2,	
respectively,	 have	 also	 been	 implicated	 in	 the	 reactivation	 of	 DnaA	 by	 promoting	
nucleotide	 exchange,	 generating	 DnaA-ATP	 from	 DnaA-ADP146.	 	 Deletion	 of	 DARS	
sequences	causes	inhibition	of	DNA	replication	due	to	a	decrease	in	the	cellular	DnaA-ATP	
concentration146.	DnaA-ADP	molecules	have	been	shown	to	assemble	on	DARS1	promoting	
the	 regeneration	of	DnaA-ATP146.	The	simultaneous	binding	of	 the	DNA	bending	proteins	
IHF	 and	 Fis	 to	 DARS2	 has	 been	 shown	 to	 facilitate	 DnaA-ATP	 regeneration	 in	 vivo135,	
providing	a	mechanism	 for	 the	 timing	of	DnaA	reactivation.	The	binding	of	 IHF	 to	DARS2	
appears	 to	 be	 cell-cycle	 regulated	 and	 not	 dependent	 on	 DNA	 replication,	 whilst	 the	
binding	 of	 Fis	 is	 linked	 to	 growth	 phase:	 occurring	 during	 exponential	 growth	 but	 not	
stationary	 phase135.	 Fis’	 role	 in	 DARS2	 stimulation	 is	 consistent	 with	 a	 report	 that	 Fis	 is	
required	for	the	stimulation	of	replication	initiation	in	rapidly	growing	cells139.		
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1.13.5:	Dynamics	of	IHF	and	Fis	Binding	
There	is	an	increasing	appreciation	of	the	importance	of	the	roles	that	IHF	and	Fis	play	in	
regulating	 DNA	 replication	 initiation,	 both	 through	 the	 regulation	 of	 available	 DnaA-ATP	
(datA/DARS2)135,136	and	via	direct	binding	to	the	replication	origin134.	 It	will	be	 interesting	
to	understand	how	the	timing	of	 IHF	and	Fis	binding	at	oriC,	datA	and	DARS	is	controlled	
and	how	these	dynamics	link	to	replication,	cell	and	growth	cycles.				
	
1.13.6:	SeqA	
SeqA	 negatively	 regulates	 DNA	 replication	 initiation	 by	 preventing	 re-initiation	 of	
replication	for	an	intermediate	period	just	after	replication	has	occurred.	It	binds	to	hemi-
methylated	GATC	sites	in	oriC	which	act	to	sequester	the	origin,	preventing	DnaA	oligomer	
formation	and	transcription	of	the	dnaA	gene	by	blocking	binding	of	the	dnaA	promotor147–
150.	 The	 E.	 coli	 replication	 origin	 contains	 11	 GATC	 sites	 which	 will	 be	 hemi-methylated	
immediately	 after	 DNA	 replication.	 This	 is	 due	 to	 the	 semi-conserved	 nature	 of	 DNA	
replication:	 the	 newly	 synthesised	 strand	will	 be	 unmethylated	whilst	 the	 parental	 DNA	
strand	 will	 be	 methylated.	 SeqA	 binds	 with	 strongest	 affinity	 to	 hemi-methylated	 GATC	
sites151.	The	SeqA	molecules	bound	at	GATC	sites	on	oriC	are	able	to	recruit	further	SeqA	
proteins	 to	 sequester	 the	 origin,	 as	 long	 as	 six	 or	 more	 of	 the	 GATC	 sites	 are	 hemi-
methylated152.	 Sequestration	 of	 the	 origin	 persists	 for	 around	 1/3	 of	 the	 cell	 cycle,	
although	it	 is	not	fully	understood	how	SeqA	is	released	after	this	time149,153.	Dam	methyl	
transferase	methylates	adenosine	bases	in	GATC	sites,	and	it	seems	likely	that	spontaneous	
dissociation	 of	 SeqA	 coupled	 with	 Dam	 methylation	 relieves	 sequestration154.	 SeqA	 has	
also	been	implicated	in	faithful	chromosome	segregation155.	
	
1.13.7:	DiaA	/HobA	
DiaA	 is	 a	 positive	 regulator	 of	 DNA	 replication	 initiation	 in	 E.	 coli.	 It	 influences	 the	
frequency	and	timing	of	DNA	replication	initiation156.	It	is	thought	to	function	by	promoting	
the	oligomerisation	of	DnaA	at	the	origin,	by	binding	to	domain	I	of	DnaA73,157,158.	HobA,	a	
structural	homolog	of	DiaA	in	H.	pylori159,	has	been	shown	to	be	an	essential	regulator	of	
DNA	 replication81.	 Both	 proteins	 form	 tetramers,	 and	 a	 HobA-DnaA	 domain	 I	 structure	
revealed	 a	 4:4	 HobA:DnaA	 domain	 I	 complex,	where	 each	 HobA	 protomer	 binds	 to	 one	
DnaA	domain	I73.	DiaA	has	been	shown	to	bind	an	equivalent	site	on	DnaA80.	Despite	this,	
45	
	
HobA	and	DiaA	are	not	 interchangeable	 in	vivo	due	 to	differences	 in	 their	 cognate	DnaA	
domain	I	sequences,	which	appear	to	have	co-evolved	with	the	regulators157.	Formation	of	
heterologous	 complexes	 can	be	 achieved	however	with	 hybrid	DnaA	molecules	 in	which	
the	 regulators’	 cognate	 DnaA	 domain	 I	 was	 exchanged	 with	 the	 heterologous	 species’	
DnaA	domain	I	(i.e.	E.	coli	DiaA	can	interact	with	a	chimeric	DnaA	protein	containing	E.	coli	
domain	 I	 fused	 to	 H.	 pylori	 domains	 II-IV).	 This	 confirmed	 that	 DiaA	 and	 HobA	 are	
functional	 homologs,	 each	 promoting	 DnaA	 binding	 at	 the	 origin,	 but	 with	 different	
dynamics	 (HobA	 accelerates	 DnaA	 binding,	 whilst	 DiaA	 decelerates	 DnaA	 binding)157.		
Structural	and	mutational	studies	with	HobA	have	led	to	the	suggestion	that	the	tetramers	
function	as	molecular	 scaffolds	 at	oriC	which	promote	 the	 formation	of	DnaA	oligomers,	
however	direct	experimental	evidence	is	still	required160.	DiaA	may	play	a	role	in	regulating	
the	 timing	of	helicase	 loading	 in	E.	 coli	as	both	DiaA	and	 the	helicase	 appear	 to	bind	an	
overlapping	site	on	DnaA,	and	DiaA	can	inhibit	helicase	loading	in	vitro80.	
	
1.14:	Regulation:	B.	subtilis	
1.14.1:	YabA		
YabA	 is	 the	 principle	 regulator	 of	 DNA	 replication	 initiation	 in	 vegetatively	 growing	 B.	
subtilis	cells161.	YabA	is	a	negative	regulator	of	DNA	replication;	a	deletion	of	yabA	(ΔyabA)	
causes	an	increased	frequency	of	initiation	events	and	asynchronous	DNA	replication161	as	
well	 as	 a	 growth	 phenotype	 associated	 with	 increased	 initiation	 events162,163.	 YabA	
interacts	with	both	the	replication	initiator,	DnaA,	and	the	DNA	polymerase	clamp,	DnaN,	
as	 revealed	 by	 yeast	 two	 hybrid	 studies	 and	 a	 Zn2+	 precipitation	 assay162,163.	 Mutations	
which	affect	the	interaction	of	YabA	with	either	DnaA	or	DnaN	in	a	yeast	two	hybrid	assay	
have	been	shown	to	act	 like	ΔyabA	mutants	 in	B.	subtilis:	 resulting	 in	 increased	 initiation	
and	asynchronous	DNA	replication163.	Furthermore,	these	mutations	have	been	shown	to	
disrupt	 the	 formation	 of	 GFP-YabA	 foci,	 which	 typically	 form	 at	 mid-cell	 (suggestive	 of	
localisation	with	 the	 replisome)164.	 	 Together	 this	 suggests	 that	 the	 interactions	between	
YabA,	DnaA	and	DnaN	are	physiologically	relevant.				
As	 a	 regulator	 interacting	 with	 DnaA	 and	 DnaN,	 YabA	 is	 reminiscent	 of	 the	 E.	 coli	
replication	regulator	Hda,	which	acts	in	the	"regulatory	inactivation	of	DnaA"	by	promoting	
the	hydrolysis	of	ATP	 in	DnaA	(and	thus	 'inactivating'	DnaA)125.	However,	YabA	 is	a	much	
smaller	protein	than	Hda,	shares	no	apparent	homology	with	Hda	(or	DnaA),	and	does	not	
promote	 DnaA-ATP	 hydrolysis	 in	 vitro109.	 Thus,	 it	 appears	 to	 employ	 an	 alternative	
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regulatory	mechanism	for	the	inhibition	of	DNA	replication,	which	also	couples	regulation	
of	replication	initiation	with	elongation	through	interactions	with	DnaA	and	DnaN.		
The	 nature	 of	 YabA's	 interaction	 with	 DnaA	 and	 DnaN	 is	 debated	 in	 the	 literature34,164.	
YabA	 is	 able	 to	 form	 a	 simultaneous	 interaction	with	 both	 DnaA	 and	DnaN	 in	 a	 yeast	 3	
hybrid	experiment163,	however	 it	 remains	unclear	whether	or	not	 this	 ternary	complex	 is	
physiologically	 relevant.	 In	particular,	 the	 role	DnaN	plays	 in	 this	 system	 is	debated.	One	
model	(Fig.	1.14,	A)	suggests	that	DnaN	tethers	DnaA	to	the	replisome	via	an	intermediary	
interaction	 with	 YabA	 (also	 giving	 physiological	 significance	 to	 a	 ternary	 complex)164.	
Another	 model	 however,	 suggests	 that	 DnaN	 removes	 YabA	 from	 oriC,	 allowing	
cooperative	 binding	 of	 DnaA	 at	 oriC34	 (Fig.	 1.14,	 B).	 The	 first	model	 suggests	 that	 DnaN	
enables	YabA's	ability	to	 inhibit	DnaA,	whilst	the	 latter	model	suggests	DnaN	antagonises	
YabA's	inhibition	of	DnaA.			
	
Figure	1.15:	Alternative	models	for	YabA’s	inhibition	of	DNA	replication:	A)	YabA	tethers	DnaA	to	
the	replisome	via	an	interaction	with	both	DnaA	and	DnaN,	titrating	DnaA	away	from	the	replication	
origin.	B)	YabA	inhibits	the	cooperative	binding	of	DnaA	at	the	origin	during	replication.	When	DnaN	
is	released	after	replication,	YabA	binds	DnaN,	releasing	DnaA.		
	
The	 first	model	 (Fig.	1.14,	A)	 is	based	on	 the	 localisation	of	DnaA	 in	wildtype	and	ΔyabA	
cells.	In	wildtype	cells,	DnaA	localises	at	the	origin	in	small	cells	(early	cell	cycle)	and	at	the	
cell	centre	(co-incident	with	DnaX	-	i.e.	replisome	localised)	in	larger	cells	(remainder	of	the	
cell	 cycle)164.	However,	 in	ΔyabA	cells,	DnaA	 localised	with	 the	origin	 throughout	 the	cell	
cycle.	 This	 led	 to	 the	 proposal	 of	 a	 tethering	model,	whereby	 YabA	 tethers	DnaA	 to	 the	
replisome	via	DnaN	for	most	of	 the	cell	cycle	 (thereby	sequestering	DnaA	away	from	the	
47	
	
origin	and	preventing	 re-initiation)164.	However,	an	earlier	 study	 suggested	 that	YabA	co-
localises	with	DnaN	only	at	 late	stages	of	 the	cell	cycle161	and	recent	studies	have	shown	
that	 increased	 levels	 of	 DnaN	 in	 the	 cell	 cause	 an	 increase	 in	 the	 number	 of	 DNA	
replication	 initiation	 events,	 and	 conversely	 decreases	 in	 the	 level	 of	 DnaN	 decreases	
initiation	events34.	 Intriguingly,	deletion	of	YabA	and	 increasing	DnaN	did	not	produce	an	
additive	affect,	suggesting	that	they	were	acting	at	the	same	rate-limiting	step.	In	addition,	
in	 a	 strain	 replicating	 from	oriN	 (i.e.	 DnaA-independent),	 YabA	was	 shown	 to	 affect	 the	
cooperativity	 of	 DnaA	 binding	 at	 oriC,	 and	 increased	 levels	 of	 DnaN	 remove	 YabA	 from	
oriC.	 This	evidence	 led	 to	 the	proposal	of	 the	 second	model	 (Fig.	 1.14,	B)	whereby	YabA	
prevents	 the	 co-operative	 binding	 of	 DnaA	 at	oriC	 until	 the	 concentration	 of	 free	 DnaN	
increases	 in	the	cell,	 removing	YabA	from	DnaA	and	enabling	the	co-operative	binding	of	
DnaA	 at	 oriC34.	 This	 is	 consistent	 with	 observations	 that	 YabA	 is	 able	 to	 disrupt	 DnaA-
oligomer	formation	on	DNA	in	vitro109.	
	
1.14.2:	Soj/Spo0J	
Soj	 is	 an	 ATPase	 which	 has	 been	 found	 to	 both	 negatively	 and	 positively	 regulate	 DNA	
replication	 in	B.	 subtilis165.	 This	 activity	 is	 dependent	 on	 its	 oligomeric	 state166,	 which	 is	
controlled	 by	 nucleotide	 binding;	 ATP-bound	 Soj	 forms	 dimers	 which	 co-operatively	
interact	with	DNA	in	an	unspecific	manner,	whilst	ADP-bound	Soj	is	monomeric167.	Dimeric	
(ATP-bound)	 Soj	 appears	 to	 stimulate	 overinitiation	 of	 replication,	whilst	monomeric	 Soj	
inhibits	 replication33,166.	 	Spo0J	 regulates	Soj	activity	by	stimulating	 the	ATPase	activity	of	
dimeric	Soj,	converting	it	back	into	its	monomeric	form166.		
Soj	 appears	 to	 interact	with	 the	 ATPase	 domain	 (III)	 of	 DnaA,	 but	 it	 does	 not	 affect	 the	
ability	 of	 DnaA	 to	 bind	 or	 hydrolyse	 ATP33.	 Instead,	 it	 acts	 by	 inhibiting	 DnaA	 oligomer	
formation	at	oriC;	a	Soj	mutant	 trapped	 in	a	monomeric	 state	has	been	shown	to	 inhibit	
DnaA	 oligomer	 formation	 both	 in	 vitro	 and	 in	 vivo33.	 Curiously,	 Soj	 trapped	 in	 a	 dimeric	
state	 is	 also	 able	 to	 interact	 with	 DnaA	 on	 a	 similar	 DnaA	 surface	 to	 monomeric	 Soj,	
without	 inhibiting	DnaA	oligomerisation.	Thus,	 it	has	been	suggested	that	monomeric	Soj	
may	 be	 acting	 to	 prevent	 conformational	 changes	 in	 DnaA	 required	 to	 form	 an	 active	
initiation	complex33	(e.g.	the	proposed	conformational	change	required	between	domains	
III	 and	 IV	 for	 open	 complex	 formation5),	 whilst	 dimeric	 Soj	may	 stabilise	 DnaA	 oligomer	
formation33.	This	is	consistent	with	evidence	that	suggests	dimeric	Soj	plays	an	active	role	
in	stimulating	DNA	replication74,75.	
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Soj	and	Spo0J	are	orthologues	of	the	proteins	ParA	and	ParB,	respectively.	ParA,	and	ParB,	
along	with	 a	 cis-acting	DNA	 sequence	parS,	 form	a	 plasmid	 partitioning	 system	 found	 in	
many	 prokaryotic	 species.	 The	 system	 ensures	 the	 partitioning	 of	 low	 copy	 number	
plasmids	 into	daughter	cells.	 In	 these	partitioning	systems,	ParB	binds	 to	parS	sequences	
on	the	plasmid,	and	ParA	forms	filaments	on	chromosomal	DNA.	An	 interaction	between	
ParA	and	ParB	simulates	ParA’s	ATPase	activity,	which	 is	 thought	to	cause	dissociation	of	
the	 terminal	 ParA	molecule	 from	 the	 filament;	 the	plasmid	 can	 then	either	dissociate	or	
translocate	along	the	chromosomal	DNA	by	binding	to	the	next	ParA	molecule.	Continuous	
cycles	 of	 ParA	 assembly	 and	 disassembly	 are	 thought	 to	 ensure	 equidistribution	 of	 the	
plasmids	within	the	cell169,	ensuring	that	in	cases	were	more	than	one	copy	of	the	plasmid	
is	present	-	they	will	be	located	on	either	side	of	the	division	plane170		
Chromosomal	 orthologues	 of	 ParA	 and	 ParB	 and	 parS	 sites	 are	 common	 throughout	
bacteria,	and	in	some	species	they	are	known	to	directly	affect	chromosome	segregation;	it	
is	 thus	 attractive	 to	 assume	 that	 the	 role	 that	 the	 ParA/ParB	 chromosomal	 orthologues	
play	 in	 chromosome	 segregation	 is	 similar	 to	 that	 of	 the	 plasmid	 partitioning	 proteins.	
However,	 the	 role	 of	 parABS	 in	many	 bacteria	 is	 still	 unclear.	 	 In	 B.	 subtilis,	 Spo0J-parS	
contributes	 to	 accurate	 chromosome	 segregation,	 but	 they	 are	 not	 essential	 for	 this	
function171.	 Instead	they	play	a	role	 in	the	recruitment	of	the	SMC	complex	to	the	origin,	
and	 it	 is	 the	 SMC	 proteins	 that	 are	 responsible	 for	 proper	 DNA	 segregation	 and	
condensation	 of	 the	 chromosome172,173.	 	 These	 combined	 roles	 of	 Spo0J	 may	 provide	 a	
mechanism	by	which	B.	 subtilis	 is	 able	 to	 co-ordinate	DNA	 replication	with	 chromosome	
segregation173.	
	
1.14.3:	DnaD	
DnaD	has	also	been	reported	to	play	a	role	in	the	regulation	of	DNA	replication	initiation	in	
B.	 subtilis.	 Like	 YabA,	 DnaD	 has	 been	 shown	 to	 inhibit	 the	 ATP-dependent	 cooperative	
binding	of	DnaA	to	oriC	DNA108	and	is	able	to	affect	the	formation	of	DnaA	helical	filaments	
in	 an	 in	 vitro	 DnaA-crosslinking	 assay109.	 This	 suggests	 that	 DnaD	 may	 play	 a	 role	 in	
regulating	B.	subtilis	DNA	replication	initiation	by	altering	the	formation	of	the	helical	DnaA	
filament	at	the	origin	of	replication.		
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1.14.4:	DnaA-Box	Clusters		
Six	DnaA-box	clusters	(DBCs)	in	B.	subtilis	found	outside	of	the	replication	origin	have	been	
shown	 to	play	a	 role	 in	 regulating	DNA	 replication.	A	deletion	 strain	 in	which	all	 six	DBC	
boxes	 were	 removed	 displayed	 an	 early	 initiation	 of	 DNA	 replication	 phenotype.	 This	
deletion	 was	 only	 significant	 when	 all	 six	 clusters	 were	 removed	 and	 could	 be	 partially	
relieved	 by	 the	 re-introduction	 of	 a	 single	DBC	 at	 various	 locations168.	Nevertheless,	 this	
indicates	that	B.	subtilis	may	be	utilising	chromosomal	locations	to	titrate	DnaA	molecules	
away	from	the	origin163.	
	
1.14.5:	Sporulation	and	DNA	Replication	
A	 significant	 characteristic	 of	 B.	 subtilis	 cells	 is	 their	 ability	 to	 sporulate	 under	 nutrient	
limiting	conditions.	This	process	of	cellular	differentiation	allows	the	cell	 form	a	dormant	
spore	under	conditions	of	nutrient	limitation.	The	endospore	is	metabolically	inactive	and	
highly	resistant	to	extreme	conditions	(such	as	high	temperatures,	desiccation	and	ionizing	
radiation).	When	 nutrient	 availability	 improves,	 the	 endospore	 can	 germinate,	 returning	
the	 cell	 to	 vegetative	 growth,	 even	 after	 thousands	 of	 years174,175.	 The	 process	 of	
sporulation,	 contrary	 to	 vegetative	 growth	 (where	 cells	 divide	 symmetrically	 at	 their	
centre),	involves	the	asymmetric	division	of	the	cell	into	a	larger	mother	cell	compartment	
and	 smaller	 forespore	 compartment	 (Fig.	 1.15).	 These	 two	 compartments	 must	 each	
contain	a	copy	of	the	organism’s	genome;	differential	gene	expression	subsequently	gives	
them	 dramatically	 different	 cell	 fates.	 The	 forespore	 is	 engulfed	 and	 nurtured	 by	 the	
mother	 cell,	 transforming	 it	 into	a	 resistant	endospore,	whilst	 the	mother	 cell	 ultimately	
lyses	 to	 release	 the	endospore176	 (Fig.	1.15).	Entry	 into	 the	sporulation	pathway	 is	under	
the	 control	 of	 a	 complex	 phosphorelay	 which	 culminates	 in	 the	 phosphorylation	 of	 the	
protein	 Spo0A,	 the	 master	 regulator	 of	 sporulation177.	 Spo0A~P	 acts	 as	 a	 transcription	
regulator,	controlling	the	expression	of	over	500	genes178.	
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Figure	1.16:	Vegetative	growth	and	sporulation	 in	B.	 subtilis	 :	 In	normal	vegetative	growth	 (blue	
arrows)	 cells	 divide	 symmetrically,	 producing	 identical	 daughter	 cells.	 During	 sporulation	 (purple	
arrows)	cells	divide	asymmetrically	forming	a	mother	cell	and	forespore;	each	receive	a	copy	of	the	
organisms	 genome,	 and	 through	 differential	 gene	 regulation	 they	 endure	 different	 fates.	 The	
mother	 cell	 engulfs	 the	 forespore,	 nurturing	 it	 into	 a	 mature	 spore	 before	 ultimately	 lysing	 to	
facilitate	the	spores	release.		
	
The	process	of	DNA	replication	must	be	coordinated	with	entry	into	sporulation	to	ensure	
that	the	cell	contains	only	two	copies	of	the	chromosome	–	one	destined	for	the	mother	
cell	 and	 the	 other	 for	 the	 forespore.	 Trapping	 of	 two	 (or	 more)	 chromosomes	 in	 the	
forespore	compartment	can	be	lethal	to	the	cell,	or	otherwise,	 lead	to	a	reduced	viability	
of	the	spore	(i.e.	an	increased	number	of	spores	fail	to	germinate	in	environments	of	high	
nutrient	availability)179.	
	
1.14.5.1:	Spo0A~P	Pulsing	is	controlled	by	Sda	and	B.	subtlis’	Chromosomal	Arrangement		
It	has	long	been	recognised	that	there	is	a	‘sensitive	period’	in	the	cell	cycle	when	the	cell	
can	 enter	 sporulation;	 if	 the	 cell	 progresses	 beyond	 this	 point	 it	 is	 committed	 to	 a	 new	
round	 of	 vegetative	 division180,181.	 This	 ‘sensitive	 period’	 is	 associated	 with	 fluctuating	
Spo0A~P	 levels,	 which	 pulse	 throughout	 the	 cell	 cycle:	 at	 their	 highest	 concentration	
immediately	 after	 rounds	 of	 DNA	 replication	 are	 complete179,182.	 As	 a	 threshold	 level	 of	
Spo0A~P	must	be	reached	for	sporulation	to	be	triggered,	this	gradual	increase	within	the	
cell	 cycle	 is	 thought	 to	 allow	 the	 turning	 on	 of	 low-threshold,	 and	 then,	 high	 threshold	
genes	which	trigger	the	sporulation	process183,184.		
Although	it	is	clear	that	Spo0A~P	pulsing	must	be	linked	to	DNA	replication,	until	recently	it	
was	not	known	how	this	is	achieved.	The	cellular	Spo0A~P	concentration	has	been	directly	
linked	to	the	expression	of	the	sporulation	inhibitor	protein,	Sda179.	Sda	is	a	histidine	kinase	
51	
	
inhibitor	 which	 inhibits	 the	 action	 of	 KinA	 and	 KinB,	 important	 members	 of	 the	
phosphorelay	responsible	for	the	phosphorylation	of	Spo0A185–187(Fig.	1.16).	Sda	expression	
levels	are	directly	controlled	by	DnaA	via	transcription	regulation179,185	and	this	expression	
correlates	with	the	presence	of	replication	active	DnaA	in	the	cell.	Thus,	Sda	levels	spike	at	
the	 same	 time	 as,	 or	 just	 after,	 the	 replisome	 forms179.	 Sda	 is	 subsequently	 rapidly	
proteolysed188.	This	provides	a	feedback	mechanism	whereby	Sda	blocks	phosphorylation	
of	 Spo0A	 and	 hence	 entry	 into	 sporulation	 during	 ongoing	 rounds	 of	 DNA	 replication179.	
However,	Sda	alone	does	not	appear	to	control	Spo0A~P	pulsing,	as	deletion	of	Sda	does	
not	stop	the	pulsing	of	Spo0F	levels	(a	‘low-threshold’	gene	under	the	control	of	Spo0A~P);	
189	suggesting	that	Spo0A~P	pulsing	still	occurs.	
	
Figure	1.17:	Phosphorelay	leading	to	the	induction	of	sporulation	:	A	series	of	phosphate	transfer	
reactions	 are	 required	 to	 obtain	 the	 threshold	 level	 of	 Spo0A~P	 needed	 for	 entry	 into	 the	
sporulation	pathway.		
The	 chromosomal	 arrangement	 of	 the	 phosphorelay	 genes	 spo0F	 and	 kinA	 has	 recently	
been	 shown	 to	 be	 important	 for	 Spo0A~P	 pulsing179.	 spo0F	 is	 located	 close	 to	 the	
replication	 origin	 whilst	 kinA	 is	 located	 near	 the	 terminus,	 leading	 to	 a	 ‘gene	 dosage’	
imbalance	during	ongoing	replication	rounds182.	The	expression	of	high	levels	of	Spo0F	has	
been	reported	to	block	the	phosphorylation	of	KinA,	blocking	entry	into	sporulation190,191.	
Due	 to	 the	 chromosomal	 arrangement	 of	 spo0F	 and	 kinA,	 two	 copies	 of	 spo0F	 will	 be	
present	 in	the	cell	during	most	of	the	period	of	DNA	replication	(as	 it	 is	replicated	early),	
alongside	 only	 one	 copy	 of	 kinA182.	Alterations	 in	 the	 chromosomal	 positioning	 of	 spo0F	
and	 induction	 of	 Spo0F	 production	 from	 an	 inducible	 promoter,	 directly	 affect	 Spo0A~P	
pulsing,	and	hence	entry	into	sporulation182.	Thus,	it	seems	that	the	high	Spo0F:	KinA	ratio	
inhibits	KinA	phosphorylation,	and	hence	entry	 into	sporulation.	 	As	 rapidly	growing	cells	
can	undergo	multiple	rounds	of	DNA	replication	at	once,	the	relative	Spo0F:	KinA	ratio	also	
provides	 a	 mechanism	 for	 inhibiting	 sporulation	 in	 high	 nutrient	 conditions	 (where	
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replication	cycles	will	be	 initiated	during	ongoing	replication	and	thus	more	copies	of	the	
Spo0F	gene	will	be	present	 in	the	cell)182.	 	Collectively,	 the	chromosomal	arrangement	of	
Bacillus	subtilis	and	direct	 inhibition	of	KinA	activity	by	Sda	serve	to	coordinate	the	entry	
into	sporulation	with	DNA	replication	–	where	Sda	serves	as	a	control	in	the	dynamic	range	
of	Spo0A	activity189.			
	
1.14.5.2:	SirA	
SirA,	a	protein	produced	under	 the	direct	control	of	Spo0A~P,	has	been	shown	to	 inhibit	
DNA	replication	in	sporulating	cells.	It	 is	responsible	for	the	control	of	chromosomal	copy	
number	in	cells	which	are	artificially	induced	to	sporulate	under	conditions	of	rapid	growth	
–	 a	 situation	 where	 cells	 will	 be	 undergoing	 multifork	 replication192.	 Inhibition	 of	 DNA	
replication	 by	 SirA	 has	 been	 shown	 to	 be	 mediated	 via	 a	 direct	 interaction	 with	 DnaA	
domain	I83,193.	SirA	overexpression	mimics	DnaA	depletion	from	the	origin,	suggesting	it	 is	
able	to	inhibit	the	co-operative	binding	of	DnaA	to	oriC	193.	The	role	of	SirA	will	be	covered	
more	thoroughly	in	section	2.2.	
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1.14.5.3:	A	Direct	Role	of	Spo0A~P	in	Replication	Control		
The	Bacillus	subtilis	replication	origin	contains	a	number	of	(mainly	imperfect)	Spo0A-boxes	
which	 partially	 overlap	 with	 the	 location	 of	 DnaA-boxes194	 (Fig.	 1.17).	 Notably,	 Spo0A-
boxes	 have	 the	 consensus	 sequence	 5ʹ-	 TGTCGAA	 -3ʹ	 which	 partially	 overlaps	 with	 the	
DnaA-box	consensus	sequence	of	5’-	TGTGNATAA	–	3’195.	Spo0A~P	has	been	shown	to	bind	
these	 Spo0A-boxes	 in	 vitro195,	 and	 mutations	 of	 these	 boxes	 that	 specifically	 alter	
consensus	away	from	Spo0A-boxes	(while	preserving	DnaA-boxes)	affects	Spo0A~P	binding	
(but	not	DnaA	binding)	to	the	origin194.	The	binding	of	Spo0A~P	to	oriC	appears	to	play	a	
role	 in	 chromosome	 copy	 number	 control,	 however	 the	 effects	 of	 the	 Spo0A-box	
mutations	are	small	compared	to	the	loss	of	copy	number	control	in	a	ΔSda	strain	(and	to	a	
lesser	extent,	ΔSirA	strain).194		This	will	be	discussed	further	in	section	2.2.		
	
Figure	 1.18:	 Overlapping	 Spo0A-boxes	 and	 DnaA-boxes	 in	 the	 replication	 origin:	 A	 number	 of	
Spo0A~P	 binding	 sites	 (Spo0A-boxes	 –	 blue)	 overlap	 with	 DnaA-boxes	 (orange)	 in	 the	 B.	 subtilis	
replication	origin.	These	have	been	shown	to	play	a	direct	role	in	inhibiting	DNA	replication.			
	
1.15:	ATP	Hydrolysis	vs.	Inhibition	of	the	DnaA-oriC	Interaction	
In	 recent	 years,	 opposing	 themes	 have	 emerged	 in	 the	 regulation	 of	 DNA	 replication	
initiation	 in	E.	coli	and	B.	subtilis.	 It	has	 long	been	recognised	 that	 the	cellular	DnaA-ATP	
concentration	 plays	 an	 important	 role	 in	 the	 regulation	 of	 E.	 coli	 replication	
initiation21,61,196.	Hda,	 along	with	 the	DNA	polymerase	 clamp,	DnaN,	 acts	 to	promote	 the	
hydrolysis	of	DnaA-ATP	after	initiation	has	occurred125.	datA,	a	site	which	until	recently	was	
thought	 to	 be	 involved	 in	 DnaA	 titration,	 also	 acts	 to	 promote	 DnaA-ATP	 hydrolysis	
following	 initiation136,	 and	 the	 DARS	 sites	 reactivate	 DnaA	 by	 promoting	 nucleotide	
exchange	 from	 ADP	 to	 ATP146.	 	 The	 DNA-binding	 proteins	 IHF	 and	 Fis	 play	 a	 role	
coordinating	DnaA-ATP	availability	by	regulating	activity	at	oriC,	datA	and	DARS;	coupling	
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DNA	 replication	 initiation	 with	 the	 cell	 cycle	 and	 growth	 rate	 by	 an,	 as	 yet,	 poorly	
understood	 mechanism134,135,145.	 Thus,	 many	 of	 E.	 coli's	 regulators	 are	 acting	 to	 control	
availability	of	DnaA-ATP	as	a	method	of	initiation	control.		
In	B.	subtilis,	no	regulator	has	been	identified	which	affects	the	conversion	of	DnaA-ATP	to	
DnaA-ADP.	Instead,	several	of	B.	subtilis’	regulators	appear	to	act	by	directly	altering	DnaA	
binding	 at	 oriC.	 The	 regulators	 YabA	 and	 DnaD	 have	 both	 been	 found	 to	 affect	 the	
cooperativity	of	DnaA-ATP	binding	at	oriC34,108,	and	both	appear	to	be	able	to	affect	DnaA	
oligomer	formation	in	vitro109.	Soj	also	appears	to	act	by	directly	inhibiting	DnaA	oligomer	
formation	 on	 DNA33.	 Furthermore,	 even	 though	 Soj	 and	 YabA	 interact	 with	 the	 ATPase	
domain	 of	 DnaA,	 neither	 protein	 has	 an	 effect	 on	 the	 ATP	 hydrolysis	 in	 DnaA-ATP33,109.	
Finally,	SirA	has	been	shown	to	affect	DnaA	localisation	in	the	cell,	mimicking	the	effects	of	
DnaA	depletion	and	leading	to	suggestions	that	it	also	acts	by	preventing	DnaA	binding	at	
oriC193.	Together,	these	results	suggest	that	the	primary	method	B.	subtilis	uses	to	 inhibit	
DNA	replication	initiation	is	to	directly	affect	DnaA	binding	to	the	origin.		
DnaA-ATP	is	required	for	the	co-operative	binding	of	DnaA	to	the	origin	in	both	E.	coli	and	
B.	 subtilis34.	 It	 is	 therefore	 curious	 that	 the	organisms	have	evolved	divergent	 regulatory	
systems.	One	simple	explaination	for	this	may	be	that	the	different	origin	architectures	of	
each	species	has	led	to	the	evolution	of	differing	regulatory	mechanisms.		Another	theory	
is	 that	 the	spontaneous	 rate	of	E.	 coli	and	B.	subtilis	DnaA-ATP	hydrolysis	 is	 substantially	
different108.	In	vitro,	the	exchange	of	DnaA-ADP	for	ATP	has	been	found	to	be	~9	x	faster	in	
B.	subtilis	compared	to	E.	coli197.	Thus,	 if	this	 is	true	 in	vivo,	stimulation	of	ATP	hydrolysis	
and	nucleotide	exchange	in	E.	coli	DnaA	would	be	expected	to	have	a	much	greater	effect	
on	replication	initiation	than	in	B.	subtilis	where	turnover	of	ATP	is	already	rapid108.	Hence,	
the	two	organisms	may	have	evolved	different	mechanisms	of	replication	regulation	due	to	
differences	in	their	intrinsic	rates	of	DnaA-ATP	hydrolysis.			
	
1.16:	DNA	Replication	as	a	Potential	Antibiotic	Target	
Much	of	our	understanding	of	bacterial	DNA	replication	 initiation	has	been	derived	 from	
studies	 in	 E.	 coli.	However	 the	 bacterial	 initiation	machinery	 and	 the	 regulation	 of	 DNA	
replication	 varies	between	prokaryotes,	making	 studies	of	 replication	 in	other	organisms	
desirable	 for	 a	 fuller	 understanding	 of	 bacterial	 replication.	 Furthermore,	 it	 has	 been	
suggested	that	DNA	replication	may	be	an	underexploited	antibiotic	target	given	the	high	
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conservation	 of	 replication	 proteins3,44.	 However	 in	 order	 to	 create	 effective	 drugs,	 it	 is	
important	 to	 understand	 which	 aspects	 are	 conserved	 between	 bacteria	 (and	 other	
domains	 of	 life)	 and	which	 are	 not44.	Gram-positive	 pathogens	 such	 as	C.	 difficile	 and	B.	
anthracis	 are	 important	 targets	 of	 new	 antibiotics.	 The	 organism	 B.	 subtilis	 provides	 a	
benign	model	for	the	study	of	DNA	replication	initiation	in	Gram-positive	bacteria;	perhaps	
revealing	important	nuances	of	DNA	replication	which	can	be	targeted	in	the	development	
of	antibiotics	against	Gram-positive	pathogens.	
	
1.17:	Aims	of	This	Project	
The	aim	of	this	project	was	to	improve	our	understanding	of	the	regulatory	mechanisms	
used	by	B.	subtilis	to	control	DNA	replication	initiation.	More	specifically,	the	project	aimed	
to	characterise	protein	regulators	of	DNA	replication	and	their	interaction	partners	using	
structural	and	biophysical	methods,	to	determine	the	molecular	mechanism	each	protein	
uses	to	regulate	DNA	replication	initiation.	The	focus	of	the	project	later	became	the	
characterisation	of	two	negative	regulators	of	B.	subtilis	DNA	replication:	SirA	and	YabA.			
The	specific	aims	of	the	project	were	to	express	and	purify	the	DNA	replication	regulator	
SirA	 in	 complex	 with	 DnaA	 domain	 I	 (SirA-DnaADI)	 in	 both	 native	 and	 SeMet	 derivative	
forms	 for	 structure	 determination;	 to	 crystallise	 and	 solve	 the	 structure	 of	 SirA-DnaADI	
using	 single	 anomolous	 dispersion	 (SAD)	 phasing	methods	 and	 to	 characterise	 the	 SirA-
DnaADI	 complex;	 and	 to	 produce	mutants	 to	 assist	 in	 the	 characterisation	 of	 SirA-DnaADI	
binding.			
For	YabA;	 to	express	and	purify	YabA	 in	native	and	SeMet	derivative	 forms	 for	 structure	
determination;	 to	 crystallise	 YabA	 and	 solve	 the	 structure	 of	 YabA	 to	 facilitate	
understanding	 of	 how	 it	 inhibits	 DNA	 replication	 initiation;	 and	 to	 carry	 out	 biophysical	
characterisation	 of	 YabA	 to	 experimentally	 validate	 an	 in	 silico	 model	 of	 YabA	 and	 gain	
understanding	of	YabA's	quaternary	architecture.		
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Chapter	2 :	Biophysical	and	Structural	Characterisation	of	SirA-DnaADI	
2.1:	Abstract	
Cells	of	B.	subtilis	can	form	endospores	in	response	to	nutrient	starvation.	This	process	of	
differentiation	requires	an	asymmetric	cell	division	creating	two	cellular	compartments,	a	
forespore	and	a	mother	cell,	each	of	which	require	a	single	copy	of	the	organism’s	genome	
to	ensure	the	fitness	of	the	resultant	spore.	DNA	replication	must	therefore	be	coupled	to	
sporulation	to	ensure	that	the	sporulating	cell	has	the	correct	chromosome	copy	number.	
SirA,	a	protein	produced	under	 the	control	of	 the	master	sporulation	regulator	Spo0A~P,	
directly	inhibits	DNA	replication	in	diploid	cells	committed	to	sporulation,	by	binding	to	the	
replication	 initiator	protein,	DnaA.	Here	we	have	 solved	 the	 structure	of	 SirA	 in	 complex	
with	domain	I	of	DnaA	(DnaADI)	revealing	a	heterodimer.	The	interacting	surfaces	of	both	
proteins	 are	α-helical	 in	 character	with	 predominantly	 apolar	 side	 chains	 contributing	 to	
the	 packing	 of	 the	 interface.	 Site-directed	 mutagenesis	 experiments	 have	 been	 used	 to	
confirm	 the	 significance	 of	 the	 interface	 for	 the	 interaction	 of	 SirA	 and	 DnaADI	 in	 vitro.	
These	results	are	further	supported	by	collaborative	work	on	site-directed	mutants	in	vivo,	
which	suggest	that	the	SirA-DnaADI	interface	identified	in	the	crystal	structure	is	significant	
for	DnaA-mediated	localisation	of	SirA	at	the	replisome	in	sporulating	cells.	
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2.2:	Introduction	
In	response	to	nutrient	starvation,	B.	subtilis	cells	enter	the	sporulation	pathway,	creating	
an	 endospore	 which	 lies	 dormant	 until	 nutrient	 conditions	 improve175.	 	 The	 process	 of	
sporulation	 involves	 the	 asymmetric	 division	 of	 the	 cell	 into	 a	 larger	 mother	 cell	 and	 a	
smaller	forespore	compartment,	each	of	which	require	one	copy	of	the	organism’s	genome	
to	 form	the	 resultant	 spore175.	Sporulation	entry	 typically	 follows	 the	completion	of	DNA	
replication	due	 to	a	 feedback	 regulatory	mechanism	which	 creates	a	pulsing	of	 Spo0A~P	
levels	with	the	cell	cycle.	The	peak	in	Spo0A~P	concentration	occurs	immediately	after	the	
completion	 of	 DNA	 replication	 (see	 section	 1.14.5).	 Although	 this	 feedback	 provides	 a	
mechanism	 for	 preventing	 replicating	 cells	 from	 entering	 sporulation,	 cells	 which	 are	
artificially	induced	to	sporulate	under	conditions	of	rapid	growth	can	still	maintain	correct	
chomosome	copy	number192.	This	implies	that	the	cell	also	carries	an	active	mechanism	for	
blocking	DNA	replication	in	cells	already	committed	to	sporulation.		
Deletion	of	a	gene	under	the	direct	control	of	Spo0A~P,	yneE	(sirA),	resulted	in	cells	which	
lose	the	ability	to	control	chromosome	number	when	induced	to	sporulate	from	conditions	
of	rapid	growth192.	Overproduction	of	 the	encoded	protein,	SirA,	 in	cells	growing	on	agar	
plates	 results	 in	 an	 inability	 to	 produce	 colonies	 and	 expression	 of	 SirA	 in	 liquid	 culture	
produces	elongated	and	anucleate	cells,	with	some	cells	containing	nucleoids	which	have	
been	severed	by	division	septa	–	a	phenotype	reminiscent	of	DnaA	depletion	192,193.	These	
experiments	 defined	 SirA	 as	 a	 negative	 regulator	 of	 DNA	 replication	 during	 spore	
formation.	 Yeast	 two-hybrid	 and	 localisation	 studies	 show	 that	 SirA	 acts	 to	 inhibit	 DNA	
replication	 via	 a	 direct	 interaction	 with	 DnaA193.	 A	 genetic	 assay	 was	 used	 to	 isolate	
mutations	 in	 DnaA	 which	 would	 allow	 the	 cell	 to	 overcome	 the	 no-growth	 phenotype	
displayed	by	cells	overproducing	SirA	on	agar	plates.	This	identified	four	strains	resistant	to	
the	overproduction	of	SirA,	which	contained	mutations	in	dnaA	that	mapped	to	a	region	on	
DnaA	 domain	 I	 (DnaADI),	 strongly	 indicating	 that	 this	 cluster	 of	 amino	 acid	 residues	 is	
located	at	the	SirA-interaction	site	on	DnaA83.		
The	major	sporulation	regulator,	Spo0A~P	has	been	shown	to	play	a	role	in	regulating	DNA	
replication	initiation	by	binding	Spo0A-boxes	within	oriC	which	overlap	with	DnaA-binding	
sites195	 (see	 section	1.14.5.3).	 Loss	of	binding	 to	 these	Spo0A	boxes	affects	 chromosome	
copy	number	control	during	sporulation194.	However,	these	effects	are	only	significant	in	a	
Δsda/ΔsirA	mutant	strain	when	sporulation	 is	 induced	 from	 low	nutrient	conditions	or	 in	
rapidly	 growing	 cells	 suddenly	 induced	 to	 sporulate194.	 Otherwise	 the	 most	 important	
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factors	 for	 copy	 number	 control	 were;	 in	 low	 nutrient	 conditions,	 Sda,	 a	 factor	 which	
inhibits	 sporulation	 entry	 in	 response	 to	 transcription	 regulation	 by	 DnaA	 (see	 section	
1.14.5.1)194;	 and	 in	 rapidly	 growing	 cells	 induced	 to	 sporulate,	 SirA194.	 This	 suggests	 that	
Sda	 and	 SirA	 are	 the	 main	 contributors	 to	 chromosome	 copy	 number	 control	 during	
sporulation,	with	Sda	acting	to	prevent	replicating	cells	from	entering	sporulation,	and	SirA	
preventing	 the	 initiation	of	new	 rounds	of	DNA	 replication	 in	 cells	 already	 committed	 to	
sporulation.		
Here,	 we	 were	 interested	 in	 studying	 the	 structure	 of	 SirA,	 to	 gain	 insight	 into	 its	
mechanism	of	action.	SirA	has	no	homologues	other	than	those	found	in	bacilli,	which	adds	
to	its	interest	as	a	structural	target.		
Preliminary	work	done	at	York	Structural	Biology	Laboratory	by	M.	Fogg	and	A.	Grahl	found	
that	the	production	of	recombinant	SirA	in	E.	coli	yielded	only	insoluble	protein	in	all	of	the	
tested	 E.	 coli	 cell	 strains	 and	 growth	 conditions198.	 However,	 the	 creation	 of	 a	 duet	
expression	 vector,	 pYSBLICDnaADISirA,	which	directs	 the	expression	of	MQAGPA-SirA	and	
histidine	 tagged	 domain	 I	 of	 DnaA	 (His6DnaADI)	 from	 separate	 T7	 promotors,	 led	 to	 the	
production	of	SirA	in	a	soluble	form	(where	SirA	is	assumed	to	be	in	complex	with	DnaADI).		
	
2.3:	Aims	
SirA	 interacts	 with	 Domain	 I	 of	 DnaA	 to	 inhibit	 DNA	 replication	 during	 the	 onset	 of	
sporulation.	There	 is	no	 structural	 information	available	about	SirA	 to	 infer	 its	molecular	
mechanism.	The	aim	of	the	work	detailed	in	this	chapter	was	to	purify	SirA	in	complex	with	
domain	 I	of	DnaA	(DnaADI)	and	solve	 the	structure	of	 the	SirA-DnaADI	 inhibitory	complex.		
Ultimately	to	use	this	structure	to	gain	insight	into	the	mechanism	SirA	employs	to	inhibit	
the	initiation	of	DNA	replication.	
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2.4:	Methods		
2.4.1:	Expression		
The	plasmid	pET-YSBLIC3C-DnaADISirA	was	 introduced	 into	E.	coli	BL21	 (DE3)	cells	 for	 the	
co-overproduction	 of	 SirA	 and	 His-tagged	 DnaADI.	 Overnight	 cell	 cultures	 were	 used	 to	
inoculate	 500	 ml	 of	 LB	 media	 supplemented	 with	 30	 μg/ml	 kanamycin.	 Cultures	 were	
grown	to	an	OD600	of	0.6-0.9	at	37	°C	with	shaking	at	180	rpm	before	protein	production	
was	 induced	 with	 1	 mM	 Isopropyl-β-D-1-thiogalactoside	 (IPTG).	 Following	 induction,	
cultures	were	 grown	 at	 37	 °C	 (180	 rpm	 shaking)	 for	 a	 further	 4	 hours	 before	 cells	were	
harvested	by	centrifugation.	SirA/DnaADI	proteins	harbouring	site-directed	mutations	were	
produced	in	an	analogous	manner.	
For	 SeMet	 substituted	 protein	 production,	 overnight	 cultures	 of	 E.	 coli	 BL21	 (DE3)	
harbouring	 pET-YSBLIC3C-DnaADISirA	 were	 used	 to	 inoculate	 500	 ml	 minimal	 media	
supplemented	with	30	μg/ml	kanamycin.	Cultures	were	grown	to	an	OD600	of	0.6-0.8	at	37	
°C	(180	rpm	shaking)	prior	to	the	addition	of	an	amino	acid	mixture	(50	mg	lysine,	50	mg	
phenylalanine,	 50	 mg	 threonine,	 25	 mg	 isoleucine,	 25	 mg	 leucine,	 25	 mg	 valine)	 to	
suppress	methionine	production	199,	and	30	mg	selenomethionine.	Cultures	were	grown	at	
37	°C	(180	rpm	shaking)	for	a	further	15	minutes	prior	to	induction	of	recombinant	protein	
production	with	1	mM	IPTG.	Cultures	were	subsequently	grown	at	30	°C	(180	rpm	shaking)	
overnight	(16-20	hours)	before	cells	were	harvested	by	centrifugation.	
	
2.4.2:	Purification		
The	protein	purification	procedure	was	identical	for	native	and	SeMet	substituted	proteins.	
Harvested	 cells	were	 resuspended	 in	50	mM	Tris	pH	8.5,	200	mM	KCl,	 20	mM	 imidazole	
and	 10	 mM	 2-mercaptoethanol	 (βME)	 (Buffer	 A),	 and	 an	 EDTA-free	 protease	 inhibitor	
cocktail	 tablet	 (Roche)	 was	 added.	 Resuspended	 cells	 were	 lysed	 by	 sonication	 and	 the	
lysate	clarified	by	centrifugation.	The	cell	 lysate	was	 loaded	on	to	a	His	Trap	FF	crude	Ni-
affinity	 column	 (GE	 Healthcare)	 and	 bound	 protein	 eluted	 with	 an	 increasing	 imidazole	
concentration	gradient	(20	–	500	mM)	by	addition	of	buffer	B	(50	mM	Tris	pH	8.5,	200	mM	
KCl,	 500	 mM	 imidazole	 and	 10	 mM	 βME).	 This	 step	 was	 followed	 by	 size-exclusion	
chromatography	 on	 a	 HiLoad	 16/60	 Superdex	 S75	 column	 (GE	 Healthcare)	 equilibrated	
with	50	mM	Tris	pH	8.5,	200	mM	KCl,	10	mM	βME	(Buffer	C).	The	chromatogram	exhibited	
two	protein	peaks.	SDS-PAGE	analysis	of	the	peak	fractions	showed	the	earlier	eluting	peak	
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corresponded	 to	 the	 SirA-His6DnaADI	 complex	 with	 the	 later	 eluting	 peak	 containing	
His6DnaADI	which	is	produced	in	excess	in	the	duet	expression	system.	The	protein	complex	
and	 DnaADI	 fractions	 were	 combined	 separately	 and	 the	 N-terminal	 histidine	 tag	 was	
removed	from	DnaADI	 in	both	cases	by	 incubation	with	3C	protease	overnight	(protease	:	
protein	ratio	of	1:50).	Passage	through	a	second	Ni-affinity	column	to	remove	the	histidine	
tag	and	the	tagged	protease	yielded	pure	protein	in	a	buffer	of	50	mM	Tris	pH	8.5,	200	mM	
KCl,	10	mM	BME.	The	proteins	were	judged	to	be	pure	according	to	Coomassie	staining	of	
SDS-polyacrylamide	gels.	
	
2.4.3:	Mass	Spectrometry	
Purified	 SirA-DnaADI	 and	 DnaADI	 were	 buffer	 exchanged	 into	 2mM	 Tris	 for	 analysis	 by	
Electrospray	 Ionisation-Mass	 Spectrometry	 (ESI-MS).	 Samples	 were	 provided	 at	 a	
concentration	of	5	mg	ml-1.	Spectra	were	obtained	and	processed	by	Simon	Grist.		
	
2.4.4:	SEC-MALLS		
SEC-MALLS	 analysis	 of	 DnaADI	 and	 SirA-DnaADI	 was	 carried	 out	 at	 a	 range	 of	 protein	
concentrations:	DnaADI	was	analysed	at	1.0	mg	ml-1,	2.5	mg	ml-1	and	5.0	mg	ml-1	and	SirA-
DnaADI	was	analysed	at	0.5	mg	ml-1,	1.0	mg	ml-1	and	2.5	mg	ml-1.	For	each	run,	100	μl	of	
sample	was	loaded	onto	a	Superdex	75	HR	10/30	size-exclusion	column	equilibrated	with	
50	mM	 Tris	 pH	 8.5,	 200	mM	KCl	 at	 a	 flow	 rate	 of	 0.5	ml/min.	 The	 eluate	was	 analysed	
successively	 by	 a	 SPD20A	 UV/Vis	 detector,	 a	 Wyatt	 Dawn	 HELEOS-II	 18-angle	 light	
scattering	 detector	 and	 a	 Wyatt	 Optilab	 rEX	 refractive	 index	 monitor	 as	 described	
previously	200.	Data	were	analysed	with	Astra	software	(Wyatt).	
	
2.4.5:	Crystallisation	and	Structure	Solution:	SirA-DnaADI	
Native	 crystals	 of	 SirA-DnaADI	 were	 grown	 in	 hanging-drops	 containing	 a	 1:1	 ratio	 of	
concentrated	 protein	 solution	 and	 reservoir	 solution.	 Native	 crystals	 suitable	 for	 data	
collection	 were	 obtained	 following	 mixing	 of	 a	 protein	 solution	 of	 6.4	 mg	 ml-1	 and	 a	
reservoir	solution	of	100	mM	HEPES	pH	7.5,	200	mM	ammonium	acetate,	25	%	(w/v)	PEG	
3350,	 1%	 (v/v)	DMF.	Crystals	were	 transferred	 to	 a	 cryoprotectant	 solution	 consisting	of	
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the	 reservoir	 solution	 containing	 20%	 (v/v)	 glycerol	 before	 being	 cryocooled	 in	 liquid	
nitrogen.	X-ray	diffraction	data	were	collected	to	1.7	Å	resolution	on	beamline	 I03	at	the	
Diamond	Light	Source	(DLS),	Harwell.	The	crystal	belongs	to	space	group	P21	with	unit	cell	
dimensions	a	=	77.3	Å,	b	=	34.7	Å,	c	=	84.7	Å	and	α	=	γ	=	90	°,	β	=	102.1	°.	SeMet	crystals	
were	 grown	 in	 hanging-drops	 containing	 a	 2:1	 ratio	 of	 concentrated	 protein	 solution:	
reservoir	 solution.	 SeMet-substituted	 crystals	 suitable	 for	 data	 collection	 were	 obtained	
using	a	protein	concentration	of	1.9	mg	ml-1	and	a	reservoir	solution	of	100	mM	MMT	pH	
6.0	(DL-malic	acid,	MES	and	Tris	buffers	in	a	molar	ratio	of	1:2:2),	20	%	(w/v)	PEG	3350,	2%	
(v/v)	 DMF.	 Crystals	 were	 soaked	 in	 a	 cryoprotectant	 solution	 consisting	 of	 the	 reservoir	
solution	 containing	 20%	 (v/v)	 glycerol	 before	 being	 cryo-cooled	 in	 liquid	 nitrogen.	 X-ray	
diffraction	 data	 were	 collected	 to	 2.1	 Å	 resolution	 on	 beamline	 I24	 at	 DLS.	 The	 crystal	
belongs	to	space	group	P21	with	cell	dimensions	a	=	51.4	Å,	b	=	35.6	Å,	c	=	63.3	Å	and	α	=	γ	
=	90	°,	β	=	92.8	°.		
Diffraction	 datasets	 obtained	 from	 the	 SeMet	 derivative	 and	 native	 crystals	 were	
processed	using	the	automated	data	processing	pipeline	Xia2	201	with	options	that	run	XDS	
202.	Data	were	merged	using	AIMLESS	203.	The	structure	of	SirA-DnaADI	was	solved	by	single-
wavelength	anomalous	dispersion	(SAD)	phasing.	Heavy	atom	sub-structure	determination,	
density	 modification	 and	 model	 building	 were	 carried	 out	 using	 the	 CRANK	 204	 pipeline	
available	within	 the	 Collaborative	 Computational	 Project	No.	 4	 (CCP4)	 program	 suite	 205.	
Nine	 selenium	atom	sites	were	 identified	using	SHELX	C/D	 206	 and	 their	positions	 refined	
using	BP3.	The	correct	hand	for	the	phases	was	identified	using	SOLOMON	207	and	density	
modification	 carried	 out	 in	 PARROT	 208	 before	 atomic	model	 building	 in	 BUCCANEER	 209.	
The	SeMet-SirA-DnaADI	model	was	partially	refined	using	maximum-likelihood	methods	in	
REFMAC	 210	 and	 manual	 model	 building	 in	 COOT	 211.	 The	 partially	 refined	 SeMet-SirA-
DnaADI	 model	 was	 used	 as	 a	 model	 for	 the	 solution	 of	 native	 SirA-DnaADI	 by	 molecular	
replacement	 with	 MOLREP	 212,	 the	 search	 for	 SirA	 molecules	 preceding	 that	 for	 DnaADI	
domains.	The	native	SirA-DnaADI	model	was	refined	through	iterative	cycles	of	refinement	
in	 REFMAC	 and	 manual	 model	 building	 in	 COOT	 to	 an	 R-factor	 of	 13.1	 (Rfree	 =	 19.7).	
Refinement	 statistics	 are	 shown	 in	 Table	 2.8.	 The	 SirA-DnaADI	 atomic	 coordinates	 and	
crystallographic	 structure	 factors	have	been	deposited	 in	 the	Protein	Data	Bank	with	 the	
accession	code	4TPS.		
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2.4.6:	Crystallisation	&	Structure	Solution:	DnaADI	
SeMet	derivative	crystals	of	His6DnaADI	were	grown	in	hanging-drops	containing	a	1:1	ratio	
of	concentrated	protein	solution	and	reservoir	solution.	Crystals	suitable	for	data	collection	
were	 obtained	 after	 3	months	 following	mixing	 of	 a	 protein	 solution	 of	 4	mg	ml-1	 and	 a	
reservoir	solution	of	100	mM	Bis-Tris	Propane	pH	7.5,	0.5%	dioxane,	25	%	(w/v)	PEG	3350.	
Crystals	were	transferred	to	a	cryoprotectant	solution	consisting	of	the	reservoir	solution	
containing	20%	(v/v)	glycerol	before	being	cryo-cooled	in	liquid	nitrogen.	X-ray	diffraction	
data	were	collected	to	2.4	Å	resolution	on	beamline	I03	at	the	Diamond	Light	Source	(DLS),	
Harwell.	The	crystal	belongs	to	space	group	P43212	with	unit	cell	dimensions	a	=	41.27	Å,	b	
=	41.27	Å,	c	=	111.46	Å	and	α	=	β=	γ	=	90	°.	A	diffraction	dataset	obtained	from	the	SeMet	
derivative	 was	 processed	 using	 MOSFLM213	 and	 data	 were	 scaled	 and	 merged	 using	
AIMLESS	 (Evans,	 2006).	 The	 structure	 of	DnaADI	was	 initially	 solved	 by	 single-wavelength	
anomalous	 dispersion	 (SAD)	 phasing,	 however	 improved	 refinement	 statistics	 were	
obtained	 when	 the	 structure	 was	 re-solved	 by	 molecular	 replacement	 using	 B.	 subtilis	
DnaADI	 structure	 from	 the	 SirA-DnaADI	 complex	 as	 a	molecular	 replacement	model.	 One	
DnaADI	molecule	was	found	to	occupy	the	asymmetric	unit,	with	a	solvent	content	of	48%.	
The	 DnaADI	 model	 was	 refined	 through	 iterative	 cycles	 of	 refinement	 in	 REFMAC	 and	
manual	model	building	 in	COOT	to	an	R-factor	of	20.9	(Rfree	=	28.6).	Refinement	statistics	
are	shown	in	Table	2.9.		
	
2.4.7:	Mutagenesis	
Six	 individual	 alanine	 substitution	 mutations	 were	 introduced	 into	 pET-YSBLIC3C-DnaADI	
SirA	 by	 site-directed	 mutagenesis.	 On	 dnaADI,	 mutations	 were	 introduced	 to	 direct	
substitutions	at	T26,	W27	and	F49.	On	sirA;	at	F14,	Y18	and	Q48.	Oligonucleotides	used	for	
the	mutagenesis	 reactions	are	 shown	 in	Table	2.1.	PCR	 reactants	and	cycling	parameters	
are	shown	in	Tables	2.2	and	2.3,	respectively.	PCR	products	(50	μl)	were	incubated	with	15	
units	of	DpnI	at	37°C	for	4-5	hours.		50μl	of	Top10	cells	were	transformed	with	2μl	of	DpnI-
digested	 product	 and	 cells	 plated	 onto	 kanamycin-supplemented	 agar	 to	 select	 for	 the	
mutated	 plasmids.	 Individual	 colonies	 were	 selected	 and	 grown	 overnight	 in	 5	 ml	 LB	
supplemented	 with	 30	 μg/ml	 kanamycin.	 Overnight	 cultures	 were	 harvested	 by	
centrifugation	and	DNA	extracted	and	purified	from	the	harvested	cells	using	a	Mini-prep	
kit	 (Qiagen).	 Introduction	of	mutations	at	 the	desired	sites	was	confirmed	by	sequencing	
(data	not	shown).	
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Table	2.1:	Oligomers	used	for	the	mutagenesis	of	pET-YSBLIC3C-DnaADI	SirA	
	
	
Table	2.2:	PCR	components	for	the	site-directed	mutagenesis	of	pET-YSBLIC3C-DnaADI	SirA	
Reactant	 Volume/	μl		(50μl	reaction)	
pET-YSBLIC3C-DnaADISirA	(100	ng	μl-1)	 1	
Mutagenesis	oligo	I	(20	pmol	μl-1)	 0.5	
Mutagenesis	oligo	II	(20	pmol	μl-1)	 0.5	
Pfu	Turbo	Buffer	 5	
dNTPs	(2mM)	 5	
Pfu	Turbo	DNA	Polymerase	(10,000	U/	ml)	 1	
DMSO	 1	
H2O	 36	
	
	
Table	2.3:	PCR	cycling	parameters	for	the	site-directed	mutagenesis	of	pET-YSBLIC3C-DnaADI	SirA	
PCR	Step	 Temperature	(°C)	 Time	/	min	 Cycles	
Initial	denature	 95	 5	 1	
Denature	 95	 1	
	
30	
Anneal	 50	 1	
Extend	 72	 10	
Final	denature	 95	 1.25	 1	
Final	extend	 72	 5	 1	
Construct	Name	 Mutagenesis	Oligomers		
pET-YSBLIC3C-DnaADIT26A	SirA	 5’–	CCGAGTTTTGAGGCTTGGATGAAGTCAACC	–3’	
5’–	GGTTGACTTCATCCAAGCCTCAAAACTCGG	–3’	
pET-YSBLIC3C-DnaADIW27A	SirA	 5’–	CGAGTTTTGAGACTGCGATGAAGTCAACC	–3’	
5’–	GGTTGACTTCATCGCAGTCTCAAAACTCG	–3’	
pET-YSBLIC3C-DnaADIF49A	SirA	 5’–	CGGCTCCCAATGAAGCTGCCAGAGACTGGC	–	3’	
5’	–	GCCAGTCTCTGGGCAGCTTCATTGGGAGCCG	–	3’	
pET-YSBLIC3C-DnaADISirAF14A	 5’	–	CCTGATCAAAGAGGAAGCTGCCAATCACTATTTCGG	–	3’	
5’	–	CCGAAATAGTGATTGGCAGCTTCCTCTTTGATCAGG	–	3’	
pET-YSBLIC3C-DnaADISirAY18A	
	
5’	–	GGAATTTGCCAATCACGCTTTCGGCCGGGAATCGG	–	3’	
5’	–		CCGATTCCCGGCCGAAAGCGTGATTGGCAAATTCC	–	3’	
pET-YSBLIC3C-DnaADISirAQ48A	
	
5’	–	GAAATGACAGAGAAAGCGATTCAATATATTACAC	–	3’	
5’	–	GTGTAATATATTGAATCGCTTTCTCTGTCATTTC	–	3’	
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2.4.8:	Solubility	Assay	
E.	 coli	 BL21	 (DE3),	 harbouring	wild	 type	 and	mutated	 pET-YSBLIC3C-DnaADISirA	 plasmids	
were	grown	in	200	ml	LB-kanamycin	until	the	OD600	reached	~0.6.	A	portion	of	cells	was	set	
aside	and	harvested	(uninduced	aliquot	(U))	while	IPTG	was	added	to	the	remaining	cells.	
After	 a	 further	 4	 hours	 growth,	 aliquots	 of	 the	 induced	 (I)	 cells	were	 taken	 and	 used	 to	
prepare	total	cell	samples.	The	remaining	cells	from	the	induced	culture	were	harvested	by	
centrifugation	and	the	cell	pellets	were	re-suspended	in	20	ml	of	50	mM	Tris	pH	8.5,	200	
mM	KCl,	20	mM	imidazole,	10	mM	2-mercaptoethanol.		Cells	were	lysed	by	sonication	and	
the	 lysate	 clarified	by	 centrifugation.	An	aliquot	of	 this	 soluble	 fraction	 (S)	was	 retained.	
The	 remaining	 lysate	 was	 loaded	 onto	 a	 1ml	 HisTrap	 FF	 crude	 Ni-affinity	 column	 (GE	
Healthcare),	washed	with	6	ml	re-suspension	buffer,	and	bound	protein	eluted	with	4	ml	of	
50	mM	 Tris	 pH	 8.5,	 200	ml	 KCl,	 500	mM	 imidazole,	 10	mM	2-mercaptoethanol	 and	 the	
eluate	 (E)	was	 collected.	 For	 each	 of	 the	wild	 type	 and	 alanine	 variants,	 samples	 of	 the	
total	 fractions	from	uninduced	(U)	and	induced	(I)	cells	together	with	the	soluble	 lysis	(S)	
and	high	 imidazole	 column	eluate	 (E)	 fractions	were	 analysed	by	 SDS	polyacrylamide	 gel	
electrophoresis	followed	by	Coomassie	blue	staining.	
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2.5:	Results	
2.5.1:	Production	of	SirA-DnaADI	
Cloning	and	expression	testing	carried	out	by	Mark	Fogg	and	Anne	Grahl	prior	to	the	start	
of	 this	 project	 revealed	 that	 production	 of	 recombinant	 His-SirA	 in	 E.	 coli	 yielded	 only	
insoluble	 protein.	 A	 number	 of	 expression	 strains	 and	 solubilisation	 buffers	were	 tested	
and	although	high	levels	of	SirA	were	consistently	produced,	the	protein	always	partitioned	
into	 the	 insoluble	 fraction	 upon	 cell	 lysis198.	 Following	 a	 report	 that	 the	 SirA	 binding	
determinants	of	DnaA	reside	 in	domain	 I	83,	a	co-expression	construct	was	created	which	
directs	 expression	 of	 dnaADI	 (fused	 to	 a	 sequence	 encoding	 an	 N-terminal	 cleavable	
polyhistadine	tag)	and	sirA	 from	separate	T7	promoters	on	the	same	vector.	Remarkably,	
this	co-expression	strategy	resulted	 in	 the	expression	of	high	 levels	of	SirA	 in	 the	soluble	
cell	fraction	after	cell	lysis	-	a	result	attributed	to	an	assumed	interaction	with	DnaADI.	The	
work	described	here	utilises	this	co-expression	vector	for	protein	production.	
Native	 and	 SeMet-substituted	 SirA-DnaADI	 were	 expressed	 as	 described	 in	 section	 2.4.1.	
Fig.	2.1	shows	expression	tests	of	both	Native	and	SeMet	forms	of	the	protein.	Expression	
of	 SirA	 and	 DnaADI	 is	 clearly	 induced	 in	 both	 SeMet	 and	Native	 cultures	 (comparison	 of	
lanes	 2	 &	 3	 and	 5	 &	 6,	 respectively).	 Both	 derivatives	 appear	 to	 have	 high	 solubility,	
although	 the	 SeMet	 derivative	 is	 slightly	 reduced	 compared	 to	 wildtype	 (lanes	 4	 and	 7	
respectively).			
	
Figure	2.1:	Expression	of	wild-type	and	SeMet-substituted	SirA-DnaADI	;	lane	1:	broad-range	
markers;	lane	2:	lysate	from	uninduced	SeMet	cell	culture;	lane	3:	total	lysate	from	induced	SeMet	
cell	culture;	lane	4:	soluble	lysate	from	SeMet	cell	culture;	lane	5:	lysate	from	uninduced	native	cell	
culture;	lane	6:	lysate	from	induced	native	cell	culture;	lane	7:	soluble	lysate	from	native	cell	culture.	
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2.5.2:	Purification	of	SirA-DnaADI	and	DnaADI	
Native	and	SeMet-derivative	SirA-DnaADI	was	purified	by	the	procedure	outlined	in	section	
2.4.2.	Clarified	 lysate	was	 loaded	onto	a	Ni-affinity	column	and	eluted	over	a	gradient	of	
increasing	 imidazole	 concentration.	 SirA-DnaADI	 is	 retained	on	 the	column	 through	a	His-
tag	located	at	the	N-terminus	of	DnaADI.	The	protein	complex	eluted	as	a	single	peak	at	an	
imidazole	 concentration	 of	 appoimately	 125	 mM.	 Fig.	 2.2,	 A,	 shows	 a	 typical	
chromatogram.	 Fractions	 containing	 protein	 eluted	 from	 the	 Ni	 column	were	 combined	
(and	 concentrated	 when	 necessary)	 to	 a	 total	 volume	 of	 less	 than	 5ml.	 For	 the	
chromatogram	in	Fig.	2.2,	A,	 fractions	9-20	were	combined	(and	concentrated	to	approx.	
5ml)	 following	 analysis	 by	 SDS-PAGE	 (Fig.	 2.2,	 B)	 which	 showed	 high	 levels	 of	 SirA	 and	
DnaADI	in	fractions	within	this	range.		
	
Figure	2.2:	Ni-affinity	chromatography	for	SirA-DnaADI:	A)	Chromatogram	showing	elution	of	
protein	 from	Ni-affinity	 column;	 In	blue,	absorbance	at	280	nm;	 in	 red,	absorbance	at	254	nm;	 in	
green;	 percentage	 of	 buffer	 B	 (buffer	 B	 concentration	 =	 500	 mM	 imidazole);	 numbers	 in	 purple	
denote	fractions	collected.	B)	SDS-PAGE	analysis	of	fractions	eluted	from	Ni-affinity	column;	Lane	1,	
broad-range	 markers;	 lane	 2,	 Flow-through	 during	 Ni-affinity	 column	 loading;	 lane	 3,	 wash	 with	
buffer	A;	 lane	4,	10	µl	Fraction	8;	 lane	5,	10	µl	Fraction	10;	 lane	6,	10	µl	Fraction	11;	 lane	7,	10	µl	
Fraction	15;	lane	8,	10	µl	Fraction	19;	lane	9,	10	µl	Fraction	20.	
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This	 SirA-DnaADI	 complex	 was	 further	 purified	 using	 size-exclusion	 chromatography.	 The	
protein	elutes	in	two	peaks	–	a	chromatogram	is	shown	in	Fig.	2.3,	A.	Analysis	by	SDS-PAGE	
(Fig.	2.3,	B)	reveals	that	the	first	peak	contains	SirA	and	DnaADI	(assumed	to	be	in	complex)	
and	the	second	peak,	DnaADI.	 	 In	the	example	shown	in	Figure	2.3,	A,	fractions	9-11	were	
combined	as	 analysis	 by	 SDS-PAGE	 indicates	 that	 these	 fractions	 contain	 the	 SirA-DnaADI	
complex.	 Fractions	 14-18	 were	 also	 combined	 as	 these	 are	 assumed	 to	 contain	 only	
DnaADI.	
	
Figure	2.3:	Size-exclusion	chromatography	for	SirA-DnaADI	:	A)	Chromatogram	showing	elution	of	
protein	from	size-exclusion	column;	In	blue,	absorbance	at	280	nm;	in	red,	absorbance	at	254	nm;	
numbers	 in	purple	denote	 fractions	 collected.	B)	SDS-PAGE	analysis	 of	 fractions	 eluted	 from	 size-
exclusion	column;	Lane	1,	broad-range	markers;	lane	2,	10µl	fraction	7;	lane	3,	10µl	fraction	8;	lane	
4,	10	µl	Fraction	9;	lane	5,	10	µl	Fraction	10;	lane	6,	10	µl	Fraction	11;	lane	7,	10	µl	Fraction	12;	lane	
8,	10	µl	Fraction	13;	lane	9,	10	µl	Fraction	14;	lane	10,	10	µl	Fraction	15.	
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The	hexa-histidine-tag	can	be	cleaved	from	His6DnaADI	in	both	the	SirA-His6DnaADI	complex	
or	His6DnaADI	alone	by	 incubation	with	3C	protease	overnight	at	a	ratio	of	approximately	
1:100	 of	 3C	 protease:	 protein	 (Fig.	 2.4).	 Pure	 protein	 is	 then	 obtained	 by	 passing	 the	
cleaved	 protein	 through	 a	 second	 Ni	 column.	 His-tagged	 protein	 and	 (His-tagged)	 3C	
protease	 are	 retained	 on	 the	 column	whilst	 pure	 SirA-DnaADI	 (or	 DnaADI)	 emerge	 in	 the	
flowthrough.	Protein	collected	 in	 the	 flowthrough	 is	 concentrated	and	 shown	to	be	pure	
according	 to	 SDS-PAGE.	 (Although	 DnaADI	 bands	 appear	 diffuse,	 this	 appears	 to	 be	 an	
artifact	of	the	protein	size	and	not	due	to	impurity,	as	the	lowest	molecular	weight	marker	
also	runs	with	a	diffuse	band).		
	
Figure	2.4:	SDS-PAGE	analysis	of	His-tag	cleavage	from	DnaADI:	Lane	1,	broad-range	markers;	lane	
2,	 SirA-His-DnaADI;	 lane	 3,	 SirA-DnaADI	 after	 overnight	 incubation	 with	 3C	 protease;	 lane	 4,	 His-
DnaADI;	lane	5,	DnaADI	after	incubation	overnight	with	3C	protease.		
	
2.5.3:	Analysis	of	Purified	SirA-DnaADI	and	DnaADI	by	SDS	and	Native-PAGE	
Purified	SirA-DnaADI	and	DnaADI	were	analysed	by	SDS-PAGE	to	assess	their	purity.	Fig.	2.5,	
A,	 shows	 SDS-PAGE	 analysis	 of	 native	 and	 SeMet	 derivatives	 of	 SirA-DnaADI	 and	 DnaADI	
both	histidine-tagged	and	un-tagged	following	purification.	All	species	appear	to	be	pure.	
For	the	SirA-DnaADI	complex	 (lanes	1-4),	 the	relative	staining	of	SirA	and	DnaADI	 indicates	
that	 the	 two	exist	 as	 a	 1:1	 complex;	 i.e.	 SirA	would	be	expected	 to	 show	a	band	almost	
twice	as	large	as	DnaADI	for	a	1:1	ratio	on	account	of	their	expected	masses	-	18,	698	Da	for	
SirA	and	11,749	(His-tagged)	or	9,	734	Da	(untagged)	for	DnaADI.		
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Native-PAGE	analysis	was	also	carried	out	for	native	and	SeMet	forms	of	SirA-DnaADI	and	
DnaADI	 to	 analyse	 the	 homogeneity	 of	 the	 complex	 and	 DnaADI	 species	 in	 both	 their	
histidine-tagged	and	untagged	forms	(Fig.	2.5,	B).	The	gel	indicates	that	native	and	SeMet	
His6DnaADI	and	DnaADI	form	a	single	homogenous	species	(Fig.	2.5	B,	lanes	5-8).	Analysis	of	
native	and	SeMet	SirA-His6DnaADI	 each	 reveal	3	bands	 (Fig.	2.5,	B,	 lanes	1-4);	 the	 lowest	
band	 in	 each	 case	 corresponds	 to	 (His6)DnaADI;	 present	 in	 the	 sample	 either	 as	 excess	
protein	remaining	with	the	complex	during	purification,	or	as	protein	that	has	dissociated	
from	 the	 complex.	 A	 band	 of	 similar	 intensity	 to	 DnaADI	 which	 appears	 just	 below	 the	
predominant	species	 in	these	samples,	 is	 likely	to	correspond	to	SirA,	consistent	with	the	
notion	 that	 a	 proportion	 of	 the	 SirA-DnaADI	 complex	 has	 undergone	 dissociation.	 The	
predominant	species	in	lanes	1-4	is	thought	to	correspond	to	the	SirA-His6DnaADI	complex.		
	
Figure	2.5:	SDS-	and	native-PAGE	analysis	of	pure	SirA-DnaADI	and	DnaADI:	:	A)	SDS-PAGE,	and	B)	
Native-PAGE.	For	A	and	B:	Lane	1,	1µg	Native	SirA-His6DnaA
DI;	lane	2,	1µg	Native	SirA-DnaADI;	lane	3,	
1µg	SeMet	SirA-His6DnaA
DI;	 lane	4,	1µg	 	SeMet	SirA-DnaADI;	 lane	5,	1µg	Native	His6DnaA
DI;	 lane	6,	
1µg	Native	DnaADI;	 lane	 7,	 1µg	 SeMet	His6DnaA
DI;	 lane	 8,	 1µg	 SeMet	DnaADI.	 For	 A	 only:	 Lane	 9,	
broad-range	markers.		
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2.5.4:	Mass	Spectrometry	
Electrospray-ionisation	 mass	 spectrometry	 was	 used	 to	 analyse	 purified	 SirA-His6DnaADI	
(i.e.	prior	to	His-tag	cleavage)	and	DnaADI	samples	with	and	without	the	histidine	tag.		
The	 spectrum	 of	 SirA-His6DnaADI	 revealed	 4	 mass	 peaks	 (Table	 2.4).	 The	 two	 higher	
molecular	 mass	 peaks	 of	 18,776	 Da	 and	 18,698	 Da	 correspond	 to	 SirA;	 the	 latter	
corresponds	 exactly	 to	 the	 expected	mass	 of	 the	 recombinant	 SirA	 construct	 (MQAGPA-
SirA	=	18,698	Da)	and	the	former	has	a	mass	78	Da	greater	than	this	(18,776	Da).	This	peak	
arises	 from	 the	 covalent	 attachment	 of	 β-mercaptoethanol	 to	 SirA	 which	 presumably	
occurred	during	purification	when	addition	of	βME	was	found	to	increase	the	solubility	of	
the	 complex	 significantly	 (βME	 has	 a	 mass	 of	 78	 Da).	 	 This	 is	 the	 larger	 peak	 in	 the	
spectrum	and	is	thus	considered	to	be	the	predominant	species.	This	βME	adduct	was	later	
observed	in	the	crystal	structure	(see	section	2.5.8.1).	The	two	lower	mass	peaks	of	11,750	
Da	 and	 9,734	 Da	 correspond	 to	 molecular	 weights	 for	 His6DnaADI	 without	 the	 initiator	
methionine	 (11,747	 Da)	 and	 DnaADI	 plus	 3	 amino	 acids,	 Gly-Pro-Ala	 (9,734	 Da)	 –	 this	 is	
equivalent	to	a	DnaADI	molecule	where	the	His-tag	has	been	removed.			
	
Table	2.4:	Peaks	observed	in	mass	spectra	of	the	SirA-His6DnaA
DI	complex	
Sample	 Peak	 Observed		
Mass	(Da)	
Calculated	Mass	(Da)	 Species	
SirA-His6DnaADI	 1	 18,775	 18,776	 SirA-βME	
2	 18,698	 18,698	 SirA	
3	 11,750	 11,880	–	131	(Met)	=	11,749	 His6DnaADI	
4	 9,735	 9,734	 DnaADI	
	
The	mass	spectra	of	His6DnaADI	and	DnaADI	produced	single	peaks	at	11,747	Da	and	9,731	
Da,	 respectively	 (Table	 2.5).	 These	 values	 are	 in	 good	 agreement	 with	 their	 theoretical	
molecular	masses.	His6DnaADI	has	a	theoretical	molecular	mass	of	11,880	Da	and	as	above,	
the	observed	mass	corresponds	to	a	loss	of	the	start	methionine	(11,749	Da).	DnaADI	has	a	
theoretical	mass	of	9,734,	in	good	agreement	with	the	empirical	mass	of	9,	731	Da.		
Samples	of	native	and	SeMet	His6DnaADI	which	had	been	stored	at	4	°C	for	approximately	4	
months	were	also	analysed	(Table	2.5).	This	protein	had	been	used	for	crystal	optimisation,	
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however	 the	 crystals	were	 not	 reproducible	with	 a	 fresh	 preparation	 of	 His6DnaADI,	 and	
mass	 spectrometry	was	 used	 to	 analyse	 the	 crystallising	 sample.	 Analysis	 confirmed	 the	
incorporation	of	2	 SeMet	 residues	 in	 the	 case	of	 SeMet	His6DnaADI,	 and	both	native	and	
SeMet	proteins	displayed	3	peaks	in	their	spectra.	In	both	cases,	these	peaks	corresponded	
to	3	different	N-terminal	 truncations	of	 the	protein;	2	within	the	His-tag,	 leaving	4	and	5	
residues	 attached,	 respectively,	 and	 one	 missing	 the	 His-tag	 and	 an	 additional	 2	 amino	
acids	at	the	N-terminus.	Crystallisation	experiments	were	subsequently	switched	to	DnaADI	
following	His-tag	cleavage,	however,	SeMet	DnaADI	diffracting	crystals	were	obtained	from	
an	earlier	crystal	 tray	and	the	structure	subsequently	solved.	This	analysis	would	suggest	
that	the	crystallising	species	did	not	contain	the	full	his-tag	(the	predominant	species	in	the	
case	of	SeMet	DnaADI	had	4	His-tag	residues).	
Table	2.5:	Peaks	observed	by	mass	spectrometry	of	DnaADI	proteins	
Sample	 Peak		 Observed	Mass	
(Da)	
Calculated	Mass	
(Da)	
Species	
His6DnaADI	 1	 11747	 11,880	–	131	(Met)		
=	11,749	
His6DnaADI	
DnaADI	 1	 9731	 9,734	 DnaADI	
His6DnaADI		
(storage	at	4°C	
for	~4	months)	
1	 10,045	 10,009	 FQGPA-DnaADI	
2	 9861		 9862	 QGPA-DnaADI	
3	 9247	 9248	 DnaADI	(-ME)	
SeMet	His6DnaADI	
(storage	at	4°C	
for	~4	months)	
1	 10,139	 10,103	 SeMet	FQGPA-DnaADI	
2	 9955	 9956	 SeMet	QGPA-DnaADI	
3	 9295	 9294	 SeMet	DnaADI	(-ME)	
	
	
2.5.5:	SEC-MALLS	
Samples	 of	 DnaADI	 and	 of	 the	 SirA-DnaDI	 complex	 were	 analysed	 by	 SEC-MALLS	 (Size	
Exclusion	Chromatography	-	Multi-Angle	Laser	Light	Scattering).	This	technique	allows	the	
weight	 average	molecular	 weight	 of	 eluting	 species	 from	 a	 size	 exclusion	 column	 to	 be	
calculated,	 thus	 the	 oligomeric	 states	 of	 proteins,	 and	 the	 stoichiometry	 of	 protein	
complexes	can	be	inferred.		
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2.5.5.1:	Analysis	of	DnaADI		
Samples	of	DnaADI	were	analysed	at	concentrations	of	1.0	mg	ml-1,	2.5	mg	ml-1	and	5.0	mg	
ml-1.	(Fig.	2.6).	Table	2.6	shows	the	elution	times	and	experimentally	determined	molecular	
masses	for	each	DnaADI	concentration.		
Some	 discrepancy	 is	 observable	 between	 samples,	 notably	 the	 elution	 time	 decreases	
slightly	and	the	measured	weight	average	molecular	mass	increases	slightly	with	increasing	
DnaADI	 concentration.	 This	 suggests	 some	 self-association	 may	 be	 occurring	 at	 higher	
concentrations.	 However,	 on	 average,	 the	 samples	 correspond	 to	 a	 weight	 average	
molecular	 mass	 of	 ~11	 kDa,	 strongly	 suggesting	 that	 DnaADI	 is	 a	 monomer	 in	 solution	
(calculated	molecular	mass	of	9.7	kDa).	
	
Figure	2.6:	Overlay	of	SEC-MALLS	analysis	for	DnaADI	at	varying	concentrations:	the	thinner	lines	
display	the	differential	refractive	index	of	the	DnaADI-containing	elute	from	a	Superdex	10/300	S75	
column	as	a	function	of	time.	Thicker	lines	show	the	weight	average	molecular	mass	of	the	eluting	
species,	calculated	from	refractive	index	and	light	scattering	measurements.	Blue	shows	analysis	of	
DnaADI	at	5	mg	ml-1;	red	at	2.5	mg	ml-1	and	green	at	1	mg	ml-1,	revealing	species	of	approximately	11	
kDa,	indicating	that	DnaADI	is	a	monomer	in	solution.		
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Table	2.6:	DnaADI	SEC-MALLS	results	
Concentration	(mg	ml-1)	 Elution	Time	(min)	 Molecular	Weight	(kDa)	
1.0	 27.9	 10.4	
2.5	 27.6	 10.9	
5.0	 27.2	 11.4	
	
2.5.5.2:	Analysis	of	SirA-DnaADI		
Samples	of	SirA-DnaADI	were	analysed	at	concentrations	of	0.5	mg	ml-1,	1.0	mg	ml-1	and	2.5	
mg	ml-1	(Fig.	2.7,	A).	Results	are	shown	in	Table	2.7.		The	elution	profile	for	SirA-DnaADI	has	
two	peaks,	a	major	peak	at	~24	minutes	and	a	minor	peak	at	~28	minutes.	The	minor	peak	
comprises	 8-12%	 of	 the	 total	 protein	 content	 in	 the	 samples	 analysed,	 and	 the	 analysis	
above	suggests	that	this	corresponds	to	monomeric	DnaADI.	The	major	peak	comprises	88-
92%	of	the	total	protein	content,	and	corresponds	to	a	weight	average	molecular	mass	of	
between	 25	 and	 28	 kDa	 (depending	 on	 concentration).	 This	 correlates	 well	 with	 a	 1:1	
heterodimer	of	SirA-DnaADI,	which	would	have	an	expected	molecular	mass	of	28.7	kDa.		
	
Table	2.7:	SirA-DnaADI	SEC-MALLS	results	
Concentration	
	(mg	ml-1)	
Peak	 Contribution	
(%)	
Elution	Time	
(Min)	
Molecular	Weight	
(kDa)	
0.5	 	
Major	
87.7	 24.1	 25.4	
1.0	 91.5	 23.8	 26.8	
2.5	 91.7	 23.7	 28.0	
0.5	 	
Minor	
12.3	 28.1	 10.0	
1.0	 9.5	 28.1	 11.8	
2.5	 8.3	 20.0	 14.7	
	
Again,	 some	 discrepancy	 in	 elution	 times	 and	 determined	 molecular	 weights	 occurs	 at	
different	SirA-DnaADI	sample	concentrations.	Notably,	a	shift	occurs	in	the	ratio		of	eluting	
species	 as	 the	 concentration	 changes.	 The	 relative	 area	 under	 the	minor	 peak	 increases	
with	respect	to	the	major	peak	as	the	concentration	decreases	(in	Fig.	2.7,	B	major	peaks	
have	been	 scaled	 to	 the	 same	height	 to	 show	 the	 relative	 shift	 in	minor	peak	 size).	 This	
change	in	the	ratio	of	eluting	species	is	accompanied	by	a	small	shift	in	the	elution	time	of	
the	major	peak	(to	a	later	time)	and	a	decrease	in	its	associated	molecular	mass.	Together	
this	 suggests	 that	 some	 complex	 dissociation	 is	 occurring	 at	 lower	 SirA-DnaADI	
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concentrations.	 Nevertheless,	 it	 is	 clear	 that	 under	 these	 experimental	 conditions,	 a	 1:1	
SirA-DnaADI	heterodimer	is	the	predominant	species.	
	
Figure	2.7:	Overlay	of	SEC-MALLS	analysis	for	SirA-DnaADI	at	varying	concentrations	:	the	thinner	
lines	 display	 the	 differential	 refractive	 index	 of	 the	 Sir-DnaADI-containing	 elute	 from	 a	 Superdex	
10/300	S75	column	as	a	function	of	time.	Thicker	lines	show	the	weight	average	molecular	mass	of	
the	eluting	species,	calculated	from	refractive	index	and	light	scattering	measurements.	Blue	shows	
analysis	of	SirA-DnaADI	at	2.5	mg	ml-1;	red	at	1.0	mg	ml-1	and	green	at	0.5	mg	ml-1.	The	major	species	
elutes	 at	 a	 mass	 of	 25-28	 kDa	 indicating	 SirA-DnaADI	 is	 a	 homodimer	 in	 solution.	 A	 peak	 at	 ~28	
minutes	is	also	visible,	deriving	from	excess/dissociating	DnaADI.	A)	Overlay	of	SEC-MALLS	traces	for	
SirA-DnaADI	 B)	Overlay	 of	 SEC-MALLS	 traces	 for	 SirA-DnaADI	with	major	 peaks	 scaled	 to	 show	 the	
change	in	ratio	of	eluting	species	with	concentration.	
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2.5.6:	Crystallisation	of	SirA-DnaADI		
Initial	 crystallisation	 conditions	 for	 native	 and	 SeMet	 derivatives	 of	 SirA-DnaADI	 were	
obtained	 from	 commercially	 available	 96	 well	 screens.	 Native	 crystals	 went	 through	
multiple	 rounds	 of	 optimisation	 in	 24-well	 format	 using	 hanging	 drop	 vapour	 diffusion	
methods.	 SeMet	 crystals	 were	 initially	 optimised	 in	 96-well	 format	 using	 sitting	 drop	
vapour	diffusion	before	further	optimisation	in	24-well	format	using	hanging	drop	vapour	
diffusion	 methods.	 Fig.	 2.8	 displays	 snapshots	 at	 stages	 of	 the	 optimisation	 process	 for	
both	Native	(Fig.	2.8,	A)	and	SeMet	(Fig.	2.8,	B)	crystals.	 In	each	case,	picture	I	shows	the	
best	condition	obtained	in	the	96	well	screen,	and	respectively,	Figure	2.8,	A,	IV	and	2.8	B,	
V	show	crystals	used	for	data	collection	for	native	and	SeMet	crystals.	(In	the	case	of	A,	IV,	
a	single	crystal	was	obtained	from	the	cluster	for	data	collection).	
	
	
Figure	2.8:	Snapshots	of	the	crystal	optimisation	process	for	native	and	SeMet	SirA-DnaADI:	A)	
Native	 SirA-DnaADI	 crystals.	 Images	 I-IV	display	 snapshots	of	 the	 crystal	 optimisation	process	with	
image	I	showing	the	best	crystals	obtained	from	96-well	commercial	screens,	and	image	IV	showing	
a	 crystal	 of	 diffraction	 quality.	B)	SeMet	 SirA-DnaADI	 crystals.	 Images	 I-V	 display	 snapshots	 of	 the	
crystal	 optimisation	 process	 with	 image	 I	 showing	 the	 best	 crystals	 obtained	 from	 96-well	
commercial	screens,	and	image	V	showing	a	crystal	of	diffraction	quality.	
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Both	native	and	SeMet	SirA-DnaADI	crystals	diffracted	in	house	to	a	resolution	beyond	2.7Å	
(Figure	2.9).	Full	3D	data	were	collected	at	Diamond	Light	Source,	Harwell.	
	
	
Figure	2.9:	In-house	testing	of	diffraction	quality	SirA-DnaADI	crystals:	Diffraction	patterns	from	in-
house	 testing	of	 crystals	of	A)	 native	 SirA-DnaADI	 and	B)	 SeMet-derivative	 SirA-DnaADI.	Data	were	
collected	from	each	crystal	at	Diamond	Light	Source,	Harwell.	
	
2.5.7:	Crystallisation	of	DnaADI	
Initial	crystallisation	conditions	for	native	and	SeMet	derivatives	of	DnaADI	were	obtained	
from	 commercially	 available	 96-well	 screens.	 Native	 and	 SeMet	 crystals	 went	 through	
multiple	 rounds	 of	 optimisation	 in	 24-well	 format	 using	 hanging	 drop	 vapour	 diffusion	
methods;	crystals	of	suitable	diffraction	quality	were	obtained	for	SeMet	DnaADI	(Fig.	2.10),	
however	 native	 crystals	 of	 DnaADI	 diffracted	 poorly	 despite	 multiple	 attempts	 at	
optimisation.	A	SAD	data	 set	was	 collected	 from	SeMet	DnaADI	 at	Diamond	Light	 Source,	
Harwell.			
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Figure	2.10:	SeMet	DnaADI	crystals	and	in-house	diffraction:	A)		SeMet	DnaADI	crystals;	Image	I	–	
best	 crystals	 formed	 in	 96-well	 commercial	 screen	 .	 Image	 II	 -	 crystal	 of	 diffraction	 quality.	 B)	
Diffraction	pattern	from	in-house	testing	of	SeMet	DnaADI	crystal.		
	
2.5.8:	SirA-DnaADI	Structure	
The	 SirA-DnaADI	 crystal	 structure	 was	 solved	 to	 1.7	 Å	 resolution	 using	 SAD	 (Single	
Anomalous	Dispersion)	phasing	methods	(Table	2.8).	Native	and	SeMet	derivative	crystals	
were	 grown	 from	 similar	 conditions	 producing	 crystals	 in	 the	 space	 group	 P21	 with	
different	unit	cells.	SeMet-derivative	crystals	contain	one	complex	per	asymmetric	unit	(i.e.	
one	 molecule	 of	 SirA	 and	 one	 molecule	 of	 DnaADI),	 whilst	 native	 crystals	 contain	 two	
complexes	per	asymmetric	unit.	 	The	SeMet-derivative	structure	was	solved	and	partially	
refined	to	allow	the	native	structure	to	be	solved	using	molecular	replacement.	The	refined	
model	encompasses	residues	2-141	of	SirA	in	both	chains	A	and	C	(Met1	and	residues	142-
148	 being	 disordered),	 and	 residues	 1-81	 of	 DnaADI	 in	 molecules	 B	 and	 D	 (Gln82	 being	
disordered).	 A	 vestigial	 N-terminal	 Gly-Pro-Ala	 sequence	 inherited	 from	 the	 DnaADI	
polyhistidine-tag	can	be	seen	 in	molecule	D,	and	an	additional	N-terminal	Ala	 is	visible	 in	
molecule	B.	SirA-DnaADI	 is	 seen	as	a	heterodimer,	with	molecules	A	 (SirA)	and	B	 (DnaADI)	
forming	one	heterodimer	and	molecules	C	and	D	forming	the	other.		
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2.5.8.1:	SirA		
SirA	consists	of	a	single	globular	domain	comprising	seven	β-strands	and	five	α-helices	 in	
the	 order	 β1-α1-α2-α3-α4-β2-β3-β4-β5-α5-β6-β7	 (Fig.	 2.11).	 The	 SirA	 fold	 consists	 of	 a	
central	 seven-stranded	 twisted	 β-sheet	with	 strand	 order	 β2-β3-β4-β5-β1-β6-β7,	 flanked	
on	 either	 side	 by	 two	 α-helical	 regions,	 one	 comprising	 helices	 α1,	 α2	 and	 α3	 and	 the	
other,	helices	α4	and	α5.	Comparison	to	other	structures	in	the	PDB	using	the	online	server	
PDBeFold	identified	similarity	to	several	structures	across	the	β1-α4-β2-β3-β4-β5-α5-β6-β7	
region	 (residues	 2-9,	 and	 54-139).	 The	 search	 did	 not	 identify	 a	 protein	 which	 also	
encompassed	 structural	 similarity	 to	 the	 DnaA-interacting	 helices	 α1-α2-α3	 (described	
below),	 however	 a	 search	 with	 these	 helices	 alone	 found	 homologous	 regions	 in	 many	
proteins	of	varying	function.		
	
Figure	2.11:	SirA	structure	and	topology	:	A)	Ribbon	diagram	of	SirA	from	the	SirA-DnaADI	complex.	
The	 chain	 is	 colour-ramped	 from	 the	 N-terminus	 (blue)	 to	 the	 C-terminus	 (red).	 B)	 SirA	 chain	
topology	diagram.	Numbers	denote	residues	at	the	start	and	end	of	each	chain.	
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Table	2.8:	Data	and	refinement	statistics	for	SirA-DnaADI	
	 SirA-DnaADI		SeMet	 SirA-DnaADI	Native		
Data	Collection	 	 	
X-ray	source	 DLS,	i24	 DLS,	i03	
Wavelength	(Å)	 0.9789	 0.9763	
Resolution	Range	(Å)	 40.8-2.09	 62.76-1.65	
Space	Group	 P1	21	1	 P21	
Unit	Cell	Parameters	 	 	
a	b	c		(Å)	 51.35,	35.63,	63.27	 77.29,	34.69,	84.74	
α	β	γ	(°)	 90,	92.77,	90	 90,	102.09,	90	
No.	of	reflections	a		 13549/989	 52893/2598	
Completeness	(%)	a	 98.7/99.1	 98.9/99.6	
Redundancy	a	 3.2/3.3	 2.8/2.8	
I/σ(I)	a	 11.9/1.9	 12.5/1.9	
Rmerge
b	(%)	a	 7.4/79.9	 3.9/45.8	
Refinement	and	Model	Statistics	 	 	
Resolution	Range	(Å)	 	 62.84-1.65	
R-factorc	(Rfree
d)	 	 13.1	(19.7)	
Reflections	(working/Rfree)	 	 50172/2706	
Outer-shell/High	Res	range	 	 1.69-1.65	
Outer-shelle/High	Res	R-factorc	
(Rfree)
d	 	 19.0	(27.9)	
Outer-shell/High	Res	Reflections	
(working/free)	 	 3677/214	
Molecules	per	asymmetric	unit	 	 4	
rmsd	from	ideal	geometryff	 	 	
Bond	Lengths	(Å)	 	 0.017	
Bond	Angles	(°)	 	 1.8	
Average	B-factor	(Å2)	 	 27.8	
Ramachandran	Plotg	 	 98.16/0.92/0.92	
	
																																								 																				
a	.	The	first	number	refers	to	the	overall	data	set,	the	second	refers	the	outer	resolution	shell;	1.68-1.65	Å;	
b	.	Rmerge=∑hkl∑i|Ii−	<	I	>	|/∑hkl	∑i	<	I	>	where	Ii		is	the	intensity	of	the	ith	measurement	of	a	reflection	with	
indexes	hkl	and	<	I	>	is	the	statistically	weighted	average	reflection	intensity.		
c	.	R-factor	=∑||Fo|	−	|Fc||/∑|Fo	|	where	Fo	and	Fc	are	the	observed	and	calculated	structure	factor	amplitudes	
respectively.	
d	.	R-free	is	the	R-factor	calculated	with	5%	of	the	reflections	chosen	at	random	and	omitted	from	refinement.	
e	.	Outer	shell	for	refinement	corresponds	to	1.69–1.65	Å.	
f	.	Root-mean-square	deviation	of	bond	lengths	and	bond	angles	from	ideal	geometry.	
g	.	Percentage	of	residues	in	most-favoured/disallowed/allowed	regions	of	the	Ramachandran	plot.	
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The	electron	density	maps	 reveal	 a	 2-mercaptoethanol	 (BME)	molecule	 linked	 through	a	
disulphide	 bond	 to	 Cys125	 of	 both	 SirA	 chains	 in	 the	 asymmetric	 unit	 (Fig.	 2.12).	 The	
presence	 of	 this	 adduct	 explains	 species	 observed	 in	 the	 electrospray	 ionization	 mass	
spectrum	of	SirA	of	18	776	Da,	79	Da	larger	than	that	of	SirA;	18	697	Da	(See	above).	BME	
was	present	during	the	purification	steps	as	 it	was	found	to	 improve	the	solubility	of	the	
SirA-DnaADI	complex.	
	
	
Figure	2.12:	2-Mercaptoenthanol	adduct	on	SirA	:	Stereoview	of	residues	in	the	neighbourhood	of	
Cys125	 of	 SirA,	 showing	 2-mercaptoenthanol	 connected	 to	 the	 thiol	 of	 the	 side	 chain	 of	 Cys125	
through	a	disulphide	bond.	Electron	density	is	shown	in	blue	contoured	at	1σ.	The	model	is	coloured	
by	atom	with	carbon	in	green,	oxygen	in	red,	nitrogen	in	blue	and	sulphur	in	yellow.	
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2.5.8.1:	DnaADI	
DnaADI	 from	B.	subtilis	 (Fig.	2.13)	consists	of	 four	alpha	helices	and	three	beta	strands	 in	
the	 order	 α1-α2-β1-β2-α3-α4-β3	 with	 a	 β-sheet	 topology	 of	 β1-β2-β3.	 It	 has	 a	 similar	
topology	 to	 the	previously	determined	structures	of	 the	corresponding	domains	of	DnaA	
from	E.	coli	(Abe	et	al.,	2007),	M.	genitalium	(Lowery	et	al.,	2007)	and	H.	pylori	(Natrajan	et	
al.,	 2009),	 sharing	 the	 K-homology	 domain	 motif	 that	 is	 widespread	 in	 single-	 stranded	
nucleic	acid	binding	proteins.	
	
2.5.9:	DnaADI	Structure	
The	 structure	 of	 DnaADI	 was	 solved	 to	 2.5	 Å	 resolution	 using	 molecular	 replacement	
methods	(Table	2.9).	An	initial	solution	was	obtained	by	SAD	phasing,	however	the	model	
could	not	be	refined	past	R/R-free	of	0.23/0.34.	Solution	by	molecular	replacement	using	
Bsu	DnaADI	from	SirA-DnaADI	allowed	a	modest	improvement	in	the	refinement	statistics,	to	
an	 R/Rfree	 of	 0.21/0.29.	 The	 2	 solutions	 superpose	 well,	 with	 little	 modification	 to	 the	
overall	 structure	 (the	N-terminal	 β-sheet	 is	 better	 defined	 in	 the	molecular	 replacement	
solution).		The	model	encompasses	residues	1	to	81	of	DnaA	(Gln82	is	disordered)	and	has	a	
topology	 as	 described	 above	 (Fig.	 2.13).	 The	 domain	 displays	 the	 same	 conformation	 in	
both	its	free	and	SirA-bound	states.		
	
Figure	2.13:	DnaADI	structures:A)	Ribbon	diagram	of	DnaADI	from	SirA-DnaADI	colour-ramped	from	
N-terminus	(blue)	to	C-terminus	(red).	B)	Structure	of	B.	subtilis	DnaADI	:	Ribbon	diagram	of	DnaADI	
(crystallised	without	SirA).	
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Table	2.9:	Data	and	refinement	statistics	for	DnaADI	
																																								 																				
h	.	The	first	number	refers	to	the	overall	data	set,	the	second	refers	the	outer	resolution	shell;	2.47-2.38	Å.	
i	.	Rmerge=∑hkl∑i|Ii−	<	I	>	|/∑hkl	∑i	<	I	>	where	Ii		is	the	intensity	of	the	ith	measurement	of	a	reflection	with	
indexes	hkl	and	<	I	>	is	the	statistically	weighted	average	reflection	intensity.	
j	.	R-factor	=∑||Fo|	−	|Fc||/∑|Fo	|	where	Fo	and	Fc	are	the	observed	and	calculated	structure	factor	amplitudes	
respectively.	
k	.	R-free	is	the	R-factor	calculated	with	5%	of	the	reflections	chosen	at	random	and	omitted	from	refinement.	
l	.	Outer	shell	for	refinement	corresponds	to	2.44-2.38	Å.	
m	.	Root-mean-square	deviation	of	bond	lengths	and	bond	angles	from	ideal	geometry.	
n	.	Percentage	of	residues	in	most-favoured/disallowed/allowed	regions	of	the	Ramachandran	plot.	
	 DnaADI	
Data	Collection	 	
X-ray	source	 DLS,	i03	
Wavelength	(Å)	 0.9686	
Resolution	Range	(Å)	 41.3-2.38	
Space	Group	 P43	21	2	
Unit	Cell	Parameters	 	
a	b	c		(Å)	 41.27,	41.27,	111.46	
α	β	γ	(°)	 90,	90,	90	
No.	of	reflections	h	 4113/411	
Completeness	(%)	h	 97.4/96.4	
Redundancy	h	 9.5/9.1	
I/σ(I)	h	 13.1/1.8	
Rmergei	(%)	h	 11.5/153	
	 	
Refinement	and	Model	Statistics	 	
Resolution	Range	(Å)	 38.7-2.38	
R-factorj	(Rfreek)	 20.9	(28.6)	
Reflections	(working/Rfree)	 3904/199	
Outer-shell/High	Res	range	 2.44-2.38	
Outer-shell	l/High	Res	R-factorj	(Rfree)k	 36.2	(63.8)	
Outer-shell/High	Res	Reflections	
(working/free)	
289/10	
Molecules	per	asymmetric	unit	 1	
rmsd	from	ideal	geometrym	 	
Bond	Lengths	(Å)	 0.018	
Bond	Angles	(°)	 1.94	
Average	B-factor	(Å2)	 57.2	
Ramachandran	Plotn	 96.3/2.5/1.2	
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2.5.10:	The	SirA-DnaADI	Interface	
The	SirA-DnaADI	 interface	 is	extensively	α-helical	 in	character,	with	 the	binding	of	SirA	 to	
DnaADI	mediated	by	helices	α1-α2-α3	on	SirA	and	helices	α2	and	α3	on	DnaADI	 (Fig.	2.14	
and	 2.15,	 A).	 The	 interaction	 between	 the	 two	 proteins	 is	 dominated	 by	 side-chain	
contacts,	with	a	significant	degree	of	hydrophobic	character.	
	
Figure	2.14:	SirA-DnaADI	complex:	Ribbon	diagram	of	SirA-DnaADI	complex	with	SirA	shown	in	light	
green	and	DnaADI	shown	in	ice	blue.		
The	complex	buries	1240	Å2	of	otherwise	accessible	surface	area,	which	comprises	8%	and	
12%	of	 the	 surface	 areas	 of	 DnaADI	 and	 SirA,	 respectively	 (with	 17	 contributing	 residues	
from	each	protein).		In	the	SirA	binding	surface	of	DnaADI,	residues	Thr26,	Trp27	and	Phe49	
contribute	 to	 the	 core	 of	 the	 interface	with	 residues	 Pro22,	 Ser23,	 Glu25,	 Ser30,	 Pro46,	
Asn47,	Glu48,	Asp52,	 Ser56	 and	 Trp53	 contributing	 to	 the	 rim.	As	 shown	 in	 Fig.	 2.15,	 B,	
these	residues	are	very	strongly	conserved	in	a	set	of	DnaA	orthologues	from	endospore-
forming	bacteria.	On	the	corresponding	DnaADI	binding	surface	of	SirA,	Phe14,	Tyr18,	Gln48	
and	Ile52	contribute	to	the	core	and	Glu13,	His17,	Val24,	Leu28,	Gln41,	Met44,	Lys47	and	
Tyr51	 contribute	 to	 the	 rim.	 Again	 core	 residues	 are	well	 conserved	 in	 SirA	 orthologues	
with	some	variation	observed	in	the	residues	constituting	the	rim	(Fig.	2.15,	C)	
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Figure	2.15:	Stereoview	of	SirA-DnaADI	interface	and	conservation	of	key	residues	A)	Stereoview	of	
the	complex	between	DnaADI	(chain	D)	and	SirA	(chain	C)	represented	as	light	blue	and	light	green	
ribbons,	respectively.	Side-chains	of	labelled	residues	are	displayed	in	cylinder	format	and	coloured	
by	atom	type	with	nitrogen	(blue),	oxygen	(red),	sulphur	(yellow)	and	carbons	coloured	in	grey	for	
DnaADI	and	green	for	SirA.	Water	molecules	are	represented	as	red	spheres,	and	polar	interactions	
are	denoted	by	dashed	lines.	B)	and	C)	Alignment	of	the	sequences	of	orthologues	of	DnaADI	(B)	and	
SirA	(C)	from	selected	Bacillus	species;	Bsu,	B.	subtilis;	Blic,	B.licheniformis;	Bant,	B.	anthracis;	Bhal,	
B.	 halodurans;	 Bcla,	 B.	 clausii;	 Gkau,	 Geobacillus	 klaustophilus;	 Oihe,	 Oceanobacillus	 iheyensis.	
Symbols	below	the	alignments	indicate	interfacial	residues	in	the	respective	molecules	contributing	
to	 the	 core	 (asterisks)	 and	 the	 rim	 (triangles).	 Secondary	 structure	 elements	 and	 residue	
numberings	 are	 displayed	 above	 the	 alignment.	 The	 images	 were	 created	 using	 ESPript	 (Gouet,	
2003).		
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2.5.10.1:	The	SirA	interaction	site	on	DnaADI	maps	to	residues	previously	implicated	in	
interaction	with	SirA	
SirA	 interacting	 residues	 on	 DnaA	 have	 been	 previously	 identified	 using	 a	 genetic	
approach.	Induction	of	SirA	production	in	vegetatively	growing	cells	inhibits	growth,	thus	B.	
subtilis	 cells	 with	 SirA	 under	 the	 control	 of	 an	 IPTG-inducible	 promoter	 are	 unable	 to	
produce	 colonies	 on	 IPTG-supplemented	 LB	 agar	 (i.e.	 have	 a	 “no-growth”	 phenotype).	 A	
screen	for	DnaA	mutations	which	could	suppress	this	no-growth	phenotype	identified	four	
strains	which	could	grow	under	conditions	of	SirA	expression,	each	harbouring	a	different	
dnaA	mutation.	Analysis	of	 the	 sequence	of	 these	dnaA	 alleles	 revealed	point	mutations	
which	would	produce	Asn47Asp,	Phe49Tyr,	Ala50Val	and	Ala50Thr	substitutions.	Yeast	two	
hybrid	analysis	was	used	to	confirm	that	these	mutants	were	unable	to	interact	with	SirA	
suggesting	that	they	affect	SirA-DnaA	complex	formation83.	
The	SirA–DnaADI	structure	reveals	that	Asn47	and	Phe49	make	direct	interactions	with	SirA	
(Fig.	2.16).	Asn47	of	DnaA	forms	a	pair	of	hydrogen	bonds	with	Gln48	on	helix	α3	of	SirA,	
and	the	side-chain	of	Phe49	of	DnaA	resides	in	a	hydrophobic	pocket	created	by	helices	α1,	
α2	and	α3	of	SirA.	In	contrast,	Ala50	does	not	contact	SirA	in	the	complex	but	its	side	chain	
is	buried	within	DnaADI	between	helices	α2	and	α3,	 in	 such	a	way	 that	 it	determines	 the	
structure	 of	 the	 interface	 (Fig.	 2.16).	 It	 is	 expected	 that	 mutations	 at	 this	 position	
introducing	 bulkier	 side-chains,	 such	 as	 valine	 or	 threonine,	would	 alter	 the	 structure	 of	
the	 interaction	 surface	 leading	 to	 a	 lower	 affinity	 for	 SirA.	 In	 summary,	 the	 structure	 of	
SirA–DnaADI	is	consistent	with	the	previous	interpretation	of	the	genetic	data.		
	
Figure	2.16:	Mapping	onto	the	structure	of	DnaADI	the	sites	corresponding	to	mutations	in	dnaA	
that	allow	growth	of	B.	subtilis	when	sirA	is	being	overexpressed	:	SirA	is	rendered	as	a	partially	
transparent	 electrostatic	 surface	 and	 DnaADI	 as	 a	 ribbon	 with	 the	 side-chains	 of	 residues	 Asn47,	
Phe49	and	Ala50	in	cylinder	format.	
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2.5.10.2:	Verifying	the	SirA-DnaADI	Interface	in	vitro	
To	 confirm	 that	 the	 protein-protein	 interface	 observed	 in	 the	 SirA-DnaADI	 structure	 is	
physiologically	relevant,	we	designed	an	assay	to	investigate	the	interaction	between	SirA	
and	DnaADI	in	vitro.	As	we	were	unable	to	express	SirA	in	a	soluble	form	in	the	absence	of	
DnaADI,	classical	mixing	experiments	were	not	possible.	Instead,	we	took	advantage	of	the	
fact	that	SirA’s	solubility	was	dependent	on	 its	co-expression	with	and	binding	to	DnaADI,	
developing	 a	 qualitative	 binding	 assay.	 We	 hypothesised	 that	 disrupting	 the	 interaction	
between	 SirA	 and	 DnaADI	 during	 co-expression	would	 reduce	 or	 abolish	 SirA’s	 solubility,	
which	we	could	observe	following	cell	lysis/protein	purification.		
Using	site-directed	mutagenesis,	we	introduced	alanine	mutations	into	the	pET-YSBLIC3C-
DnaADISirA	 co-expression	 vector	 at	 codons	 which	 specify	 residues	 located	 in	 the	
structurally	 determined	 SirA-DnaADI	 interface.	 Three	 substitutions	 were	 made	 on	 SirA:	
Phe14Ala,	Tyr18Ala	and	Gln48Ala;	residues	contributing	respectively,	45	Å2,	50	Å2	and	75	
Å2	to	the	buried	surface	area	of	the	interface	(Fig.	2.17,	A).	Additionally,	the	hydroxyl	group	
of	 Tyr18	 forms	a	hydrogen	bond	with	 the	 carboxyl	 group	on	Asp52	of	DnaADI	 and	Gln48	
forms	 a	 pair	 of	 hydrogen	 bonds	 with	 Asn47	 of	 DnaADI	 (via	 side	 chain-side	 chain	
interactions).	Three	mutations	were	also	made	on	DnaADI:	Thr26Ala,	Trp27A	and	Phe49Ala;	
contributing	respectively,	75	Å2,	50	Å2,	and	135	Å2	of	buried	surface	area	to	the	interface.	
(Fig.	2.17,	B)	After	confirmation	of	these	mutations	by	sequencing,	expression	trials	were	
conducted	 in	 E.	 coli	 BL21	 (DE3)	 cells.	 The	 solubility	 of	 the	 recombinant	 proteins	 was	
compared	to	wild	type	proteins	by	SDS-PAGE	analysis	of	cell	 fractions	following	 lysis.	The	
effect	 of	 each	mutation	on	 the	 interaction	between	 SirA	 and	DnaADI	was	 further	 probed	
using	 a	 Ni	 pull-down	 assay.	 Soluble	 cell	 lysate	 was	 loaded	 onto	 a	 Ni-affinity	 column,	
washed	 extensively	with	 loading	 buffer	 and	 eluted	with	 a	 high	 imidazole	 concentration.	
Expression	 from	 pET-YSBLIC3C-DnaADISirA	 directs	 the	 expression	 of	 DnaADI	 with	 a	
hexahistidine-tag	and	untagged	SirA.	Thus,	histidine-tagged	DnaADI	 is	expected	to	bind	to	
the	 column,	but	any	 retention	of	 SirA	 is	expected	 to	be	mediated	by	 its	 interaction	with	
histidine-tagged	DnaADI.		
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Figure	2.17:	Residues	within	the	SirA-DnaADI	interface	chosen	as	sites	for	site-directed	
mutagenesis:	A)	Core	residues	from	the	DnaADI	-interacting	surface	of	SirA	which	were	chosen	as	
sites	for	alanine	substitution.	DnaADI	is	shown	as	an	electrostatic	surface	with	SirA	represented	as	a	
green	ribbon	with	the	side-chains	of	F14,	Y18	and	Q48	displayed	as	cylinders.		B)	Core	residues	from	
the	SirA	 interacting	 surface	of	DnaADI	which	were	chosen	as	 sites	 for	alanine	substitution.	 	 SirA	 is	
shown	as	an	electrostatic	surface	with	DnaADI	represented	as	a	blue	ribbon	with	the	side-chains	of	
T26,	W27	and	F49	displayed	as	cylinders.	
	
The	expression	experiments	indicate	a	reduced	solubility	of	SirA	in	soluble	lysate	fractions	
from	cells	producing	SirA	with	the	mutations	Phe14Ala,	Tyr18Ala	and	Gln48Ala	(Fig.	2.18,	
lanes	 4,	 8,	 12	 and	 17).	 Furthermore,	 a	 reduced	 amount	 of	 the	modified	 SirA	 protein	 is	
eluted	 in	 the	 high	 imidazole	 fraction	 during	 the	Ni-pull	 down	 experiments,	 compared	 to	
that	 observed	 for	 wildtype	 SirA	 (Fig.	 2.18,	 lanes	 5,	 9,	 13	 and	 18).	 	 The	 DnaA	 mutants	
Trp27Ala	and	Phe49Ala	appear	to	show	only	a	negligible	level	of	soluble	SirA	in	the	soluble	
lysis	fractions	(Fig.	2.18,	lanes	27	and	31)	and	show	no	or	very	little	SirA	eluting	in	the	high	
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imidazole	 fraction	 after	 the	 Ni-pull	 down	 experiment	 (Fig.	 2.18,	 lanes	 28	 and	 32).	 DnaA	
Thr26Ala	 shows	 near-wild	 type	 solubility	 and	 SirA	 recovery	 after	 the	 Ni-pull	 down	 (Fig.	
2.18,	lanes	22	and	23).		This	implies	that	all	mutations	on	SirA	and	the	DnaA	Trp27Ala	and	
DnaA	Phe49Ala	mutations	elicit	weaker	binding	of	SirA	to	DnaADI.		
	
Figure	2.18:	SDS-PAGE	analysis	for	SirA	solubility	assay:	Cultures	of	cells	induced	to	express	wild	
type	 and	 alanine-substituted	 variants	 of	 His6DnaA
DI	 and	 SirA	 were	 grown	 and	 soluble	 cell	 lysate	
passed	over	a	Ni-NTA	column.	Samples	of	cell	lysate	of	fractions	from	uninduced	cells	(U),	induced	
cells	 (I)	 and	 soluble	 lysate	 (S)	were	 analysed	 as	well	 as	 samples	 of	 the	 flowthrough	 from	 the	Ni-
column	 load	 (F)	 and	 a	 high-imidazole	 elution	 fraction	 (E).	 Lanes	 1,	 14	 and	 23	 contain	 molecular	
weight	 markers.	 Uninduced	 (U),	 Total	 (T),	 Soluble	 (S)induced	 (I),	 Flowthrough	 (F)	 and	 Eluate	 (E)	
fractions	were	 loaded	 for	 the	wild	 type	proteins	 in	 Lanes	2-5,	 and	 for	wild	 type	DnaADI	 produced	
together	 with	 SirA	 mutants	 as	 follows;	 SirA(F14A)	 in	 Lanes	 6-9:	 SirA(F18A)	 in	 Lanes	 10-13:	
SirA(Q48A)	 in	Lanes	15-18.	Uninduced	(U),	Total	(T)Induced,	FlowthroughSoluble	(S)	and	Eluate	(E)	
samples	 of	 SirA	 and	 the	 DnaADI	 variants	 were	 loaded	 as	 follows;	 DnaADI(T26A)	 in	 Lanes	 19-22:	
DnaADI(W26A)	in	Lanes	24-27;	DnaADI(F49A)	in	Lanes	28-31.		
89	
	
However,	 interpretation	 of	 these	 results	 is	 complicated	 by	 the	 variability	 in	 the	 level	 of	
DnaADI	 present	 in	 these	 fractions.	 Thus,	 the	 elution	 fractions	 shown	 in	 Fig.	 2.18,	 were	
diluted	 to	 normalise	 DnaADI	 quantities	 to	 an	 approximately	 equivalent	 amount,	 and	
samples	again	resolved	by	SDS-PAGE.	(Fig.	2.19)	This	clearly	demonstrates	that	mutations	
in	DnaADI	of	Trp27Ala	and	Phe49Ala	have	the	most	significant	effect	on	SirA	solubility,	with	
little	 discernable	 SirA	 present	 in	 the	 eluate	 fractions.	 In	 contrast,	 DnaA	 Thr26Ala	 shows	
similar	 levels	 of	 SirA	 in	 the	 Ni	 pull-down	 as	 observed	 for	 wildtype.	 	 The	 SirA	mutations	
Phe14Ala,	Tyr18Ala	and	Gln48Ala	display	a	more	modest	effect,	with	an	obvious	reduced	
quantity	 of	 SirA	 present	 in	 each	 elute	 compared	 to	 wildtype.	 Quantification	 of	 the	 SirA	
band	intensities	in	Fig.	2.19	by	the	software	ImageJ	suggests	that,	relative	to	the	wild	type	
SirA,	there	 is	a	1.5-fold	 lower	recovery	of	SirA	Phe14Ala	and	SirA	Gln48Ala	and	a	2.5-fold	
lower	recovery	of	SirA	Tyr18Ala.	
	
Figure	2.19:	SDS-PAGE	analysis	showing	normalised	levels	of	DnaADI:	Samples	of	the	eluate	
fractions	containing	approximately	normalized	levels	of	DnaADI	were	loaded	so	that	the	efficiency	of	
SirA	pull-down	 could	be	 compared.	 Lane	1:	molecular	weight	markers;	 Lane	2:	wild	 type	DnaADI–
SirA;	Lanes	3–5:	Native	DnaADI	and	the	SirA	variants,	loaded	as	follows;	Lane	3:	SirA(F14A),	Lane	4:	
SirA(Y18A),	Lane	5:	SirA(Q48A).	Lanes	6–8:	Samples	of	native	SirA	and	the	DnaADI	variants,	loaded	as	
follows;	Lane	6:	DnaADI	(T26A),	Lane	7:	DnaADI	(W27A),	Lane	8:	DnaADI	(F49A).	
	
	
Together	these	results	correlate	well	with	the	SirA-DnaA	interface	inferred	from	the	crystal	
structure.	Residues	Phe14,	Tyr18	and	Gln48	of	SirA	all	form	side	chain	contacts	with	DnaADI	
which	would	be	weakened	by	a	truncation	of	these	side	chains	to	alanine	(Fig.	2.17,	A).	The	
residues	 Trp27	 and	 Phe49	 on	 DnaA	 have	 side	 chains	 which	 project	 into	 a	 hydrophobic	
pocket	on	the	surface	of	SirA,	contributing	to	extensive	van	der	Waals	contacts	across	the	
SirA-DnaA	 interface	 (Fig.	2.17,	B).	Truncation	of	either	of	 these	 residues	 to	alanine	has	a	
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clear	 effect	 on	 the	 SirA-DnaA	 interaction,	 presumably	 due	 to	 a	 loss	 of	 van	 der	 Waals	
contacts.	 By	 contrast,	 Thr26	 of	 DnaA	 sits	 at	 the	 edge	 of	 the	 hydrophobic	 pocket,	 and	
although	largely	buried,	the	hydroxyl	group	remains	solvent	exposed	(it	is	able	to	hydrogen	
bond	 with	 a	 water	 molecule	 on	 the	 protein	 surface).	 Crucially,	 the	 substitution	 of	
threonine	to	alanine	is	less	dramatic	than	the	other	mutations,	allowing	DnaA	Thr26Ala	to	
maintain	its	interaction	with	SirA	(Fig.	2.17,	B).	
	
2.5.11:	Comparison	of	SirA-DnaADI	structure	with	HobA-DnaADI	structure	
The	 structure	 of	 the	 SirA-DnaADI	 complex	 and	 that	 of	 HobA-DnaADI	 73	 (a	 structure	 of	H.	
pylori	DnaADI	bound	to	a	regulator	of	this	organism,	HobA)	were	compared	to	one	another.	
Strikingly,	 this	 revealed	 that	 HobA	 and	 SirA	 bind	 to	 the	 same	 structural	 site	 on	 DnaADI,	
burying	equivalent	surface	residues	(Fig.	2.20,	A	and	B).	This	is	particularly	surprising	given	
the	 divergent	 effects	 on	 DnaA	 exerted	 by	 SirA	 and	 HobA.	 HobA	 is	 a	 stimulator	 of	
replication	initiation	in	H.	pylori,	essential	to	the	organism's	survival.	Thus,	HobA	and	SirA	
are	able	to	achieve	opposing	regulatory	functions	by	binding	to	the	same	structural	site	on	
DnaADI.	Despite	a	shared	structural	topology	however,	residues	contributing	to	this	binding	
site	are	not	conserved	between	H.pylori	and	B.	subtilis	 (Fig.	2.20,	C),	perhaps	reflecting	a	
divergence	 in	 their	 respective	 regulatory	 mechanisms.	 Nevertheless,	 this	 indicates	 an	
important	structural	site	on	DnaADI	for	the	regulation	of	replication	initiation.	
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Figure	2.20:	Comparison	of	B.	subtilis	SirA-DnaADI	with	H.	pylori	HobA-DnaADI:	A)	Ribbon	diagram	
of	the	B.	subtilis	SirA-DnaADI	complex	with	SirA	shown	in	light	green	and	DnaADI	shown	in	blue.		B)	
Ribbon	diagram	of	the	H.	pylori	HobA-DnaADI	complex	(PDB	id	code:	2wp0)	with	two	molecules	of	
HobA	shown	in	yellow	and	light	green,	and	two	molecules	of	DnaADI	shown	in	blue	and	coral.	The	
binding	 surfaces	 of	 SirA	 or	 HobA	 on	 DnaADI	 in	 (A)	 and	 (B)	 are	 shown	 in	 purple.	 C)	Alignment	 of	
DnaADI	 from	 B.	 subtilis,	 E.	 coli	 and	 H.	 pylori.	 Symbols	 below	 the	 alignments	 indicate	 interfacial	
residues	 on	 DnaADI	 in	 the	 SirA–DnaADI	 structure;	 core	 residues	 are	 indicated	 by	 asterisks	 and	
residues	 in	 the	 rim	 by	 triangles.	 Secondary	 structure	 elements	 and	 residue	 numberings	 are	
displayed	above	the	alignment.	The	images	were	created	using	ESPript	(Gouet,	2003).	
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2.6:	Discussion	
DNA	 replication	 initiation	 is	 strictly	 regulated	 to	 ensure	 chromosome	 copy	 number	 is	
coordinated	with	cell	division	and	differentiation.	The	prokaryotic	 initiator	protein,	DnaA,	
has	a	number	of	 identified	regulators	which	vary	across	bacterial	species122.	 In	B.	subtilis,	
several	 regulators	of	DNA	 replication	 initiation	have	been	 identified,	 two	of	which	act	at	
the	 entry	 to	 sporulation.	 Spo0A~P	 is	 thought	 to	 bind	 to	 Spo0A	 boxes	 located	 at	 the	
replication	origin,	occluding	DnaA	box	 regions	and	 thus,	preventing	DnaA	binding	 to	oriC	
194.	 	 Additionally,	 the	 regulator	 SirA	 is	 known	 to	 assist	 with	 the	 maintenance	 of	
chromosome	copy	number	on	entry	into	sporulation192,193.	Here,	we	have	elucidated	SirA’s	
mode	of	binding	to	DnaADI	by	solving	the	crystal	structure	of	SirA	in	an	inhibitory	complex	
with	DnaADI.	Collaborative	studies	with	Nadia	Rostami	and	Heath	Murray	at	the	University	
of	Newcastle	have	confirmed	the	physiological	 relevance	of	 the	SirA-DnaADI	complex	and	
these	are	described	below.	
SirA	 has	 recently	 been	 shown	 to	 form	 foci	 at	 the	 mid-cell	 during	 sporulation	 in	
approximately	20%	of	cells,	150	mins	after	sporulation	is	induced	(Fig.	2.21,	A).	These	foci	
were	shown	not	to	coincide	with	replication	origins	which	are	located	at	the	cell	poles	(Fig.	
2.21,	B),	and	moreover,	SirA	was	found	to	co-localise	with	DnaN	(the	polymerase	β-clamp	
(Fig.	 2.21,	 C),	 suggesting	 that	 SirA	 is	 associated	with	 the	 replisome	 (and	 away	 from	 the	
origins)	during	the	early	stages	of	sporulation214.		
	
Figure	2.21:	Localisation	of	SirA	in	vivo:	Figure	to	show	GFP-SirA	localisation	in	vivo;	adapted	from	
figure	produced	by	N.	Rostami	and	H.	Murray.	All	images	are	150	mins	post	starvation	in	sporulating	
B.	subtilis	cells.	Scale	bars	=	3µm	A)	GFP–SirA	foci	formation	(at	maximum	150	mins	post	starvation).	
Membrane	 dye	 FM5-95	 was	 used	 to	 highlight	 cell	 outlines.	 B)	 Localisation	 of	 GFP–SirA	 foci	
compared	to	replication	origins.	C)	Co-localisation	of	GFP–SirA	foci	and	DnaN-mCherry	foci.			
93	
	
Furthermore,	 the	 mutations	 on	 SirA	 which	 were	 found	 to	 disrupt	 the	 SirA-DnaADI	
interaction	in	vitro	(above);	Phe14Ala,	Tyr18Ala	and	Gln48Ala,	significantly	reduce	SirA	foci-
formation	 (Phe14Ala,	Tyr18Ala	 to	background	 levels	and	Gln48Ala	2.5-fold)	 (Fig.	2.22,	A),	
demonstrating	the	necessity	of	these	residues	for	localisation	of	SirA	at	the	replisome.	The	
mutations	 on	 DnaA;	 Thr26Ala,	 Trp27Ala	 and	 Phe49Ala	 could	 not	 be	 introduced	 into	 B.	
subtilis	cells,	suggesting	that	they	may	also	play	a	role	in	an	essential	interaction	between	
DnaA	 and	 the	 replication	 machinery214.	 By	 contrast,	 the	 previously	 identified	 mutations	
Asn47Ala	 and	Ala50Val	 83	 could	be	 readily	 introduced	 into	dnaA	 and	were	 also	 found	 to	
have	a	significant	effect	on	SirA	foci	formation	-	Asn47Ala	reduced	foci	formation	2.4-fold,	
whilst	Ala50Val	reduced	them	to	background	levels214	(Fig.	2.22,	B).	Together,	these	results	
indicate	that	the	SirA-DnaADI	interface	identified	in	the	crystal	structure	is	required	for	SirA	
foci	 formation,	 and	 that	 SirA	 localisation	 at	 the	 replisome	 is	mediated	 by	 an	 interaction	
with	DnaA.		
	
Figure	2.22:	Effect	of	mutations	in	the	SirA-DnaA	interface	on	GFP-SirA	foci	formation	in	vivo:	
Figure	adapted	from	a	figure	originally	produced	by	N.	Rostami	and	H.	Murray.	All	 images	are	150	
mins	post	starvation	in	sporulating	B.	subtilis	cells.	Scale	bars	=	3µm	A)	Images	to	show	amino	acid	
substitutions	F14A,	Y18A	and	Q48A	in	SirA	inhibit	GFP-SirA	foci	formation	in	vivo.	Quantification	of	a	
representative	 dataset	 is	 shown	 below.	 B)	 	 Images	 to	 show	 amino	 acid	 substitutions	 N47H,	 and	
A50V	 in	DnaA	 inhibit	GFP-SirA	 foci	 formation	 in	vivo.	Quantification	of	a	 representative	dataset	 is	
shown	below.	
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In	addition,	the	above	mutations	in	SirA	were	able	to	overcome	the	phenotypes	shown	by	
induction	of	wildtype	SirA	 in	vegetatively	growing	cells	on/in	both	solid	and	liquid	media.	
As	 described	 earlier,	 induction	 of	 wild	 type	 SirA	 from	 an	 inducible	 promotor	 inhibits	
vegetative	cell	growth	on	solid	media192,193.	 It	also	produces	elongated	cells	with	a	 single	
nucleoid	 in	 liquid	media.	However,	 the	 introduction	of	mutations	directing	the	Phe14Ala,	
Try18Ala	and	Gln48Ala	substitutions	into	sirA	allowed	cell	growth	on	solid	media	(Fig.	2.23,	
A)	 and	 produced	 cells	 which	 had	 a	 normal	 DNA	 distribution	 and	 morphology	 in	 liquid	
media	(Fig.	2.23,	B)214.	This	suggests	that	the	amino	acids	necessary	for	SirA	localisation	are	
also	essential	for	inhibiting	DnaA	activity	in	vivo.	Altogether,	these	results	provide	a	strong	
physiological	relevance	to	the	SirA-DnaADI	interface	identified	in	the	crystal	structure.			
	
Figure	2.23:	Growth	phenotypes	of	wild-type	SirA	vs.	SirA	variants:	Figure	adapted	from	a	figure	
originally	produced	by	N.	Rostami	and	H.	Murray.	A)	Wild-type	and	mutant	sirA	were	placed	under	
control	 of	 an	 IPTG-inducible	 promoter	 and	 streaked	 on	 nutrient	 agar	 plates	 in	 the	 presence	 and	
absence	of	 IPTG	 (3	mM).	 	B).	Comparison	of	overexpression	of	wild-type	and	mutant	SirA	 in	 cells	
grown	in	 liquid	media.	 Images	taken	180	min	post-induction	of	gene	expression	(with	3mM	IPTG).	
Membrane	 dye	 FM5-95	was	 used	 to	 highlight	 cell	 outlines	 and	DAPI	was	 used	 to	 stain	 the	 DNA.	
Scale	bar	=	3	μm.		
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The	structure	of	SirA-DnaADI;	an	inhibitory	complex	of	DnaADI,	complements	that	of	HobA-
DnaADI	 from	H.	 pylori73	 where	 DnaADI	 is	 in	 a	 complex	 which	 leads	 to	 activation	 of	 DNA	
replication	 initiation.	As	previously	 inferred,	we	have	 found	 that	SirA	binds	a	 structurally	
equivalent	site	on	DnaADI	as	the	regulators	HobA73	and	DiaA80;	structural	homologues	from	
the	 organisms	 H.	 pylori	 and	 E.	 coli,	 respectively.	 HobA	 and	 DiaA	 are	 activators	 of	 DNA	
replication	initiation,	known	to	form	tetramers	which	promote	the	oligomerisation	of	DnaA	
at	 oriC157.	 Each	 HobA/DiaA	 tetramer	 binds	 to	 four	 DnaADI	 molecules	 in	 a	 way	 that	 is	
thought	 to	 facilitate	 DnaA-binding	 to	 the	 array	 of	 DnaA-boxes	 distributed	 at	 oriC160.	
Conversely,	 SirA	 binds	 only	 one	 molecule	 of	 DnaADI	 in	 a	 manner	 which	 inhibits	 DNA	
replication	 initiation.	 Although	 SirA	 and	 HobA/DiaA	 have	 quite	 different	 3D	 folds,	 each	
masks	a	structurally	equivalent	surface	on	DnaA.	 It	 is	 intriguing	therefore,	that	they	elicit	
such	different	regulatory	outcomes.		
It	has	previously	been	suggested	that	SirA	inhibits	DNA	replication	initiation	by	preventing	
the	binding	of	DnaA	at	oriC	based	on	the	fact	that	induction	of	SirA	reduces	the	number	of	
DnaA-GFP	 foci	 at	 oriC	 during	 vegetative	 growth,	 and	 that	 the	 amount	 of	 DnaA	 at	 oriC	
decreases	 in	 a	 SirA-dependent	 manner	 following	 the	 induction	 of	 sporulation83,193.		
However,	the	finding	that	SirA	forms	foci	at	the	mid-cell	during	sporulation,	at	sites	distal	
from	 the	 replication	 origins	 suggests	 that	 SirA	 cannot	 be	 directly	 inhibiting	 DnaA	
oligomerisation	at	oriC.	In	E.	coli,	DnaADI	is	thought	to	play	a	role	in	oligomerisation,	and	is	
suggested	 to	 form	 dimers	 mediated	 on	 one	 surface	 of	 DnaADI	 75.	 The	 corresponding	
'dimerisation	 surface'	 in	 B.	 subtilis	 DnaADI	 is	 located	 opposite	 the	 SirA	 binding	 surface,	
suggesting	that	SirA	could	not	inhibit	this	mode	of	dimerisation.	However,	in	B.	subtilis,	we	
did	not	observe	DnaADI	mediating	dimer	or	oligomer	formation	in	vitro,	and	the	equivalent	
tryptophan	residue	to	that	essential	in	E.	coli	is	buried	within	the	DnaADI	structure	in	both	
its	‘free’	and	‘SirA-bound’	forms,	suggesting	that	B.	subtilis	DnaADI	does	not	form	dimers	in	
an	analogous	manner	to	the	E.	coli	orthologue.	There	is	no	published	evidence	to	suggest	
that	B.	subtilis	DnaADI	mediates	dimer	formation.	Collectively,	this	evidence	suggests	SirA	is	
not	likely	to	act	by	inhibiting	DnaADI-DnaADI	interactions.		
Based	on	the	observation	that	SirA	accumulates	at	the	replisome	during	sporulation,	and	
that	this	interaction	appears	to	be	mediated	by	DnaADI,	one	hypothesis	for	SirA’s	inhibition	
mechanism	is	that	SirA	interacts	with	replisome-bound	DnaA	in	a	manner	which	stabilises	
the	replisome-DnaA	complex,	and	thus	inhibits	DnaA	from	re-binding	to	oriC.	This	is	similar	
to	 the	 DnaA-tethering	 model	 proposed	 for	 YabA215.	 However,	 the	 observation	 that	 the	
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mutations	Thr26Ala,	Trp27Ala	and	Phe49Ala	could	not	be	introduced	to	dnaA	suggests	that	
these	residues	may	be	involved	in	an	essential	interaction	with	another	component	of	the	
initiation	 complex,	 and	 thus	 SirA	may	 instead	act	by	 inhibiting	 this	 interaction.	 In	E.	 coli,	
DnaADI	 is	 directly	 implicated	 in	 the	 recruitment	 of	 the	 DNA	 helicase74.	 However,	 in	 B.	
subtilis	 there	 is	 no	 evidence	 for	 a	 direct	 interaction	 between	 DnaA	 and	 the	 helicase.	B.	
subtilis	 helicase	 recruitment	 requires	 two	 additional	 essential	 DNA	 remodelling	 proteins	
DnaD	 and	DnaB37;	 DnaD	 interacts	 directly	with	DnaA,	 and	 forms	multimeric	 scaffolds	 on	
DNA100.	DnaD	subsequently	 recruits	DnaB,	which	 is	 thought	 to	bridge	an	 interaction	with	
the	 helicase-helicase	 loader38.	 Thus,	 SirA	 may	 serve	 to	 inhibit	 a	 DnaA-DnaD	 interaction	
which	arrests	the	assembly	of	the	initiation	complex.	
In	summary,	the	SirA-DnaADI	complex	presented	here	is	the	first	of	DnaADI	in	an	inhibitory	
complex.	 It	 defines	 the	 interaction	 surfaces	 of	 SirA	 and	DnaADI	 and	 the	 stoichiometry	 of	
their	 interaction.	The	complex	 is	physiologically	relevant,	as	sporulating	cells	 in	B.	subtilis	
containing	mutations	in	the	SirA-DnaADI	interface	have	been	shown	to	affect	GFP-SirA	foci	
formation	at	the	replisome.	These	results	will	assist	the	elucidation	of	SirA’s	mechanism	of	
action,	which	is	limited	by	our	current	knowledge	of	the	role	of	DnaADI	in	DNA	replication	
initiation	within	B.	subtilis.	
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Chapter	3 :	YabA	Biophysical	Characterisation	
3.1:	Abstract		
YabA	 is	 a	 key	 regulator	 of	 DNA	 replication	 in	 B.	 subtilis;	 it	 controls	 the	 timing	 and	
synchrony	 of	 DNA	 replication	 in	 vegetatively	 growing	 cells	 by	 a	 currently	 unknown	
mechanism	of	action.	 In	an	attempt	 to	provide	structural	 insight	 into	YabA's	mechanism,	
an	 in	silico	model	of	YabA	has	been	produced	based	on	regions	of	homology	within	YabA	
for	 a	 leucine	 zipper	 domain	 and	 a	 Zn-binding	 domain.	 The	 initial	 model	 is	 a	 dimer,	
resembling	the	shape	of	a	hammer;	however	YabA	has	been	experimentally	determined	to	
be	a	tetramer.	Therefore,	three	potential	'dimer	of	dimer'	models	have	been	proposed	to	
account	 for	 the	 tetramer	 structure.	 Here,	 we	 have	 used	 biophysical	 methods	 to	
characterise	 the	 shape	of	YabA,	 to	determine	which	of	 the	proposed	 tetramer	models	 is	
the	most	consistent	with	YabA's	experimental	behaviour.	Initial	characterisation	of	YabA	by	
SEC-MALLS	and	AUC	suggested	that	(as	expected)	our	recombinant	YabA	forms	a	tetramer,	
and	 that	 this	 tetramer	 has	 an	 elongated	 structure.	 Individual	 domains	 of	 YabA	 were	
subsequently	cloned,	produced	and	characterised	to	further	analyse	the	overall	quaternary	
structure.	 These	 results	 suggest	 that	 the	model	which	 is	 the	most	 consistent	with	our	 in	
vitro	knowledge	of	YabA	resembles	a	'doggy	bone':	in	this	model,	two	coiled-coil	domains	
form	an	elongated	helical	'core'	with	two	Zn-cluster	domains	residing	at	either	end	of	the	
structure.	
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3.2:	Introduction	
YabA	 is	 a	 negative	 regulator	 of	 DNA	 replication	 in	B.	 subtilis,	 affecting	 the	 synchrony	 of	
DNA	 replication	 and	 frequency	 of	 DNA	 replication	 initiation161.	 YabA	 has	 been	 shown	 to	
form	 physiologically	 relevant	 interactions	 with	 both	 the	 DNA	 replication	 initiator,	 DnaA,	
and	 the	 DNA	 polymerase	 clamp,	 DnaN162,163.	 Although	 this	 is	 reminiscent	 of	 the	 E.	 coli	
regulator	Hda,	which	hydrolyses	ATP	within	DnaA	as	 a	method	 for	down-regulating	DNA	
replication	 initiation125,126,128,	 it	 is	clear	that	YabA	must	employ	a	different	mechanism	for	
regulating	 DNA	 replication	 initiation	 frequency.	 	 YabA	 shares	 no	 homology	with	Hda	 (or	
DnaA)	and	does	not	affect	the	turnover	of	ATP	in	DnaA109	.	YabA	has	been	shown	to	affect	
the	cooperativity	of	DnaA	binding	at	oriC	34,	and	over-expression	of	DnaN	has	been	shown	
to	 increase	 DNA	 replication	 events	 in	 a	 manner	 which	 mimics	 a	 YabA	 deletion	
phenotype34,216.	 YabA	 is	 conserved	 in	 low-GC	 Gram	 positive	 bacteria,	 representing	 a	
distinct	 family	 of	 replication	 regulator	 proteins.	 This	 makes	 its	 molecular	 mechanism	 of	
significant	interest.	Models	have	been	proposed	for	YabA's	activity,	but	an	understanding	
of	 the	structure	of	YabA	 (and	 its	 interactions	with	DnaA	and	DnaN)	would	help	 to	better	
understand	the	mechanism	YabA	uses	to	regulate	the	initiation	of	DNA	replication.				
Homology	 based	 sequence	 analysis	 suggests	 that	 YabA	 consists	 of	 an	N-terminal	 leucine	
zipper	motif,	and	a	C-terminal	zinc-binding	domain	separated	by	an	area	of	poor	sequence	
conservation163.	 Collaborators	 L.	 Felicori	 and	 F.	Molina	 have	 proposed	 an	 in	 silico	 dimer	
model	of	YabA	(Fig.	3.1)	based	on	structural	templates	which	were	identified	due	to	their	
homology	to	either	the	leucine	zipper	or	zinc-binding	portion	of	YabA.	In	the	dimer	model,	
the	N-terminal	region	forms	an	α-helical	coiled-coil	domain	connected	to	two	adjacent	Zn-
binding	domains	via	a	flexible	'hinge'	region.	The	overall	shape	of	the	dimer	resembles	that	
of	a	hammer,	with	the	coiled-coil	domain	forming	the	handle	and	the	Zn-binding	domains	
forming	the	hammerhead.	
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Figure	 3.1:	 In	 silico	 model	 of	 YabA:	 Model	 of	 YabA	 created	 using	 constraint-based	 homology	
modelling	in	the	program	MODELLER	(9v8).	YabA	forms	a	dimer	which	resembles	a	hammer.	The	N-
terminal	leucine	zipper	residues	from	a	coiled-coil	domain	(the	hammer's	handle)	which	is	linked	to	
two	Zn-binding	domains	via	a	 'flexible	hinge'.	The	Zn-binding	domains	lie	adjacent	to	one	another,	
forming	the	hammerhead.		
	
YabA	has	been	previously	shown	to	form	tetramers	in	solution163;	an	observation	which	is	
not	 directly	 addressed	 by	 the	 dimer	 model	 of	 YabA.	 However,	 this	 discrepancy	 can	 be	
reconciled	by	assuming	that	the	model	is	able	to	form	a	tetramer	from	a	dimer	of	dimers.	It	
is	 not	 immediately	 obvious	 how	 this	 dimer	 of	 dimers	would	 form	 however,	 and	 thus,	 3	
alternative	 conformations	 have	 been	 proposed	 (Fig	 3.2).	 In	 the	 first,	 (Fig.	 3.2,	 A)	 the	
hammerhead	regions	of	 the	YabA	dimers	come	together	to	 form	a	group	of	4	Zn-binding	
domains	with	 the	 coiled-coil	 domains	 protruding	 out	 in	 opposite	 directions.	 Overall	 this	
produces	an	elongated	structure	which	 represents	 'beads	on	a	 rail'.	 In	 the	second	model	
(Fig	 3.2,	 B),	 'doggy	bones',	 the	dimers	 associate	 via	 their	N-terminal	 coiled-coil	 domains,	
and	the	Zn-binding	domains	are	separated	at	either	end	of	the	model	-	again	this	displays	
an	 overall	 elongated	 structure.	 In	 the	 final	 model,	 'bunch	 of	 flowers',	 the	 dimers	 lie	
parallel,	with	both	coiled-coil	domains	together	and	all	Zn-binding	domains	associated	with	
one	another,	forming	a	more	compact	structure	than	the	first	two	models.		
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Figure	3.2:	YabA	tetramer	models	:	proposed	dimers	of	dimers	of	YabA	(models	of	the	tetramer).	A)	
The	dimers	come	together	at	their	Zn-binding	domains	to	form	a	structure	resembling	'beads	on	a	
rail'.	B)	 The	 dimers	 come	 together	 at	 their	 coiled-coil	 domains,	 resembling	 'doggy	 bones'.	C)	 The	
dimers	 run	 parallel	 to	 one	 another,	 with	 both	 coiled-coil	 and	 Zn-binding	 domains	 together,	
resembling	a	'bunch	of	flowers'.		
	
Here	 we	 are	 interested	 in	 using	 biophysical	 characterisation	 to	 identify	 which	 of	 the	
tetrameric	models	 of	 YabA	 is	most	 consistent	with	 YabA's	 behaviour	 in	 vitro.	 Identifying	
YabA's	shape	will	aid	our	understanding	of	how	YabA	interacts	with	DnaA	and	DnaN.		
A	 construct	 which	 directs	 the	 expression	 of	 full	 length	 YabA	 with	 an	 N-terminal	 hexa-
histidine	 tag	was	 previously	 cloned	 at	 YSBL	 by	M.	 Fogg.	 This	 construct	 has	 been	 utilised	
here	for	the	production	of	YabA.		
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3.3:	Aims		
Understanding	 the	quaternary	 structure	of	YabA	may	provide	 insight	 into	 its	 interactions	
with	both	DnaA	and	DnaN,	and	thus	the	potential	mechanisms	YabA	employs	to	regulate	
the	 initiation	 of	 DNA	 replication.	 The	 purpose	 of	 this	 work	 was	 to	 determine	 which	 of	
several	 proposed	 in	 silico	 tetramer	models	 are	most	 consistent	with	YabA's	behaviour	 in	
vitro.	The	initial	aim	of	the	work	was	to	produce	YabA	by	expression	in	E.	coli	and	to	purify	
it	 by	 chromatography	 methods.	 Subsequently,	 to	 carry	 out	 SEC-MALLS	 and	 AUC	
experiments	 with	 purified	 YabA	 to	 characterise	 its	 quaternary	 structure.	 Using	 these	
results,	we	planned	to	develop	further	hypotheses	to	investigate	the	quaternary	structure	
of	YabA.	
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3.4:	Methods		
3.4.1:	YabA	Expression	
The	plasmid	pET-YSBLIC3C-YabA	was	 introduced	 into	E.	coli	BL21	(DE3)	cells	 for	the	over-
expression	 of	 yabA.	 Overnight	 LB	 cultures	 were	 used	 to	 inoculate	 500	 ml	 LB	 cultures	
supplemented	with	30	μg	ml-1	kanamycin.	Cultures	were	grown	to	an	OD600	of	0.6-0.8	at	37	
°C	(shaking	at	180	rpm)	before	protein	production	was	induced	with	1	mM	IPTG.	Following	
induction,	 cultures	were	 grown	at	 16	 °C	 (180	 rpm	 shaking)	overnight	 (~20	hours)	 before	
cells	were	harvested	by	centrifugation.	
	
3.4.2:	YabA	Purification	
Harvested	 cells	 were	 re-suspended	 in	 a	 buffer	 of	 50	 mM	 Tris,	 500	 mM	 NaCl,	 20	 mM	
Imidazole,	 containing	 an	 EDTA-free	 protease	 inhibitor	 cocktail	 tablet	 (Roche).	 Re-
suspended	 cells	 were	 lysed	 by	 sonication	 and	 lysate	 clarified	 by	 centrifugation.	 The	 cell	
lysate	was	loaded	on	a	HisTrap	FF	crude	Ni-affinity	column	(GE	Healthcare)	at	approx.	2-2.5	
mL/min	and	bound	protein	eluted	over	an	increasing	imidazole	concentration	gradient	(0	–	
500	mM).	Fractions	containing	YabA	were	concentrated	to	less	than	2	mL	for	size-exclusion	
chromatography.	 Protein	 was	 loaded	 onto	 a	 HiLoad	 16/60	 Superdex	 S200	 column	 (GE	
Healthcare)	equilibrated	with	50mM	Tris,	150	mM	NaCl	and	run	at	0.75	ml/min.	Fractions	
containing	 YabA	were	 combined	 according	 to	 analysis	 by	 SDS-PAGE,	 and	 the	 N-terminal	
histidine	tag	was	removed	by	incubation	with	3C	protease	overnight	at	a	protease:protein	
ratio	of	1:50.	Passage	through	a	second	Ni-affinity	column	to	remove	the	histidine	tag	and	
tagged	 protease	 yielded	 pure	 protein	 in	 a	 buffer	 of	 50	mM	 Tris,	 150	mM	NaCl,	 20	mM	
Imidazole.	Protein	was	assessed	as	pure	according	to	analysis	by	SDS-PAGE.	
	
3.4.3:	Analytical	Ultracentrifugation:	YabA	
A	 sedimentation	 velocity	 (SV)	 experiment	 was	 carried	 out	 across	 a	 range	 of	 YabA	
concentrations	(0.07	mg	ml-1,	0.15	mg	ml-1,	0.31	mg	ml-1,	0.63	mg	ml-1,	1.25	mg	ml-1)	in	50	
mM	Tris,	150	mM	NaCl.	The	SV	experiment	was	run	at	50,000	rpm	at	20	°C	using	an	Optima	
XL/I	 (Beckman)	 instrument	 and	 an	 AN50Ti	 rotor,	 with	 scans	 measured	 at	 275	 nm.	 The	
results	were	analysed	to	provide	a	frictional	ratio	and	sedimentation	coefficient	specific	to	
YabA	(analysis	carried	out	by	A.	Leech).	These	results	were	then	compared	to	theoretical	
values	calculated	for	various	tetrameric	YabA	models.		
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3.4.4:	Cloning:	YabA1-58	and	YabA70-119	
Constructs	 encoding	 YabA	 N-terminal	 domain	 (YabA1-58)	 and	 YabA	 C-terminal	 domain	
(YabA70-119)	 were	 cloned	 using	 a	 deletion	 mutagenesis	 method.	 	 A	 whole	 vector	
amplification	 of	 pET-YSBLIC-YabA	 was	 performed	 by	 PCR	 using	 primers	 which	 would	
produce	 a	 desired	 deletion	 in	 the	 YabA	 coding	 region	 (Table	 3.1).	 PCR	 reactants	 and	
conditions	are	listed	in	Tables	3.2	and	3.3.	45μl	of	PCR	product	was	incubated	with	1.5	μl	
DpnI	(15	units)	at	37	°C	for	4-5	hours,	before	transformation	into	Top10	competent	cells.	
1μl	of	digested	product	was	added	to	50	μl	Top10	competent	cells	before	incubation	for	30	
minutes	on	 ice.	Cells	were	heat-shocked	at	42	 °C	 for	50	seconds	before	re-incubation	on	
ice	 for	 10	minutes.	 150	μl	 LB	media	was	 added	 and	 cells	were	 incubated	 at	 37°C	 for	 60	
minutes	prior	to	plating	of	100	μl	of	the	culture	onto	LB	agar	supplemented	with	30	μg	ml-1	
kanamycin.	Plates	were	incubated	for	18-20	hours	at	37°C	until	the	production	of	colonies	
around	1.0-1.5	mm	in	diameter.	Cultures	containing	5	ml	LB	supplemented	with	30	μg	ml-1	
kanamycin	 and	 a	 single	 colony	 were	 incubated	 at	 37	 °C	 overnight,	 before	 isolation	 of	
plasmid	DNA	using	a	mini-prep	kit	 (Qiagen).	Resultant	plasmids	were	analysed	by	double	
digest	 and	 sequences	 confirmed	 to	 be	 correct	 by	 sequencing	 (GATC).	 The	 recombinant	
plasmids	 (pET-YSBLIC3C-YabA1-58	 and	 pET-YSBLIC3C-YabA70-119)	 direct	 the	 expression	 of	
YabA	residues	1	to	58	or	70-119	fused	to	a	3C	cleavable	N-terminal	His-tag.		
	
Table	3.1:	YabA	construct	primers	and	coding	regions:	:	 listed	are	the	primers	used	for	cloning	of	
YabA	constructs	and	their	resultant	coding	regions.	Bases	written	 in	bold	have	been	appended	for	
annealing	or	insertion	into	the	YSBLIC3C	vector.	
	
	
	 	
Construct	 Residues	of	
YabA	
Encoded	
Cloning	Primers	 Template	
pET-YSBLIC3C-
YabA1-58	 1-58	
Fwd	 5'-CGACGCAGCAGTAACGCGCCTTC	TCCTCACATATGGC-3'	 pET-
YSBLIC3C-
YabA	Rev	 5'-AAGGCGCGTTACTGCTGCGTCGT	ATCGTCCAGC-3'	
pET-YSBLIC3C-
YabA70-119	 70-119	
Fwd	 5'-AGGGACCAGCAAAAACACAGAA	GACAGAGCAAACTGATATAGGG-3	 pET-
YSBLIC3C-
YabA	Rev	 5'-GTCTTCTGTGTTTTTGCTGGTCC	CTGGAACAGAACTTCC-3'	
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Table	3.2:	PCR	components	for	cloning	pET-YSBLIC3C-YabA1-58	and	pET-YSBLIC3C-YabA70-119	
Reactant	 Volume/	μl		(50μl	reaction)	
pET-YSBLIC3C-YabA	(100	ng	μl-1)	 1	
Oligo	I	(20	pmol	μl-1)	 0.5	
Oligo	II	(20	pmol	μl-1)	 0.5	
KOD	Hot	Start	DNA	Polymerase	Buffer	(10x)	 5	
dNTPs	(2mM)	 5	
KOD	Hot	Start	DNA	Polymerase	(1,000	U/	ml)	 1	
MgSO4	(25mM)	 2	
H2O	 35	
	
	
Table	3.3:	PCR	Conditions	for	cloning	of	pET-YSBLIC3C-YabA1-58	and	pET-YSBLIC3C-YabA70-119	
Step	 Temperature	/°C	 Duration	/min	 Cycles	
Initial	Denature	 94	 5	 1	
Denature	 94	 1	 	
30	Annealing	 55	 1	
Extension	 72	 7	
Final	Extention	 72	 3	 1	
	
	
3.4.5:	Double	Digest	
50	μg	DNA	was	digested	with	10	units	of	NcoI	and	10	units	of	NdeI	 in	NEB	buffer	2	at	a	
total	volume	of	25	μl.	The	mixture	was	incubated	for	1	hour	at	37	°C	before	a	20μl	sample	
was	combined	with	5μl	DNA	loading	dye	and	analysed	on	a	1%	agarose	gel.		
	
3.4.6:	Expression:	YabA1-58	and	YabA70-119	
The	 recombinant	 plasmid	 pET-YSBLIC3C-YabA1-58	 or	 pET-YSBLIC3C-YabA70-119	 was	
introduced	into	E.	coli	BL21	(DE3)	cells	for	over-expression.		
For	small	scale	expression	tests,	200	μl	of	overnight	LB	culture	was	used	to	inoculate	10	ml	
LB	cultures	supplemented	with	30	μg	ml-1	kanamycin.	Cultures	were	grown	to	an	OD600	of	
0.6-0.8	at	37	°C	 (shaking	at	180	rpm)	before	cells	 from	1	ml	of	culture	were	havested	by	
centrifugation,	 and	 protein	 production	was	 induced	 in	 the	 remaining	 culture	with	 1	mM	
IPTG.	Following	induction,	cultures	were	grown	at	37°C	for	4	hours,	or	16°C	for	18-20	hours	
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with	shaking	at	180	rpm.	Cells	 from	1	ml	of	culture	were	harvested	by	centrifugation	 for	
analysis	of	protein	production.			
For	large	scale	expression,	overnight	LB	cultures	were	used	to	inoculate	500	ml	LB	cultures	
supplemented	with	30	μg	ml-1	kanamycin.	Cultures	were	grown	to	an	OD600	of	0.6-0.8	at	37	
°C	(shaking	at	180	rpm)	before	protein	production	was	induced	with	1	mM	IPTG.	Following	
induction,	 cultures	were	grown	at	37°C	 for	4	hours,	with	 shaking	at	180	 rpm.	Cells	were	
subsequently	harvested	by	centrifugation	(Sorvall	RC	5B	Plus,	15	min	at	15	K	(SS34	rotor)).	
The	 pelleted	 cells	 were	 re-suspended	 in	 50	 mM	 Tris	 pH	 8.0,	 500	 mM	 NaCl,	 20	 mM	
Imidazole	(purification	lysis	buffer)	prior	to	re-pelleting	by	centrifugation	(10	min,	5K),	for	
storage	at	-20°C.	
	
3.4.7:	Purification:	YabA1-58	and	YabA70-119	
YabA1-58	and	YabA70-119	were	purified	by	the	procedure	outlined	for	YabA	 in	section	3.4.2.	
with	a	modified	size-exclusion	step;	protein	fractions	were	combined	and	concentrated	to	
≤	1	mL	and	loaded	onto	a	HiLoad	16/60	Superdex	S75	column	(GE	Healthcare).	
	
3.4.8:	Mass	Spectrometry	
Purified	 YabA1-58	 and	 YabA70-119	 were	 buffer	 exchanged	 into	 2	 mM	 Tris	 for	 analysis	 by	
Electrospray	 Ionisation-Mass	 Spectrometry	 (ESI-MS).	 Samples	 were	 provided	 at	 a	
concentration	of	5	mg	ml-1.	Spectra	were	obtained	and	processed	by	A.	Leech.		
	
3.4.9:	Circular	Dichroism	
Circular	dichroism	spectra	were	recorded	at	20	°C	on	a	Jasco	J-810	CD	spectrophotometer	
using	 a	 quartz	 cell	 with	 a	 0.1	 cm	 path	 length.	 Experiments	 were	 carried	 out	 at	 a	
concentration	of	 0.2	mg	mL-1	 in	 a	buffer	of	 20	mM	K	Phosphate.	 Spectra	were	 recorded	
across	 the	 wavelength	 range	 of	 260	 nm	 -	 185	 nm.	 A	 scan	 of	 the	 buffer	 (20	 mM	 K	
Phosphate)	 was	 also	measured	 and	 subtracted	 from	 the	 protein	 spectra	 to	 remove	 any	
contribution	from	the	buffer.	
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3.4.10:	SEC-MALLS	
To	determine	the	oligomeric	state	of	YabA,	YabA1-58	and	YabA70-119	analysis	was	carried	out	
by	 SEC-MALLS.	 100	 μl	 samples	 of	 protein	 were	 loaded	 onto	 a	 size-exclusion	 column	
equilibrated	with	50	mM	TRIS	pH	8.0,	150	mM	NaCl.	YabA	was	loaded	at	a	concentration	of	
2.5	mg	ml-1	onto	a	Superdex	200	HR	10/30	column.	YabA1-58	and	YabA70-119	were	loaded	at	a	
concentration	 of	 5	 mg	 mL-1	 onto	 a	 Superdex	 75	 HR	 10/30	 column.	 The	 eluate	 was	
successively	analysed	by	a	SPD20A	UV/Vis	detector,	a	Wyatt	Dawn	HELEOS-II	18-angle	light	
scattering	detector	and	a	Wyatt	Optilab	 rEX	 refractive	 index	monitor.	Data	was	analysed	
with	Astra	software	(Wyatt).		
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3.5:	Results		
3.5.1:	YabA	Protein	Production	
The	vector	pET-YSBLIC3C-YabA	directs	the	expression	of	YabA	with	an	N-terminal	cleavable	
hexa-histidine	 tag.	 YabA	 was	 over-expressed	 from	 this	 vector	 yielding	 soluble	 protein	
following	the	procedure	outlined	in	methods	(section	3.4.1).	Analysis	of	protein	production	
and	solubility	by	SDS-PAGE	 (Fig.	3.3)	 showed	 that	high	 levels	of	YabA	protein	production	
were	induced	(Fig.	3.3,	lane	3)	and	that	this	protein	was	soluble	in	a	re-suspension	buffer	
of	50	mM	Tris	pH	8.0,	500	mM	NaCl	and	20	mM	Imidazole	(Fig.	3.3,	lane	4).		
	
Figure	3.3:	Production	of	YabA:	1)	Low	molecular	weight	markers;	2)	Lysate	 from	un-induced	cell	
culture;	3)	Lysate	from	cell	culture	induced	to	produce	YabA;	4)	soluble	cell	lysate	from	cell	culture	
induced	to	produce	YabA.			
	
3.5.2:	YabA	Purification	
YabA	can	be	purified	by	a	combination	of	Ni-affinity	and	size-exclusion	chromatography	as	
outlined	 in	section	3.4.2.	Clarified	cell	 lysate	containing	His-tagged	YabA	 is	 loaded	onto	a	
Ni-affinity	column	before	elution	over	an	increasing	imidazole	gradient	(20-500	mM).	YabA	
elutes	from	the	column	in	a	single	peak	at	an	imidazole	concentration	of	approx.	200mM	(a	
chromatogram	 is	 shown	 in	 Fig.	 3.4,	 A).	 A	 shoulder	 is	 visible	 on	 the	 left-hand	 side	 of	 the	
peak	 indicating	 elution	 of	 some	 protein	 at	 a	 lower	 imidazole	 concentration.	 Analysis	 by	
SDS-PAGE	 shows	 that	 although	 YabA	 elutes	 across	 the	 entirety	 of	 the	 peak,	 the	 protein	
eluting	 in	 the	 shoulder	 region	 at	 a	 lower	 imidazole	 concentration	 contains	 more	
contaminants	 (Fig.	 3.5,	 lane	 4).	 Therefore,	 only	 protein	 contributing	 to	 the	main	 peak	 is	
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combined	 (in	 this	 case,	 fractions	 19	 to	 35).	 The	 combined	 fractions	 are	 concentrated	 to	
approx.	2ml	for	size-exclusion	chromatography.	The	chromatogram	from	the	size-exclusion	
run	contains	two	peaks	(3.4,	B);	a	minor	peak	at	approx.	48	ml	and	a	major	peak	approx.	70	
ml.	Analysis	by	SDS-PAGE	indicates	that	the	minor	peak	contains	a	small	quantity	of	YabA	
(suspected	 aggregate)	 and	 some	 contaminants	 (Fig.	 3.5,	 lane	 8)	 whilst	 the	 major	 peak	
contains	the	majority	of	YabA	protein	(Fig.	3.5,	lanes	9-11).			
	
Figure	 3.4:	 YabA	 purification	 by	 Ni-affinity	 and	 size-exclusion	 chromatography:	 Chromatograms	
showing	elution	of	 YabA	protein	 from;	A)	 a	Ni-affinity	 column;	 and	B)	 a	 size-exclusion	 column.	 In	
blue,	 absorbance	 at	 280	 nm;	 in	 red,	 absorbance	 at	 254	 nm;	 numbers	 in	 purple	 denote	 fractions	
collected.	
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Fractions	 containing	 YabA	 are	 combined	 and	 the	 histidine	 tag	 is	 removed	 by	 incubation	
overnight	with	3C	protease	 (Fig.	3.5,	 lanes	14	and	15).	The	protein	 is	 then	passed	over	a	
second	 Ni-column	 where	 tagged-protease	 and	 un-cleaved	 proteins	 are	 retained	 on	 the	
column,	whilst	pure	YabA	emerges	in	the	flowthrough	(Fig.	3.5,	lane	15).		
	
	
Figure	 3.5:	 YabA	 purification	 shown	 by	 SDS-PAGE:	 lane	 1)	 Broad-range	 markers.	 Lanes	 2-7)	
fractions	from	Ni-affinity	chromatography:	lane	2)	Flowthrough	during	column	loading;	lane	3)	wash	
with	buffer	A;	 lane	4)	10	µl	 fraction	11;	 lane	5)	10	µl	 fraction	18;	 lane	6)	10µl	 fraction	27;	 lane	7)	
10µl	fraction	35.	Lanes	8-11)	fractions	from	size-exclusion	chromatography:		lane	8)	10µl	fraction	26;	
lane	9)	10µl	fraction	36;	lane	10)	10µl	fraction	41;	lane	11)	10µl	fraction	44.	Lane	12)	Low	molecular	
weight	markers;	lane	13)	blank;	lane	14)	His-YabA	(combined	fractions	after	size	exclusion);	lane	15)	
YabA	in	flow-through	from	2nd	Ni-affinity	column	following	His-tag	removal.	
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3.5.3:	SEC-MALLS:	YabA	
To	determine	 the	oligomeric	 state	of	 recombinant	YabA,	analysis	was	carried	out	by	 size	
exclusion	chromatography	multi-angle	laser	light	scattering	(SEC-MALLS).	The	technique	is	
used	to	determine	accurate	molecular	masses	in	solution,	allowing	the	oligomeric	state	of	
the	protein	to	be	inferred.	Analysis	of	YabA	at	2.5	mg	ml-1	produced	an	elution	profile	with	
a	 single	peak	at	~26.5	min	 (Fig.	3.6).	This	corresponds	 to	an	empirical	molecular	mass	of	
58.7	 kDa.	 The	 calculated	 mass	 of	 YabA	 is	 14.3	 kDa,	 thus	 YabA	 appears	 to	 be	 forming	
tetramers	 in	 solution	 (14.3	 kDa	 x	 4	 =	 57.3	 kDa),	 consistent	 with	 the	 oligomeric	 state	
previously	reported163.		
	
	
Figure	3.6:	SEC-MALLS	analysis	of	YabA	:	The	thinner	line	displays	the	differential	refractive	index	of	
the	YabA	containing	elute	from	a	Superdex	10/300	S200	column	as	a	function	of	time.	The	thicker	
line	show	the	weight	average	molecular	mass	of	the	eluting	species,	calculated	from	refractive	index	
and	 light	scattering	measurements.	Analysis	was	carried	out	at	2.5	mg	ml-1,	 revealing	a	species	of	
approximately	58.7	kDa,	indicating	that	YabA	is	a	tetramer	in	solution.		
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3.5.4:	AUC:	YabA	
The	in	silico	dimer	model	of	YabA	has	been	proposed	to	form	a	tetramer	of	YabA	in	one	of	
3	ways:	A)	with	all	C-terminal	domains	together	(beads	on	a	string)	B)	with	all	N-terminal	
domains	 together	 (doggy	 bones)	 or	 C)	 with	 both	 N	 and	 C-	 terminal	 domains	 together	
(bunch	of	flowers)	(Fig.	3.2).	To	help	determine	which	model	was	more	consistent	with	the	
conformation	 of	 YabA	 in	 vitro,	 analytical	 ultracentrifugation	 was	 used	 to	 provide	
information	on	the	shape	of	YabA.	Using	a	sedimentation	velocity	experiment,	a	frictional	
ratio	and	sedimentation	coefficient	was	calculated	for	YabA,	which	was	then	compared	to	
theoretical	values	for	each	of	the	three	proposed	YabA	tetramer	models	(Table	3.4).	YabA	
was	 found	 to	 have	 a	 sedimentation	 coefficient	 of	 approx.	 3.0	 and	 a	 frictional	 ratio	 of	
approx.	1.75.	When	compared	 to	 the	 theoretical	values	 for	 the	YabA	tetramers,	 this	was	
judged	to	be	most	consistent	with	the	more	elongated	models	of	YabA;	namely	the	‘beads	
on	a	string’	and	‘doggy	bones’	models	and	inconsistent	with	the	theoretical	values	for	the	
‘bunch	of	flowers’	model.	(Analysis	performed	by	Andrew	Leech).		
	
Table	3.4:	Analysis	of	YabA	by	AUC	
	 YabA	
(empirical)	
Beads	 on	 a	 Rail	
(theoretical)	
Doggy	 Bones	
(theoretical)	
Bunch	 of	 Flowers	
(theoretical)	
Frictional	Ratio	 1.75	 1.71	 1.64	 1.44	
Sedimentation	
Coefficient	
3.0	 3.08	 3.21	 3.68	
	
These	data	allowed	us	 to	 rule	out	 the	 ‘bunch	of	 flowers	model’,	but	did	not	give	a	 clear	
indication	which	of	the	other	two	models	was	more	likely.	However,	we	proposed	that	we	
could	differentiate	between	the	‘beads	on	a	string’	and	doggy	bones’	models	by	analysing	
the	respective	oligomeric	states	of	the	N-	and	C-terminal	domains	of	YabA.	For	the	‘beads	
on	a	string’	model,	we	would	expect	the	C-terminal	domains	to	form	a	tetramer,	whist	the	
N-terminal	domains	form	dimers.	However,	for	the	‘doggy	bones’	model,	we	would	expect	
the	N-terminal	domains	to	form	a	tetramer	and	the	C-terminal	domains	to	form	dimers.			
As	 the	 central	 residues	 of	 YabA	 (assumed	 to	 reside	 between	 the	 N-	 and	 C-terminal	
domains)	 are	 poorly	 conserved	 (Fig.	 3.7)	 and	 contain	many	 trypsin	 cleavage	 recognition	
sites,	we	initially	attempted	to	separate	the	two	domains	by	limited	p
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the	 results	 of	 limited	 proteolysis	 experiments	 on	 YabA	 were	 hard	 to	 reproduce,	 giving	
inconsistent	proteolysis	products.	 	Thus,	YabA	N-	and	C-terminal	domains	were	cloned	to	
allow	protein	production,	purification	and	ultimately,	analysis	of	the	domains	separately.		
	
Figure	3.7:	Alignment	of	the	sequences	of	orthologues	of	YabA	from	selected	Bacillus	species:	Bsu,	
B.	 subtilis;	 Blic,	 B.licheniformis;	 Bant,	 B.	 anthracis;	 Bhal,	 B.	 halodurans;	 Bcla,	 B.	 clausii;	 Gkau,	
Geobacillus	klaustophilus;	Oihe,	Oceanobacillus	iheyensis.	Secondary	structure	elements	taken	from	
the	in	silico	model	of	YabA	and	residue	numberings	are	displayed	above	the	alignment.	The	images	
were	created	using	ESPript	(Gouet,	2003).		
	
3.5.5:	Cloning	of	YabA	N-	and	C-terminal	domains	
Sequence	comparison	of	Bacillus	YabA	proteins	shows	that	YabA	 is	poorly	conserved	 in	a	
central	 region	 between	 the	 N-terminal	 leucine	 zipper	 domain	 and	 the	 C-terminal	 Zn-
binding	 domain	 (Fig.	 3.7).	 A	 comparison	 of	 this	 sequence	 conservation	 and	 the	 in	 silico	
YabA	 model	 (Fig.	 3.1)	 informed	 the	 construct	 design	 for	 the	 cloning	 of	 the	 N-	 and	 C-
terminal	domains	of	YabA.	The	YabA	N-terminal	domain	is	well	conserved	up	to	residue	54,	
however	 the	 model	 predicts	 that	 the	 N-terminal	 helix	 extends	 to	 residue	 58,	 thus	 a	
construct	was	created	consisting	of	residues	1-58,	hereafter	known	as	YabA1-58.	YabA’s	C-
terminus	 is	 conserved	 from	 residue	 79	 to	 the	 C-terminal	 residue,	 however	 the	 in	 silico	
model	predicts	helical	structure	between	residues	72	and	82;	thus	a	C-terminal	construct	
was	 designed	 to	 also	 encompass	 these	 residues.	 A	 construct	 was	 created	 containing	
residues	70-119,	hereafter	known	as	YabA70-119.		
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Vectors	 encoding	 YabA1-58	 and	 YabA70-119	 were	 created	 using	 a	 deletion	 mutagenesis	
method	in	which	oligonucleotides	were	designed	to	create	a	deletion	within	the	yabA	gene	
on	the	pET-YSBLIC3C-YabA	vector.	PCR	was	used	to	amplify	the	pET-YSBLIC3C-YabA	vector	
with	 oligonucleotides	 which	 would	 result	 in	 the	 deletion	 of	 a	 section	 of	 the	 yabA	 gene	
encoding	 residues	 59-119	 or	 encoding	 residues	 1-69	 for	 the	 YabA1-58	 and	 YabA70-119	
products,	 respectively.	 PCR	 products	 from	 this	 amplification	 can	 be	 seen	 in	 Fig.	 3.8.	 The	
PCR	 products	 for	 YabA1-58	 and	 YabA70-119	 were	 expected	 to	 contain	 5570	 and	 5546	 base	
pairs,	respectively.	This	is	very	close	to	the	number	of	base	pairs	in	the	template	(5570	bps)	
therefore	 it	would	 be	 very	 difficult	 to	 differentiate	 between	 the	 two	 on	 an	 agarose	 gel.	
However,	as	a	strong	band	can	be	seen	around	the	expected	number	of	base	pairs	for	the	
product,	 and	 template	 concentration	 is	 very	 low,	 it	was	assumed	 that	 the	bands	 seen	 in	
Fig.	3.8	were	the	expected	products	and	that	PCR	had	been	successful.		
	
Figure	 3.8:	 PCR	of	 YabA1-58	 and	 YabA70-119:	 Lane	 1)	 1kb	DNA	 ladder;	 lane	 2)	 5	 µl	 PCR	product	 for	
yabA1-58;	5	µl	PCR	product	for	YabA70-119.		
	
PCR	 products	 were	 treated	 with	 DpnI	 to	 digest	 the	 template,	 before	 transformation	 of	
Top10	cells.	DNA	was	isolated	from	several	of	the	resulting	colonies.		Double	digests	were	
performed	 as	 described	 in	 section	 3.4.5	 to	 identify	 recombinant	 plasmids	 containing	
products	 of	 the	 desired	 size	 (Fig.	 3.9).	 A	 double	 digest	 of	 the	 PCR	 template	 DNA,	 pET-
YSBLIC-YabA,	with	NcoI	and	NdeI	 is	expected	to	produce	two	products;	one	of	5310	base	
pairs,	and	another	of	443	base	pairs,	as	can	be	seen	 in	Fig.	3.9,	 lane	1.	The	same	double	
digest	of	pET-YSBLIC-YabA1-58	or	pET-YSBLIC-YabA70-119	is	expected	to	yield	products	of	5310	
base	 pairs	 and	 260	 bps	 or	 236	 bps,	 respectively.	 Bands	 in	 Fig.	 3.9,	 lane	 2,	 show	 the	
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expected	number	of	base	pairs	 for	pET-YSBLIC-YabA1-58	 (5310	and	260	bps)	 and	bands	 in	
Fig.	3.9,	 lane	5,	 show	 the	expected	number	of	base	pairs	 for	pET-YSBLIC-YabA70-119	 (5310	
and	236	bps).	These	plasmids	were	subsequently	confirmed	as	correct	by	DNA	sequencing.	
		
	
Figure	3.9:	Double	digests	of	YabA1-58	and	YabA70-119	:	Lane	1)	double	digest	products	of	0.5	µg	pET-
YSBLIC3C-YabA;	 lane	 2)	 double	 digest	 products	 of	 0.5	 µg	 pET-YSBLIC3C-yabA1-58;	 lane3-5)	 double	
digest	products	of	0.5	µg	pET-YSBLIC3C-yabA70-119	I-III;	lane	6)	12	µl	Hyperladder	I.		
	
3.5.6:	Protein	production:	YabA1-58	and	YabA70-119	
The	recombinant	plasmids	pET-YSBLIC-YabA1-58	and	pET-YSBLIC-YabA70-119	were	introduced	
into	E.	coli	BL21	(DE3)	cells	for	protein	production.	Small	scale	expression	tests	carried	out	
with	post-induction	growth	at	either	16	 °C	 for	~20	hours	or	37	 °C	 for	~4	hours	 indicated	
that	 protein	 production	 was	 inducible	 at	 both	 temperatures	 and	 yielded	 a	 significant	
amount	 of	 over-expression	 of	 the	 gene(s)	 and	 that	 the	 protein	 was	 soluble	 when	 re-
suspended	in	'buffer	A'	(50mM	Tris	pH	8.0,	500	mM	NaCl	and	20	mM	Imidazole)	(Fig.	3.10).		
Post-induction	growth	at	37	°C	for	4	hours	was	subsequently	used	for	protein	production	in	
large	 scale	 cell	 cultures	 as	 these	 appeared	 to	 have	 a	 slightly	 increased	 yield	 over	 those	
grown	at	16	°C	post-induction.	
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Figure	3.10:	Expression	of	YabA1-58	and	YabA70-119	:	lane	1)	10µl	lysate	from	un-induced	cell	culture	
containing	pET-YSBLIC3C-YabA1-58;	 lane	2)	10µl	 lysate	from	cell	culture	 induced	to	express	YabA1-58	
at	37	°C;	lane	3)	10µl	soluble	lysate	from	cell	culture	induced	to	express	YabA1-58	at	37	°C;	;	lane	4)	
10µl	 lysate	from	cell	culture	 induced	to	express	YabA1-58	at	16	°C;	 lane	5)	10µl	soluble	 lysate	from	
cell	 culture	 induced	 to	express	YabA1-58	 at	16	 °C;	 lane	6)	broad-range	markers;	 lane	7)	10µl	 lysate	
from	un-induced	cell	culture	containing	pET-YSBLIC3C-YabA70-119;	lane	8)	10µl	lysate	from	cell	culture	
induced	 to	 express	 YabA70-119	 at	 37	 °C;	 lane	 9)	 10µl	 soluble	 lysate	 from	 cell	 culture	 induced	 to	
express	YabA70-119	at	37	°C;	;	lane	10)	10µl	lysate	from	cell	culture	induced	to	express	YabA70-119		at	
16	°C;	lane	11)	10µl	soluble	lysate	from	cell	culture	induced	to	express	YabA70-119	at	16	°C.	
	
3.5.7:	YabA1-58	and	YabA70-119	Purification	
YabA1-58	and	YabA70-119	can	be	purified	in	an	analogous	manner	to	YabA	(see	section	3.4.2).	
Proteins	were	assessed	as	pure	according	to	staining	on	SDS-PAGE	(Fig.	3.11).	
	
Figure	 3.11:	 YabA1-58	 and	 YabA70-119	 following	 purification:	 lane	 1)	 broad-range	molecular	weight	
markers;	Lane	2)	10	µg	of	YabA1-58;	10	µg	of	YabA1-58.	
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3.5.8:	Mass	Spectrometry	
YabA1-58	and	YabA70-119	were	analysed	by	electrospray	ionisation	–	mass	spectrometry	(ESI-
MS)	for	molecular	weight	determination.	Results	are	shown	in	Table	3.5.		
For	YabA1-58,	 the	main	peak	 in	the	processed	spectrum	is	a	mass	of	7195	Da.	This	 is	1	Da	
away	 from	 the	 theoretical	 mass	 of	 recombinant	 YabA1-58,	 which	 is	 7196	 Da	 (within	
experimental	error).		The	main	peak	in	the	processed	spectrum	for	YabA70-119	is	at	6067	Da,	
exactly	the	theoretical	mass	of	recombinant	YabA70-119.	In	both	cases	this	indicates	that	the	
protein	has	been	produced	as	designed	and	been	isolated	to	a	high	purity.	
	
Table	3.5:	Mass	spectrometry	analysis	of	YabA1-58	and	YabA70-119	
Sample	 Peak	 Observed	Mass	(Da)	 Theoretical	Mass	(Da)	 Species	
YabA1-58	 1	 7195	 7196	 YabA1-58	
YabA70-119	 1	 6067	 6067	 YabA70-119	
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3.5.9:	Circular	Dichroism:	YabA,	YabA1-58	and	YabA70-119	
Circular	dichroism	was	used	to	determine	that	YabA,	YabA1-58	and	YabA70-119	were	folded	in	
vitro	and	to	assess	the	overall	secondary	structure	composition	of	YabA.	Circular	dichroism	
spectra	 were	 recorded	 for	 YabA,	 YabA1-58	 and	 YabA70-119	 (Fig.	 3.12).	 The	 spectra	 show	
strong	secondary	structure	characteristics	 in	all	cases:	all	species	show	shallow	minima	in	
their	molar	 ellipticity	 across	 the	wavelength	 range	of	 205-225	nm	and	 increase	 in	molar	
ellipticity	at	wavelengths	lower	than	205	nm.	This	indicates	that	the	proteins	are	folded	in	
solution.	In	addition,	spectra	from	all	3	proteins	are	consistent	with	a	high	percentage	of	α-
helical	character.	
	
Figure	3.12:	Overlay	of	CD	spectra	for	YabA,	YabA1-58	and	YabA70-119:	:	In	Blue:	spectrum	for	YabA;	in	
red:	CD	spectrum	for	YabA1-58	and	in	green:	CD	spectrum	for	YabA70-119.	
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3.5.10:	SEC-MALLS:	YabA1-58	and	YabA70-119		
To	 further	 our	 understanding	 of	 YabA’s	 tetrameric	 conformation,	 YabA1-58	 and	 YabA70-119	
were	analysed	by	SEC-MALLS	to	determine	their	oligomeric	state	in	vitro.		
The	 N-terminal	 fragment,	 YabA1-58,	 elutes	 at	 ~21.5	 min,	 with	 an	 associated	 empirical	
molecular	weight	of	27.7	kDa	(Fig.	3.13).	This	is	approximately	4	times	the	calculated	mass	
of	YabA1-58	(7.2	KDa	x	4	=	28.8	KDa)	indicating	that	YabA’s	N-terminal	domain	(YabA1-58)	is	a	
tetramer.	 Interestingly,	 the	 C-terminal	 fragment,	 YabA70-119,	 elutes	 from	 the	 column	 in	 a	
single	 peak	 at	 a	 much	 later	 retention	 time	 of	 ~28	 min.	 This	 peak	 has	 an	 associated	
empirical	mass	of	6.2	kDa.	This	 is	 very	 close	 to	 its	 calculated	mass	of	6.0	KDa,	 indicating	
that	the	YabA	C-terminal	domain	exists	as	a	monomer.	This	experiment	implies	therefore	
that	 the	 principle	 quarternary	 structure	 determinants	 of	 YabA	 must	 reside	 in	 the	 N-
terminal	domain	of	the	molecule.		
	
Figure	3.13:	Overlay	of	SEC-MALLS	analysis	for	YabA1-58	and	YabA70-119	:	the	thinner	lines	display	the	
differential	 refractive	 index	of	 the	 YabA1-58	 or	 YabA70-119	 containing	elute	 from	a	 Superdex	10/300	
S75	 column	 as	 a	 function	 of	 time.	 Thicker	 lines	 show	 the	weight	 average	molecular	mass	 of	 the	
eluting	 species,	 calculated	 from	 refractive	 index	 and	 light	 scattering	 measurements.	 Red	 shows	
analysis	 of	 YabA1-58	 at	 5	 mg	 ml-1,	 revealing	 a	 species	 of	 approximately	 27.7	 kDa,	 indicating	 that	
YabA1-58	is	a	tetramer	in	solution.	Blue	shows	analysis	of	YabA70-119	at	5	mg	ml-1,	revealing	species	of	
approximately	6.2	kDa,	indicating	that	YabA70-119	is	a	monomer	in	solution.		
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3.6:	Discussion		
	YabA	is	a	negative	regulator	of	DNA	replication	in	B.	subtilis.	Known	to	interact	with	both	
the	 DNA	 polymerase	 clamp,	 DnaN,	 and	 the	 DNA	 replication	 initiator	 protein	 DnaA162,163,	
YabA	 controls	 the	 timing	 and	 synchrony	 of	 DNA	 replication	 in	 vegetatively	 growing	 B.	
subtilis	cells161.	YabA	has	been	shown	to	affect	the	co-operativity	of	DnaA	binding	at	oriC	34,	
and	DnaN	has	been	implicated	in	the	YabA-dependent	regulation	of	DNA	replication	events	
34,216.	 As	 there	 are	 no	 known	 homologous	 protein	 structures	 of	 YabA	 available,	 little	
structural	 information	 is	 available	 about	 YabA	which	 can	 help	 to	 infer	 its	mechanism	 of	
action.	An	in	silico	model	of	a	YabA	dimer	has	been	proposed	based	on	homology	to	YabA's	
predicted	leucine	zipper	and	Zn-binding	domains	(personal	communication,	L.	Felicori	and	
F.	 Molina).	 However,	 YabA	 is	 known	 to	 form	 tetramers,	 and	 this	 is	 believed	 to	 be	 its	
biologically	active	form.	In	order	to	reconcile	this	discrepancy	with	the	dimer	model,	it	was	
proposed	 that	 the	model	 could	 form	a	 tetramer	 from	a	dimer	of	dimers.	 This	presented	
three	 obvious	 possibilities	 for	 the	 formation	 of	 the	 tetramer;	 'beads	 on	 a	 rail',	 'doggy	
bones'	or	'bunch	of	flowers'	(Fig.	3.2).		
	 The	results	presented	above	are	least	consistent	with	the	'bunch	of	flowers'	model;	
initial	 analysis	 of	 full	 length	 YabA	 by	 SEC-MALLS	 and	 AUC	 demonstrated	 that	 the	 YabA	
tetramer	 is	more	 consistent	with	 the	elongated	 shape	 found	 in	 the	 'beads	on	a	 rail'	 and	
'doggy	 bones'	 models.	 Analysis	 of	 the	 individual	 N-	 and	 C-terminal	 domains	 of	 YabA	
indicates	that	the	N-terminal	leucine	zipper	domain	forms	a	tetramer,	consistent	with	both	
the	 'doggy	 bones'	 and	 'bunch	 of	 flowers'	models.	 The	 C-terminal	 Zn-binding	 domain,	 by	
contrast,	 appears	 to	 be	 monomeric	 in	 solution.	 Although	 none	 of	 the	 tetramer	 models	
directly	predict	a	 ‘monomeric’	Zn-binding	domain,	 the	predictions	are	not	exhaustive.	An	
independent	Zn-binding	domain	 is	most	 consistent	with	 the	 'doggy	bones'	model,	where	
these	 domains	 could	 have	 more	 freedom	 to	 extend	 away	 from	 one	 another	 without	
disruption	of	 the	 tetramer	 (beads	on	a	 rail)	or	 steric	hindrance	 (bunch	of	 flowers).	 Thus,	
collectively	the	results	are	most	consistent	with	a	'doggy	bones'	model	which	has	both	an	
elongated	shape,	and	tetrameric	determinants	which	reside	in	the	N-terminal	domain.		
The	DnaA	and	DnaN	binding	determinants	of	YabA	have	been	shown	to	reside	in	YabA's	C-
terminal	 domain163.	 The	binding	 determinants	 are	 predicted	 to	 be	 close	 together163,	 and	
when	mapped	onto	the	in	silico	dimer	model,	these	binding	sites	would	overlap.	A	ternary	
complex	between	YabA,	DnaA	and	DnaN	has	been	observed	by	yeast	3	hybrid	screening	(in	
vivo)163,	 suggesting	 that	 the	 production	 of	 this	 complex	 is	 possible,	 and	 potentially	
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physiologically	 relevant.	 (In	 one	model	 of	 inhibition,	 YabA	 has	 been	 proposed	 to	 tether	
DnaA	to	the	replisome	via	DnaN	in	a	ternary	complex215).	Conceptually,	the	formation	of	a	
ternary	complex	is	easiest	to	imagine	in	the	experimentally-supported	doggy	bones	model,	
where	 DnaA	 and	 DnaN	 could	 bind	 at	 either	 end	 of	 the	 YabA	 tetramer.	 In	 the	 other	
tetramer	models,	'beads	on	a	rail'	and	'bunch	of	flowers',	more	steric	hindrance	would	be	
anticipated	in	order	to	allow	simultaneous	DnaA	and	DnaN	binding	(this	 is	especially	true	
for	 the	 beads	 on	 a	 rail	model	where	 some	of	 the	DnaA	 and	DnaN	binding	 determinants	
would	 be	 obscured	 by	 the	 YabA-YabA	 interface).	 Although	 this	 model	 supports	 the	
possibility	 of	 a	 ternary	 complex,	 the	 complex	 itself	 has	 yet	 to	 be	 proved	 physiologically	
relevant.	It	is	important	to	note	therefore	that	the	doggy	bones	model	in	no	way	excludes	
the	possibility	of	a	competitive	model	of	binding	for	DnaA	and	DnaN,	as	has	been	proposed	
in	recent	literature34.	It	is	necessary	to	improve	our	current	understanding	of	YabA's	mode	
and	 stoichiometry	 of	 binding	 to	 DnaA	 and	 DnaN	 in	 order	 to	 further	 elucidate	 YabA's	
mechanism	of	action.		
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Chapter	4 :	Crystallisation	of	YabA	Constructs	
4.1:	Abstract	
YabA	is	a	key	regulator	of	DNA	replication	initiation	in	vegetatively	growing	B.	subtillis	cells.	
An	 inhibitor	 of	 DNA	 replication,	 it	 is	 known	 to	 affect	 both	 the	 synchrony	 and	 timing	 of	
replication	 initiation	via	a	mechanism	which	 involves	both	DnaA	and	DnaN.	As	no	known	
homologues	of	YabA	are	available	in	the	PDB,	little	structural	information	is	available	to	aid	
the	elucidation	of	 YabA's	mechanism.	Here,	 following	 failed	 attempts	 at	 full-length	 YabA	
crystallisation,	a	structure	of	YabA's	N-terminal	domain	was	solved,	revealing	a	4-stranded	
anti-parallel	coiled-coil	domain	with	2	C-terminal	extensions;	determining	the	location	of	2	
C-terminal	 domains	 at	 either	 end	 of	 the	 coiled-coil.	 The	 work	 presented	 here,	 and	
collaborative	 studies	 which	 provide	 additional	 structural	 and	 functional	 information	
delineate	 the	overall	 architecture	of	 YabA	and	provide	 insight	 into	 the	ability	of	 YabA	 to	
bind	multiple	binding	partners	during	the	regulation	of	DNA	replication	initiation.	
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4.2:	Introduction	
YabA	regulates	DNA	replication	events	in	the	Gram-positive	organism	B.	subtilis.	A	negative	
regulator	 of	 DNA	 replication,	 YabA	 affects	 both	 timing	 and	 synchrony	 in	 vegetatively	
growing	cells161,	and	interacts	with	DnaA	and	the	DNA	polymerase	clamp,	DnaN162,163.	YabA	
is	 known	 to	 affect	 co-operative	 binding	 of	 DnaA	 at	 oriC	 34,	 and	 has	 been	 shown	 to	 be	
capable	 of	 disrupting	 DnaA	 oligomerisation	 in	 vitro	 109	 however	 YabA's	 mechanism	 of	
action	 remains	 unclear.	 Models	 proposed	 include	 a	 mechanism	 by	 which	 YabA	 tethers	
DnaA	 to	 the	 replisome	 via	 DnaN	 (thus	 preventing	 re-initiaion	 by	 DnaA	 during	
replication)215,	and	a	mechanism	where	YabA	antagonises	DnaA's	interaction	with	oriC	only	
in	 the	 absence	 of	 DnaN34;	 in	 this	 model,	 competitive	 binding	 of	 'free'	 DnaN	 to	 YabA	
removes	YabA	from	oriC/DnaA,	allowing	DnaA	to	co-operatively	bind	oriC	(and	initiate	DNA	
replication).	 As	 YabA	 has	 no	 known	 homologues,	 no	 structural	 evidence	 is	 available	 to	
support	 either	 mechanism.	 	 YabA	 is	 known	 to	 form	 tetramers163,	 however	 the	
stoichiometry	 of	 its	 interaction	with	DnaN	 and	DnaA	 is	 unknown	 and	 it	 remains	 unclear	
whether	 or	 not	 a	 ternary	 complex	 would	 be	 physically	 possible	 -	 especially	 considering	
YabA's	binding	determinants	to	DnaA	and	DnaN	lie	sequentially	close	together	(suggesting	
overlapping	binding	sites)163.	Thus,	understanding	the	tertiary	and	quaternary	structure	of	
YabA	may	provide	insight	into	its	interactions	with	both	DnaA	and	DnaN,	and	consequently	
its	 mechanism	 of	 action.	 Here	 we	 aim	 to	 solve	 the	 structure	 of	 YabA	 by	 X-ray	
crystallography.	
	
Prior	work	carried	out	by	M.	Fogg	at	YSBL	identified	expression	and	purification	conditions	
for	 YabA,	 and	 resulted	 in	 the	 formation	 of	 crystals	which	 diffracted	 to	 ~2.7Å	 resolution.	
Data	were	 collected	 at	 Diamond	 Light	 Source,	 however	 it	was	 not	 possible	 to	 solve	 this	
data	set	due	to	a	lack	of	phasing	possibilities;	no	molecular	replacement	model	is	available	
due	 to	 lack	 of	 homology	with	 other	 proteins	 and	 attempts	 to	 produce	 SeMet-derivative	
YabA	 in	E.	coli	B834	cells	was	unsuccessful	because	the	derivative	protein	separated	 into	
the	insoluble	fraction	following	cell	lysis.		
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4.3:	Aims	
Elucidating	the	structure	of	YabA	will	provide	a	framework	for	exploring	and	understanding	
its	 interactions	 with	 DnaA	 and	 DnaN;	 shedding	 new	 light	 onto	 its	mechanism	 of	 action.	
Here,	we	aim	to	solve	the	structure	of	YabA	using	X-ray	crystallography.	The	initial	aims	of	
this	 work	 were	 to	 establish	 robust	 conditions	 for	 B.	 subtilis	 YabA	 crystallisation,	 and	
establish	 expression	 conditions	 for	 a	 soluble	 form	 of	 SeMet	 YabA,	 which	 could	 be	
crystallised	to	facilitate	structure	solution.	
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4.4:	Methods		
4.4.1:	Cloning:	Geobacillus	stearothermophilus	YabA,	DnaAIII-IV,	and	DnaN	
The	coding	sequences	for	yabA,	dnaN	and	domains	III-IV	of	dnaA	(determined	by	sequence	
similarity	to	B.	subtilis	dnaA)	were	amplified	by	PCR	from	G.	stearothermophilus	genomic	
DNA	 using	 gene	 specific	 primers	 appended	 to	 sequences	 which	 facilitate	 entry	 into	 the	
pET-YSBLIC3C	vector	by	 ligation	 independent	cloning	(See	Tables	4.1,	4.2	and	4.3)217.	PCR	
products	were	run	on	a	1%	agarose	gel	and	gel	purified	using	a	QIAquick	Gel	Extraction	kit	
(Qiagen).	 0.2	 pmol	 of	 gel	 purified	 PCR	 product	 was	 incubated	 with	 0.4	 µl	 T4	 DNA	
polymerase	(2.5	units	µl-1)	in	the	presence	of	2.5	mM	dATP	(total	volume	20	µl)	at	22°C	for	
30	 mins,	 followed	 by	 incubation	 at	 75°C	 for	 20	 mins.	 This	 generates	 5’	 single	 stranded	
overhangs	as	a	result	of	T4	DNA	polymerases’	combined	3’	to	5’	exonuclease	and	its	5’	to	3’	
DNA	polymerase	activities.	Complementary	overhangs	were	generated	on	 linearised	pET-
YSBLIC3C	 vector	 using	 T4	 DNA	 polymerase	 and	 dTTP	 under	 the	 same	 conditions.	 2µl	 of	
Insert	and	1ul	vector	were	annealed	by	incubation	for	20	mins	at	room	temperature.	50	µl	
E.	coli	XL-1	Blue	cells	were	transformed	with	2	µl	annealed	product	via	heatshock	at	42°C	
and	plated	onto	LB	agar	supplemented	with	30	μg	ml-1	kanamycin	and	incubated	overnight	
at	37	°C.	Colonies	were	grown	to	a	diameter	of	~1	mm.	Overnight	cultures	were	set	up	in	
LB	supplemented	with	30	μg	ml-1	kanamycin	and	containing	1	transformant	colony.	Plasmid	
DNA	was	isolated	from	each	overnight	culture	using	a	QIAprep	Spin	Miniprep	kit	(Qiagen).	
Plasmid	 sequences	 were	 confirmed	 to	 be	 correct	 by	 DNA	 sequencing.	 The	 resultant	
plasmids,	 pET-YSBLIC3C-GstYabA,	 pET-YSBLIC3C-GstDnaN	 and	 pET-YSBLIC3C-GstDnaAIII-IV			
encode	YabA,	DnaN	or	domains	III-IV	of	DnaA,	respectively,	each	fused	to	an	N-terminal	3C	
cleavable	hexahistidine	tag.		
	
Table	4.1:	PCR	components	for	cloning	from	G.	stearothermophilus	
Reactant	 Volume/	μl	(50μl	reaction)	
G.	stearothermophilus	genomic	DNA	(50	ng	ul-1)	 0.5	
Forward	Primer	(20	pmol	μl-1)	 1	
Reverse	Primer	(20	pmol	μl-1)	 1	
KOD	Hot	Start	Polymerase	Buffer	(10x)	 5	
dNTPs	(2mM)	 5	
KOD	Hot	Start	DNA	Polymerase	(1,000	U/	ml)	 1	
MgSO4	(25mM)	 2	
H2O	 34.5	
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Table	4.2:	PCR	cycling	parameters	for	cloning	from	G.	stearothermophilus	
Step	 Temperature	/°C	 Duration	/seconds	 Cycles	
Initial	Denature	 94	 120	 1	
Denature	 94	 30	 	
35	Annealing	 52	 30	
Extension	 72	 60	
Final	Extention	 72	 180	 1	
	
	
Table	4.3:	Primers	used	for	cloning	from	G.	stearothermophilus	
	
	
4.4.2:	Cloning:	YabA1-58,	YabA70-119	and	YabAΔ59-69	
YabA1-58	and	YabA70-119	were	cloned	as	detailed	in	section	3.4.4.	YabAΔ59-69	was	cloned	in	a	
analogous	 manner,	 by	 a	 deletion	mutagenesis	 method.	 A	 whole	 vector	 amplification	 of	
pET-YSBLIC-YabA	 was	 performed	 by	 PCR	 using	 oligonucleotides	 which	 would	 produce	 a	
deletion	of	residues	59-69	(inclusive)	from	the	YabA	coding	region	of	the	vector	(Table	4.4).	
PCR	conditions	were	as	detailed	in	Table	3.3.	45μl	of	PCR	product	was	incubated	with	1.5	
μl	DpnI	(15	units)	at	37	°C	for	4-5	hours,	before	transformation	into	Top10	competent	cells.	
1μl	of	digested	product	was	added	to	50	μl	Top10	competent	cells	before	incubation	for	30	
minutes	on	 ice.	Cells	were	heat-shocked	at	42	 °C	 for	50	seconds	before	re-incubation	on	
ice	 for	 10	minutes.	 150	μl	 LB	media	was	 added	 and	 cells	were	 incubated	 at	 37°C	 for	 60	
minutes	prior	to	plating	of	100	μl	of	the	culture	onto	LB	agar	supplemented	with	30	μg	ml-1	
kanamycin.	Plates	were	incubated	for	18-20	hours	at	37°C	until	the	production	of	colonies	
around	1.0-1.5	mm	in	diameter.	Cultures	containing	5	ml	LB	supplemented	with	30	μg	ml-1	
Construct	 Encodes	 Cloning	Primers	
pET-YSBLIC3C-
GstYabA	 YabA	
Fwd	 5'-	CCAGGGACCAGCAGTAGATAAAAAAGA	AGTGTTTCGATCAGTGGCC-3'	
Rev	 5'-GAGGAGAAGGCGCGTTATTTGTTCAAA	AACGACAAGCAAAACAAACAATCGC-3'	
pET-YSBLIC3C-
GstDnaN	
	
DnaN	
Fwd	 5’-	CCAGGGACCAGCAGTGAACATTTCCAT	TGACCGCGAAGC	-3’	
Rev	 5’-	GAGGAGAAGGCGCGTTAATATGTTCTC	ACCGGCAAAATGAGCTGA	-3’	
pET-YSBLIC3C-
GstDnaAIII-IV	
DnaA	
residues	
114-448	
Fwd	 5’-	CCAGGGACCAGCAAATCCGAAATACAC	GTTCGATACGTTTGTCATCG	-3’	
Rev	 5’-	GAGGAGAAGGCGCGTTACTTCAGCTTT	TCTTGAATCTCTTGTATATGCCTTTGC-3’	
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kanamycin	 and	 a	 single	 colony	 were	 incubated	 at	 37	 °C	 overnight,	 before	 isolation	 of	
plasmid	DNA	using	a	mini-prep	kit	 (Qiagen).	Resultant	plasmids	were	analysed	by	double	
digest	 and	 sequences	 confirmed	 to	 be	 correct	 by	 sequencing	 (GATC).	 The	 recombinant	
plasmid	pET-	YSBLIC3C-YabAΔ59-69	directs	 the	expression	of	 residues	1-58	 fused	directly	 to	
residues	70-119	of	YabA	with	a	3C	cleavable	N-terminal	His-tag.		
	
Table	4.4:	YabA	construct	primers	and	coding	regions	of	YabAΔ59-69	
	
	
4.4.3:	Double	Digest	
50	μg	DNA	was	digested	with	10	units	of	NcoI	and	10	units	of	NdeI	 in	NEB	buffer	2	at	a	
total	volume	of	25	μl.	The	mixture	was	incubated	for	1	hour	at	37	°C	before	a	20μl	sample	
was	combined	with	5ul	DNA	loading	dye	and	analysed	on	a	1%	agarose	gel.				
	
4.4.4:	Expression	Testing	(Small-Scale	Cultures)	
The	relevant	recombinant	pET-YSBLIC3C	plasmid	was	introduced	into	a	strain	of	E.	coli	for	
over-expression.	 Small	 scale	 expression	 tests	 were	 carried	 out	 to	 assess	 the	 protein	
production	 and	 solubility	 of	 protein	 from	 each	 construct.	 	 For	 all	 constructs,	 expression	
tests	 were	 carried	 out	 in	 E.	 coli	 BL21	 (de3)	 cells.	 For	 pET-YSBLIC3C-GstYabA,	 additional	
expression	tests	were	carried	out	in	BL21	(plysS)	and	C41	(de3)	cells.	200	μl	of	overnight	LB	
culture	was	used	to	inoculate	10	ml	LB	cultures	supplemented	with	30	μg	ml-1	kanamycin.	
Cultures	were	grown	to	an	OD600	of	0.6-0.8	at	37	°C	(shaking	at	180	rpm)	before	cells	from	
1	ml	 of	 culture	were	havested	by	 centrifugation,	 and	protein	production	was	 induced	 in	
the	remaining	culture	with	1	mM	IPTG.	Following	 induction,	cultures	were	grown	at	37°C	
for	4	hours,	or	16°C	 for	18-20	hours	with	 shaking	at	180	 rpm.	Cells	 from	1	ml	of	 culture	
were	 harvested	 by	 centrifugation	 for	 analysis	 of	 protein	 production.	 Protein	 production	
and	solubility	was	assessed	by	SDS-PAGE.			
Construct	 Residues	 of	
YabA	Encoded	
Cloning	Primers	 Template	
Used	
pET-YSBLIC3C-
YabAΔ59-69	
1-58,	70-119	 Fwd	 5'-GGACGATACGACGCAGCAGAAA	
ACACAGAAGACAGAGC-3'	
YSBLIC3C-
YabA	
pET-YSBLIC3C-
YabAΔ59-69	
1-58,	70-119	 Rev	 5'-GCTCTGTCTTCTGTGTTTTCTGCT	
GCGTCGTATCGTCC-3'	
YSBLIC3C-
YabA	
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4.4.5:	Protein	Production	
YabA,	YabA1-59	and	YabA70-119	
For	the	large-scale	production	of	B.	subtilis	YabA,	YabA1-58	or	YabA70-119	see	section	3.4.6.		
	
YabAΔ59-69	
For	the	production	of	YabAΔ59-69,	pET-YSBLIC3C-	YabAΔ59-69	was	introduced	into	E.	coli	BL21	
(de3)	cells.	Overnight	LB	cultures	were	used	to	inoculate	500	ml	LB	cultures	supplemented	
with	30	μg	ml-1	kanamycin.	Cultures	were	grown	to	an	OD600	of	0.6-0.8	at	37	°C	(shaking	at	
180	 rpm)	 before	 protein	 production	was	 induced	with	 1	mM	 IPTG.	 Following	 induction,	
cultures	were	grown	at	37°C	for	4	hours,	with	shaking	at	180	rpm.	Cells	were	subsequently	
harvested	by	centrifugation	(Sorvall	RC	5B	Plus,	15	min	at	15	K	(SS34	rotor)).	The	pelleted	
cells	 were	 re-suspended	 in	 50	 mM	 Tris	 pH	 8.0,	 500	 mM	 NaCl,	 20	 mM	 Imidazole	
(purification	lysis	buffer)	prior	to	re-pelleting	by	centrifugation	(10	min,	5K),	for	storage	at	-
20°C.	
	
SeMet-YabA	
Overnight	 cultures	 of	 E.	 coli	 BL21	 (DE3)	 harbouring	 pET-YSBLIC3C-YabA	 were	 used	 to	
inoculate	500	ml	minimal	media	 supplemented	with	30	μg/ml	 kanamycin.	 Cultures	were	
grown	to	an	OD600	of	0.6-0.8	at	37	°C	(180	rpm	shaking)	prior	to	the	addition	of	an	amino	
acid	mixture	(50	mg	lysine,	50	mg	phenylalanine,	50	mg	threonine,	25	mg	isoleucine,	25	mg	
leucine,	 25	 mg	 valine)	 to	 suppress	 methionine	 production	 199,	 and	 30	 mg	
selenomethionine.	 Cultures	 were	 grown	 at	 37	 °C	 (180	 rpm	 shaking)	 for	 a	 further	 15	
minutes	prior	 to	 induction	of	 recombinant	protein	production	with	1	mM	 IPTG.	Cultures	
were	subsequently	grown	at	30	°C	(180	rpm	shaking)	overnight	(16-20	hours)	before	cells	
were	harvested	by	centrifugation.	
	
4.4.6:	Protein	Purification	
Purifications	 of	 YabA,	 YabA1-58,	 YabA70-119	 were	 carried	 out	 as	 detaited	 in	 section	 3.4.7.	
SeMet-YabA	and	YabAΔ59-69	can	also	be	purified	by	an	analogous	procedure.		
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4.4.7:	Mass	Spectrometry	
Purified	 YabA,	 SeMet-YabA	 and	 YabAΔ59-69	 were	 buffer	 exchanged	 into	 2mM	 Tris	 for	
analysis	by	Electrospray	Ionisation-Mass	Spectrometry	(ESI-MS).	Samples	were	provided	at	
a	concentration	of	5	mg	ml-1.	Spectra	were	obtained	and	processed	by	Simon	Grist.		
	
4.4.8:	SEC-MALLS:	YabAΔ59-69	
To	determine	the	oligomeric	state	of	YabAΔ59-69	analysis	was	carried	out	by	SEC-MALLS.	A	
100	 μl	 sample	 of	 protein	 at	 2.5	 mg	 ml-1	 was	 loaded	 onto	 a	 size-exclusion	 column	
equilibrated	with	50	mM	TRIS	pH	8.0,	150	mM	NaCl.	The	eluate	was	successively	analysed	
by	a	SPD20A	UV/Vis	detector,	a	Wyatt	Dawn	HELEOS-II	18-angle	 light	scattering	detector	
and	a	Wyatt	Optilab	rEX	refractive	 index	monitor.	Data	was	analysed	with	Astra	software	
(Wyatt).		
	
4.4.9:	Crystallisation	Screening	
A	range	of	commercially	available	96-well	crystallisation	screens	were	utilised	to	screen	for	
conditions	from	which	a	purified	YabA	derivative	would	crystallise.	Each	screen	was	set	up	
as	a	 sitting-drop	experiment	with	300	nl	drops	containing	a	1:1	 ratio	of	protein	 solution:	
reservoir	solution.	Reservoirs	contained	54	µl	of	reservoir	solution.	Table	4.5	shows	which	
crystal	screens	were	used	for	each	purified	protein,	and	the	concentration	of	the	protein	
added	to	the	crystallisation	drop.			
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Table	4.5:	96-well	crystallisation	screens	set	up	for	YabA	and	YabA-derivatives	
Purified	Protein	 Concentration	 Crystal	Screen	
YabA	
8	mg	ml-1	
JCSG+,	SALT	RX,		
CSS	(Tris	pH	7.5)	
30	mg	ml-1	 PACT,	INDEX	
45	mg	ml-1	 PACT,	INDEX	
100	mg	ml-1	 PACT,	INDEX	
YabA	 (Stored	 at	 4°C	
for	2	Weeks)	
30	mg	ml-1	 PACT,	INDEX	
SeMet	YabA	 30	mg	ml-1	
PACT,	INDEX,		
Morpheus,	Ammonium	Sulfate	
YabA1-58	 12.9	mg	ml-1	 JCSG+,	PACT	
YabA70-119	
9.7	mg	ml-1	 JCSG+,	PACT	
20	mg	ml-1	 PEG	Ion,	INDEX,		
YabAΔ59-69	 11.5	mg	ml-1	 JCSG+,	PACT	
	
4.4.10:	Crystallisation	and	Structure	Solution:	YabA1-58	
YabA1-58	 crystals	 were	 grown	 in	 hanging	 drops	 containing	 a	 1:1	 ratio	 of	 concentrated	
protein	solution	at	9.75	mg	ml-1	and	a	reservoir	solution	of	0.1	M	Bis-Tris	Propane	pH	6.0,	
0.35	 M	 ammonium	 acetate	 and	 20%	 PEG	 6K.	 	 Crystals	 were	 transferred	 to	 a	 cryo-
protectant	solution	consisting	of	85%	reservoir	solution	supplemented	with	15%	ethylene	
glycol	prior	to	being	cryo-cooled	in	liquid	nitrogen.	X-ray	diffraction	data	were	collected	to	
2.0	 Å	 resolution	 on	 beamline	 i04	 at	 the	 Diamond	 Light	 Source	 (DLS),	 Harwell.	 	 The	
diffracting	crystal	belongs	to	the	space	group	I222	with	unit	cell	dimensions	of	a	=	49.08	Å,	
b	 =	 73.77	 Å,	 c	 =	 88.64	 α	 =	 β	 =	 γ	 =	 90.00	 °.	 Data	 was	 processed	 using	 the	 automated	
processing	 pipeline	 software	 XIA2	 201,	 which	 utilised	 the	 software	 XDS202.	 	 Data	 were	
subsequently	merged	using	AIMLESS.	The	structure	was	solved	by	molecular	replacement	
using	 the	 program	 PHASER218,	 and	 YabA1-62	 as	 a	 search	 model	 (a	 partial	 YabA	 structure	
obtained	by	L.	Terradot	following	protein	degradation	during	crystallisation).	Two	YabA1-62	
molecules	were	found	in	the	asymmetric	unit.	The	YabA1-58	model	was	refined	by	iterative	
rounds	 of	 maximum-likelihood	 refinement	 methods	 in	 REFMAC210	 and	 manual	 model	
building	in	COOT211	to	an	R-factor	of	24.2	(28.2).	Data	and	refinement	statistics	are	shown	
in	Table	4.8.	
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4.5:	Results	 	
4.5.1:	YabA	Crystallisation	
Commercially	available	96-well	screens	were	used	in	sitting-drops	to	screen	for	conditions	
from	which	YabA	would	 crystallise.	 	 Initial	 screening	produced	 crystals	 after	3	days	 from	
conditions	B7,	B8,	B9	and	F5	of	the	PACT	screen219	and	F5	of	the	INDEX	screen220	from	YabA	
protein	at	30	mg	ml-1.	However,	this	protein	had	been	stored	at	4	°C	for	2	weeks	prior	to	
screening,	 and	 the	 same	 screens	 with	 freshly	 prepared	 protein	 (at	 the	 same	
concentration),	did	not	produce	crystals.	Furthermore,	 in	 the	 first	 instance,	crystals	were	
reproducible	in	24-well	hanging-drop	format	with	protein	taken	from	the	same	preparation	
(also	stored	at	4°C).	However	if	protein	from	a	new	preparation	was	used,	crystals	did	not	
appear	 under	 the	 same	 conditions.	 Analysis	 of	 the	 ‘crystallising	 protein’	 by	 SDS-PAGE	
revealed	that	it	was	heavily	degraded,	suggesting	that	these	crystals	were	not	of	full-length	
protein	 (Fig.	 4.1).	 Thus,	 optimisation	 experiments	 were	 terminated.	 	 All	 other	 (i.e.	
subsequent)	crystallisation	screens	were	set	up	with	freshly	prepared	protein	(<1	day	post-
purification	or	from	protein	which	had	been	flash	frozen	and	stored	at	-80°C	immediately	
after	purification),	however,	no	alternative	crystallisation	conditions	were	obtained.			
	
Figure	4.1:	SDS-PAGE	analysis	of	YabA	after	storage:	lane	1)	1	µg	YabA	after	storage	at	4	°C	for	27	
days	 (crystallising	 ‘YabA’);	 lane	2)	1	µg	YabA	after	storage	at	4	°C	 	 for	2	days;	 lane	3)	Broad-range	
molecular	weight	markers.	
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4.5.2:	SeMet	YabA	
To	 the	 best	 of	 our	 knowledge,	 there	 a	 no	 solved	 structures	 of	 proteins	 homologous	 to	
YabA	available	 in	 the	PDB;	making	 structure	 solution	by	molecular	 replacement	unlikely.	
Therefore	 phasing	 using	 heavy-atoms	 is	 a	 desirable	 course	 for	 structure	 solution.		
Unfortunately,	previous	efforts	 to	produce	SeMet-substituted	YabA	were	unsuccessful	as	
YabA	partitioned	into	the	insoluble	fraction	when	produced	in	the	methionine	auxotroph	E.	
coli	strain,	B834	(Mark	Fogg,	personal	communication).	Therefore,	an	alternative	method	
for	SeMet-substituted	protein	production	was	trialled,	whereby	proteins	can	be	produced	
in	any	E.	coli	strain,	but	under	conditions	which	 inhibit	normal	methionine	production.	 In	
this	method,	 the	amino	acids	 leucine,	 isoleucine,	 lysine,	phenylalanine	and	threonine	are	
added	 to	 the	culture	 to	 inhibit	 the	natural	methionine	biosynthesis	pathway199;	 SeMet	 is	
also	 added	 to	 cultures	 and	 becomes	 incorporated	 into	 the	 protein	 in	 the	 absence	 of	
normal	 methionine	 production.	 Using	 this	 method,	 SeMet-substituted	 YabA	 can	 be	
produced	in	E.	coli	BL21	(DE3)	which	partitions	into	the	soluble	fraction	after	cell	lysis.	(Fig.	
4.2).	(Selenium	incorporation	was	later	confirmed	by	mass	spectrometry	-	see	below.)		
	
Figure	 4.2:	 SDS-PAGE	 analysis	 of	 SeMet-substituted	 YabA	 production:	 lane	 1)	 lysate	 from	 cells	
induced	to	produce	SeMet-YabA;	lane	2)	Soluble	lysate	from	cells	induced	to	produce	SeMet-YabA;	
lane	3)	broad-range	molecular	weight	markers.	
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4.5.3:	Purification	
SeMet-substituted	 YabA	 can	 be	 purified	 in	 an	 analogous	 manner	 to	 native	 YabA,	 (see	
sections	3.4.2	and	3.5.2).	SeMet	substituted	protein	 is	 judged	pure	by	staining	after	SDS-
PAGE	(Fig.	4.3).	
	
Figure	4.3:	SeMet	YabA	following	purification:	lane	1)	10	µg	of	SeMet	YabA	following	purification;	
lane	2)	broad-range	molecular	weight	markers.	
	
4.5.4:	Mass	Spectrometry	
Samples	 of	 YabA	 and	 SeMet-YabA	 were	 analysed	 by	 electrospray	 ionisation	 mass	
spectrometry	for	molecular	weight	determination.	These	results	were	used	to	infer	correct	
production	 and	 purification	 of	 the	 recombinant	 protein,	 and	 in	 the	 case	 of	 the	 SeMet-
derivative,	that	Se	had	been	incorporated.	Results	are	shown	in	Table	4.6.		
For	YabA,	 the	main	peak	 in	the	processed	spectrum	showed	a	mass	of	14,324	Da.	This	 is	
the	 same	 as	 the	 theoretical	mass	 of	 recombinant	 YabA	 (14,324	 Da)	 suggesting	 that	 the	
protein	has	been	produced	as	anticipated	and	isolated	to	a	high	purity.	 	For	SeMet-YabA,	
the	main	peak	in	the	spectrum	shows	a	mass	of	14,419	Da,	1	Da	away	from	the	theoretical	
mass	of	SeMet-YabA,	assuming	incorporation	of	2	selenium	atoms	at	methionine	residues	
1	and	34.	The	observed	mass	of	SeMet-YabA	is	95	Da	higher	than	native	YabA,	 indicating	
that	 incorporation	 of	 2	 Se	 atoms	 has	 occurred;	 selenium	 is	 47	 Da	 heavier	 than	 sulphur,	
thus	an	addition	of	94	Da	to	YabA’s	mass	indicates	incorporation	of	2	selenium	atoms.		
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Table	4.6:	Mass	spectrometry	analysis	of	YabA	and	SeMet-YabA	
Sample	 Peak	 Observed	Mass	(Da)	 Theoretical	Mass	(Da)	 Species	
YabA	 1	 14,324	 14,324	 YabA	
SeMet-YabA	 1	 14,419	 14,418	 SeMet-YabA	
	
	
4.5.5:	Crystallisation:	SeMet-YabA	
Four	96-well	crystallisation	screens	were	set	up	with	SeMet-YabA	at	30	mg	ml-1.	A	crystal	
which	diffracted	to	~7	Å	spacing	in-house	was	obtained	from	the	PACT	screen,	condition	C8	
(0.1	M	Hepes	pH	7.0,	0.2	M	ammonium	chloride	and	20%	PEG	6K),	however	the	crystal	was	
judged	as	too	weak	for	data	collection	and	crystals	were	not	reproducible	in	either	24-well	
or	 96-well	 optimisation	 screens.	 Furthermore,	 the	 original	 crystal	 had	 taken	 13	 days	 to	
form,	so	it	is	unclear	whether	or	not	it	may	have	been	a	product	of	YabA	degradation.	
	
4.5.6:	Geobacillus	stearothermophilus	YabA,	DnaN	and	DnaAIII-IV	
Thermophilic	 bacteria	 produce	 proteins	 with	 increased	 stability	 at	 higher	
temperatures221,222.	 For	 this	 reason,	 proteins	 from	 thermophilic	 species	 of	 bacteria	 are	
frequently	utilised	for	crystallisation	as	they	are	more	 likely	to	carry	an	orthologue	which	
has	increased	rigidity,	improving	the	likelihood	of	crystallisation	(or	producing	crystals	with	
better	 packing	 (and	 thus	 obtaining	 diffraction	 to	 a	 higher	 resolution)	 over	 their	 non-
thermophilic	 orthologues.	 YabA	 was	 cloned	 from	 the	 thermophilic	 bacterial	 species	
Geobacillus	stearothermophilus	in	the	hope	that	it	might	prove	to	be	a	better	candidate	for	
crystallisation.	 YabA's	 interaction	 partners	 DnaN,	 and	 domains	 III-IV	 of	 DnaA	 (DnaAIII-IV)	
were	 concurrently	 cloned	 from	 the	 same	 species	 to	 facilitate	 interaction	 assays	 or	 co-
crystallisation	in	the	future.			
	
4.5.7:	Cloning:	Geobacillus	stearothermophilus	YabA,	DnaN	and	DnaAIII-IV	
yabA,		dnaAIII-IV	and	dnaN	were	amplified	from	the	Geobacillus	stearothermophilus	genome	
by	 PCR	 (Fig.	 4.4,	 A).	 	 Although	 the	 PCR	 products	 appeared	 somewhat	 dirty,	 attempts	 to	
amplify	the	genes	using	a	higher	annealing	temperature	during	PCR	cycles	did	not	yield	any	
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products.	 Thus,	 PCR	 products	 were	 gel	 purified	 using	 a	 QIAquick	 Gel	 Extraction	 kit	
(Qiagen).	 Purified	 PCR	 products	 can	 be	 seen	 in	 Figure	 4.4,	 B.	 	 Purified	 products	 were	
inserted	 into	 the	 pET-YSBLIC3C	 vector	 via	 ligation	 independent	 cloning.	 Recombinant	
plasmids	 were	 amplified	 by	 growth	 in	 the	 E.	 coli	 strain	 XL1-blue	 and	 purified	 using	 a	
QIAprep	 Spin	 Miniprep	 kit	 (Qiagen).	 Correct	 sequences	 and	 vector	 insertions	 were	
confirmed	by	DNA	sequencing	(TF,	University	of	York).		
	
	
Figure	 4.4:	 1%	 Agarose	 gel	 showing	 PCR	 products	 for	 cloning	 of	 G.	 stearothermophilus	 yabA,	
dnaN,	 dnaAIII-IV:	 A)	 PCR	 products:	 Lane	 1)	 6	 µl	 hyperladder	 I;	 lane	 2)	 5	 µl	 PCR	 product	 from	
amplification	of	Gst	yabA	;	lane	3)	5	µl	PCR	product	from	amplification	of	Gst	DnaN;	lane	4)	5	µl	PCR	
product	from	amplification	of	Gst	dnaAIII-IV;	 lane	6)	6	µl	hyperladder	 I.	 	B)	Gel	extraction	products:	
lane	1)	6	µl	hyperladder	I;	lane	2)	5	µl	gel-purified	Gst	yabA;	lane	3)	5	µl	gel-purified	Gst	dnaN;	lane	
4)	5	µl	gel-purified	Gst	dnaAIII-IV.	
	
4.5.8:	Protein	Production:	G.	stearothermophilus	YabA,	DnaN	and	DnaAIII-IV	
Small	 scale	 trial	 cultures	 for	 the	 production	 of	 G.	 stearothermophilus	 YabA,	 DnaN	 and	
DnaAIII-IV	were	 carried	out	 as	 detailed	 in	 section	4.4.4	 to	 test	 for	 conditions	under	which	
soluble	proteins	 could	be	produced.	 	As	 an	 initial	 test,	 recombinant	plasmids	harbouring	
the	YabA,	DnaN	and	DnaAIII-IV	genes,	 respectively,	were	 introduced	 into	E.	coli	BL21	(DE3)	
cells	 for	 protein	 production.	 Unfortunately,	 these	 tests	 did	 not	 yield	 a	 positive	 result.	
Inducible	YabA	expression	is	observed	when	cells	are	grown	at	both	16	°C	and	37	°C	post-
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induction	 (bands	at	approx.	14	kDa,	 Fig.	4.5,	 lanes	3	and	5),	however,	 this	protein	 is	not	
soluble	in	the	chosen	re-suspension	buffer	of	50	mM	Tris	pH	8.0,	150	mM	NaCl	and	20	mM	
Imidazole.	 	 Production	 of	 DnaAIII-IV	 and	 DnaN	 is	 less	 clear	 (Fig.	 4.5,	 lanes	 7-14);	 bands	
indicating	protein	production	would	be	expected	at	approx.	51	kDa	for	DnaAIII-IV	and	42	kDa	
for	 DnaN,	 respectively.	 It	 is,	 however,	 unclear	 whether	 any	 of	 the	 bands	 around	 these	
weights	correspond	to	DnaAIII-IV	or	DnaN,	as	no	clear	induction	of	expression	is	detectable	
(Fig.	4.5,	lanes	8,	11	and	13).		
	
Figure	4.5:	Expression	of	G.	stearothermophilus	yabA,	dnaN	and	dnaAIII-IV	in	E.	coli	BL21	(DE3):	A)	
YabA	(low	salt	buffer)	and	DnaAIII-IV	and	B)	DnaN	and	YabA	(high	salt	buffer).	Samples	in	lanes	1-14	
were	 re-suspended	 in	 low-salt	 buffer,	 samples	 in	 lanes	 16-19	 in	 high	 salt	 buffer:	 Lanes	 1	 and	15)	
broad-range	molecular	 weight	markers;	 lanes	 2-6	 and	 16-19)	 Expression	 of	Gst	 YabA.	 Lanes	 7-9)	
Expression	of	Gst	dnaAIII-IV.	Lanes	10-14)	Expression	of	Gst	dnaN.	In	each	case,	samples	are	shown	in	
adjacent	ascending	lanes	of	10µl	lysate	from	un-induced	cell	culture	containing	relevant	vector;	10µl	
lysate	 from	 cells	 induced	 to	 produce	 protein	 at	 16°C;	 10µl	 soluble	 lysate	 from	 cells	 induced	 to	
produce	protein	at	16°C;	10µl	lysate	from	cells	induced	to	produce	protein	at	37°C	and	10µl	soluble	
lysate	 from	 cells	 induced	 to	 produce	 protein	 at	 37°C	 (with	 the	 exception	 of	 DnaAIII-IV,	 where	
production	could	not	be	tested	at	37°C).	
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As	YabA	 is	 the	major	 target	 in	 this	project,	efforts	were	 focused	on	 trying	 to	 improve	 its	
solubility.	Re-suspension	in	a	buffer	with	increased	salt	concentration	was	trialled,	making	
the	re-suspension	buffer	the	same	as	that	used	for	B.	subtilis	YabA	(50mM	Tris	pH	8.0,	500	
mM	 NaCl,	 20	 mM	 imidazole).	 Unfortunately,	 YabA	 was	 still	 insoluble	 under	 these	
conditions	(Fig.	4.5,	lanes	16	to	19).	Trials	of	gene	expression	in	different	E.	coli	cell	strains	
BL21	(pLysS)	and	C41	were	also	carried	out,	however	the	YabA	protein	produced	in	these	
strains	was	also	insoluble	(re-suspension	buffer:	50	mM	Tris	pH	8.0,	500	mM	NaCl,	20	mM	
imidazole)	 Fig.	 4.6.	 At	 this	 stage,	 work	 with	 the	 G.	 stearothermophilus	 proteins	 was	
terminated.	 Although	 there	 are	many	 other	 cell	 strains	 and	 solubilisation	 buffers	 which	
could	be	trialled,	as	conditions	for	all	 three	proteins	required	optimisation,	this	would	be	
time	expensive.		Conditions	for	significant	levels	of	expression	and	solubility	were	already	
known	for	constructs	expressing	B.	subtilis	YabA,	DnaA	and	DnaN,	thus	it	was	decided	that	
optimisation	of	G.	stearothermophilus	protein	expression	should	be	deferred	 in	 favour	of	
working	with	the	B.	subtilis	counterparts.		
	
Figure	 4.6:	 Expression	of	G.	 stearothermophilus	 yabA	 in	E.coli	 BL21	 (pLysS)	 and	C41	 :	 Lanes	 2-6	
show	samples	of	expression	in	E.	coli	BL21	(pLysS),	lanes	7-11	show	samples	of	expression	in	E.	coli	
C41.	 Lane	 1)	 broad-range	 molecular	 weight	 markers;	 lane	 2)	 10µl	 lysate	 from	 un-induced	 BL21	
(pLysS)	 cell	 culture	 containing	 pET-YSBLIC3C-GstYabA;	 lane	 3)	 10µl	 lysate	 from	 BL21	 (pLysS)	 cells	
induced	to	produce	Gst	YabA	at	37°C;	lane	4)	10µl	soluble	lysate	from	BL21	(pLysS)	cells	induced	to	
produce	Gst	YabA	at	37°C;	lane	5)	10µl	lysate	from	BL21	(pLysS)	cells	induced	to	produce	Gst	YabA	
at	16°C;	 lane	6)	10µl	 soluble	 lysate	 from	BL21	 (pLysS)	 cells	 induced	 to	produce	Gst	YabA	at	16°C;	
lane	7)	10µl	lysate	from	un-induced	C41	cell	culture	containing	pET-YSBLIC3C-GstYabA;	lane	8)	10µl	
lysate	from	C41	cells	induced	to	produce	Gst	YabA	at	37°C;	lane	9)	10µl	soluble	lysate	from	C41	cells	
induced	 to	produce	Gst	YabA	at	37°C;	 lane	10)	10µl	 lysate	 from	C41	cells	 induced	 to	produce	Gst	
YabA	at	16°C;	lane	11)	10µl	soluble	lysate	from	C41	cells	induced	to	produce	Gst	YabA	at	16°C;	lane	
12)	broad-range	molecular	weight	markers.	
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4.5.9:	Cloning	of	YabAΔ59-69	
As	outlined	in	section	3.1,	YabA	contains	a	poorly	conserved	central	region	around	amino	
acids	 59-69.	 This	 region	 is	 predicted	 to	 be	 disordered	 and	 is	 likely	 to	 be	 vulnerable	 to	
proteolysis,	thus	producing	a	construct	with	a	deletion	in	this	central	region	may	create	a	
more	ordered	product	which	 is	easier	 to	crystallise.	 	A	YabA	construct	with	a	deletion	of	
residues	 59-69	 (inclusive)	 was	 produced,	 using	 the	 same	 deletion	 mutagenesis	 cloning	
method	 described	 in	 section	 3.5.5),	 to	 create	 a	 vector	 encoding	 residues	 1-58	 directly	
fused	to	residues	70-119	of	YabA	with	an	N-terminal	cleavable	Histidine	tag.		The	deletion	
product	was	produced	by	PCR	(Fig.	4.7,	A,	lane	2)	and	introduced	into	E.	coli	Top10	cells	for	
vector	amplification.	Double	digests	were	performed	on	purified	plasmid	DNA	to	assess	for	
the	deletion	(33	bases)	(Fig.	4.7,	B).	A	small	reduction	in	size	over	the	full-length	yabA	gene	
(lane	 1)	 can	 be	 observed	 (lanes	 2-6),	 indicating	 the	 production	 of	 a	 product	 with	 the	
desired	deletion.	Production	of	a	product	encoding	residues	1-58	fused	to	residues	70-119	
of	YabA	was	subsequently	confirmed	by	DNA	sequencing.		
	
	
Figure	4.7:	Cloning	of	yabAΔ59-69:	A)	PCR	product	for	yabAΔ59-69:	lane	1)	1kb	DNA	ladder;	lane	2)	5	µl	
PCR	product	for	yabAΔ59-69.	B)	Test	digests	for	recombinant	plasmids:	lane	1)	double	digest	products	
of	 0.5	µg	pET-YSBLIC3C-YabA;	 lane	2-5)	double	digest	products	of	 0.5	µg	pET-YSBLIC3C-yabAΔ59-69;	
lane	6)	12	µl	Hyperladder	I.		
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4.5.10:	Protein	Production:	YabAΔ59-69	
Small	 scale	 expression	 tests	were	 carried	 out	 as	 described	 in	 section	 4.4.4	 to	 determine	
suitable	 expression	 and	 solubilisation	 conditions	 for	 YabAΔ59-69.	 The	 recombinant	 plasmid	
pET-YSBLIC-YabAΔ59-69	 was	 introduced	 into	 E.	 coli	 BL21	 (DE3)	 cells	 for	 test	 expression	 in	
small	scale	cultures.	Post-induction	growth	was	carried	out	at	16	°C	for	~20	hours	and	37	°C	
for	 4	 hours.	 Growth	 at	 both	 temperatures	 showed	 a	 significant	 level	 of	 inducible	 gene	
expression	 (Fig.	 4.8,	 lanes	 3	 and	 5)	 and	 that	 a	 significant	 proportion	 of	 this	 protein	was	
soluble	 in	 the	 chosen	 re-suspension	 buffer	 of	 50	mM	Tris	 pH8.0,	 500	mM	NaCl,	 20	mM	
imidazole.	 Protein	 production	 at	 37	 °C	 gave	 a	 higher	 yield	 of	 protein	 than	 at	 16	 °C,	
therefore	subsequent	large-scale	protein	production	was	carried	out	at	37	°C.		
	
Figure	 4.8:	 Expression	 of	 yabAΔ59-69:	 lane	 1)	 broad-range	 markers;	 lane	 2)	 10µl	 lysate	 from	 un-
induced	cell	culture	containing	pET-YSBLIC3C-YabAΔ59-69;	lane	3)	10µl	lysate	from	cell	culture	induced	
to	 express	 YabAΔ59-69	 at	 37	 °C;	 lane	 4)	 10µl	 soluble	 lysate	 from	 cell	 culture	 induced	 to	 express	
YabAΔ59-69	at	37	°C;	;	lane	5)	10µl	lysate	from	cell	culture	induced	to	express	YabAΔ59-69	at	16	°C;	lane	
6)	10µl	soluble	lysate	from	cell	culture	induced	to	express	YabAΔ59-69	at	16	°C.	
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4.5.11:	Purification:	YabAΔ59-69	
YabAΔ59-69	was	purified	in	an	analogous	manner	to	YabA	(section	3.4.2).	Purified	protein	is	
shown	in	Figure	4.9.		
	
Figure	4.9:	YabAΔ59-69	following	purification:	lane	1)	broad-range	molecular	weight	markers;	
Lane	2)	10	µg	of	YabAΔ59-69	following	purification.	
	
4.5.12:	SEC-MALLS:	YabA	Δ59-69	
The	 oligomeric	 state	 of	 YabAΔ59-69	 was	 analysed	 by	 SEC-MALLS	 (Fig.	 4.10).	 	 Native	 YabA	
forms	a	 tetramer	 in	vitro,	and	this	 is	thought	 to	be	 its	 functional	state.	Thus,	 to	gain	any	
functional	 insight	 from	a	 structure	 (or	 otherwise)	 of	 YabAΔ59-69,	 it	must	 be	 able	 to	 retain	
YabA’s	tetrameric	state.		
YabA	Δ59-69	elutes	at	approx.	18.5	minutes	from	a	Superdex	S75	column,	with	an	associated	
molecular	 weight	 of	 50.6	 kDa.	 This	 is	 approximately	 four	 times	 the	 calculated	 mass	 of	
YabAΔ59-69	(13.0	kDa	x	4	=	52.0	kDa)	indicating	that	YabAΔ59-69	is	a	tetramer	in	solution.	We	
conclude	therefore,	that	deletion	of	residues	59-69	of	YabA,	does	not	affect	its	oligomeric	
state	(consistent	with	the	oligomerisation	determinants	of	YabA	residing	in	the	N-terminal	
domain).		
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Figure	 4.10:	 SEC-MALLS	 analysis	 of	 YabAΔ59-69:	 the	 thinner	 line	 displays	 the	 differential	 refractive	
index	of	the	YabAΔ59-69	containing	eluate	from	a	Superdex	10/300	S75	column	as	a	function	of	time.	
The	 thicker	 line	 shows	 the	weight	average	molecular	mass	of	 the	eluting	 species,	 calculated	 from	
refractive	 index	and	 light	scattering	measurements.	Analysis	was	carried	out	at	a	concentration	of	
2.5	mg	ml-1.	The	major	species	elutes	at	a	mass	of	50	kDa	indicating	that	YabAΔ59-69	is	a	tetramer	in	
solution.	
	
4.5.13:	Crystallisation:	YabA1-58,	YabA70-119	and	YabAΔ59-69	
96-well	 commercial	 crystallisation	 screens	were	 set	 up	 for	 each	of	 the	proteins	 YabA1-58,	
YabA70-119	and	YabAΔ59-69.	Although	crystallisation	conditions	were	not	identified	for	YabA70-
119	and	YabAΔ59-69,	crystals	of	YabA1-58	formed	from	multiple	conditions	in	PACT	and	JCSG+	
screen(s).	 Optimisation	 was	 carried	 out	 in	 24-well	 format,	 allowing	 crystals	 suitable	 for	
data	collection	to	be	obtained.		
	
4.3.14:	Diffraction	Testing	and	Data	Collection	of	YabA1-58	
In	house	testing	of	YabA1-58	crystals	showed	diffraction	to	~3.0	Å.	Test	images	from	the	two	
'best'	crystals	were	indexed	in	MOSFLM,	revealing	two	crystal	forms:	I222	and	P622.	Unit	
cell	 dimensions	 are	 shown	 in	 Table	 4.8.	 Strikingly,	 the	 same	 crystal	 forms	 and	 unit	 cell	
dimensions	had	been	observed	for	putative	full-length	YabA	data	collected	by	Mark	Fogg	c.	
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2011	 (Table	 4.7).	 In	 that	 case,	 crystals	 were	 grown	 in	 24-well	 plates,	 in	 hanging	 drops	
containing	 1µl	 YabA	 at	 26	mg	ml-1	 and	 1µl	 reservoir	 solution.	 Crystals	with	 space	 group	
I222	grew	from	conditions	of	0.1	M	Bis-Tris	propane	pH	6.0,	23	%	(w/w)	PEG	5000	MME	
and	0.1	M	NaSCN	(somewhat	similar	to	YabA1-58	crystal	growth	conditions	of	0.1	M	Bis-Tris	
Propane	 pH	 6.0,	 0.35	 M	 ammonium	 acetate	 and	 20%	 PEG	 6K)	 and	 crystals	 with	 space	
group	P622	grew	from	0.1	M	sodium	formate,	20%	PEG	3350.	Crystals	formed	after	a	few	
weeks.	(M.	Fogg,	personal	communication).	The	fact	that	the	YabA1-58	crystals	and	putative	
full-length	 YabA	 crystals	 grown	 in	 2011	 share	 the	 same	 space	 group	 and	 unit	 cell	
dimensions	 demonstrates	 that	 data	 collected	 previously	must	 have	 been	 obtained	 from	
crystals	 of	 a	degraded	 form	of	 the	protein.	 This	 is	 in	 agreement	with	 the	extended	 time	
required	to	grow	those	crystals.		A	full	dataset	of	YabA1-58	was	collected	on	beamline	i04	at	
Diamond	Light	Source,	Harwell.	
	
Table	4.7:	Unit	cell	dimensions	for	YabA1-58	and	putative	full-length	YabA	crystals	
Crystal	 Space	Group	 α	β	γ	(°)	 a	(Å)	 b	(Å)	 c	(Å)	
YabA1-58	 I222	 90,	90,	90	 49	 74	 89	
YabA	 I222	 90,	90,	90	 49	 74	 88	
YabA1-58	 P622	 90,	90,	120	 83	 83	 107	
YabA	 P622	 90,	90,	120	 83	 83	 108	
	
	
4.3.15:	N-terminal	Domain	Structure	
Concurrently	and	independently	of	the	crystallisation	of	YabA1-58,	our	collaborators	at	the	
University	 of	 Lyon,	 France,	 solved	 a	 fragment	 YabA	 structure	 using	 a	 Pt-derivative	 for	
phasing.	Crystals	had	formed	following	protein	degradation	 in	drops	containing	YabA	and	
DnaN.	 This	model	was	 used	 to	 solve	 the	 structure	 of	 YabA1-58	 by	molecular	 replacement	
methods	 (Table	4.8).	 The	YabA1-58	 crystal	used	 for	 structure	 solution	crystallised	 in	 space	
group	 I222,	with	unit	 cell	parameters	of	a	=	48.95	Å,	b	=	73.50	Å,	 c	=	88.78	 	α	=	β	=	γ	=	
90.00	 °.	 Two	 YabA1-58	 molecules	 are	 seen	 in	 the	 asymmetric	 unit.	 The	 refined	 model	
encompasses	residues	1	to	54	of	YabA	in	chain	A	and	residues	3	to	52	of	YabA	in	chain	B.		
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The	 structure	 delineates	 the	 N-terminal	 domain	 of	 YabA,	 which	 comprises	 of	 a	 single	
extended	α-helix	(~13	turns),	with	a	slight	curvature.	Two	of	these	molecules	make	up	the	
asymmetric	 unit,	 a	 parallel	 coiled-coil	 motif	 which	 crosses	 near	 the	 C-terminus	 in	 a	
configuration	resembling	a	pair	of	tweezers	(Fig.	4.11,	A).	The	molecules	in	the	asymmetric	
unit	 form	a	tetramer	with	two	symmetry	related	molecules,	A’	and	B’	creating	an	overall	
structure	 which	 can	 be	 described	 as	 having	 a	 4-stranded	 anti-parallel	 coiled-coil	
architecture	 (Fig.	 4.11,	 B).	 This	 helical	 bundle	 is	 expected	 to	 be	 the	 functional	 assembly	
(tetramer	 confirmed	 in	 vitro	 by	 SEC-MALLS).	 The	 arrangement	 of	 the	 helices	 in	 the	
tetramer	 is	 such	 that	 the	 bundle	 comprises	 two	 pairs	 of	 parallel	 helices,	 with	 a	 closely	
associated	region	across	~7	turns	at	the	N-terminus	(Fig.	4.11,	B	and	C).		
	
Figure	4.11:	YabA1-58	structure:	A)	Ribbon	diagram	of	the	asymmetric	unit	of	YabA1-58;	chain	A	(blue)	
spans	residues	Met	1	to	Asp	54	of	YabA	and	chain	B	(green)	spans	residues	Lys	3	to	Leu	52	of	YabA	–	
the	two	chains	form	a	dimer	which	resembles	a	pair	of	tweezers.	B)	YabA	Tetramer;	ribbon	diagram	
of	 tetrameric	 YabA1-58	 colour-ramped	 from	blue	 (N-terminus)	 to	 red	 (C-terminus).	C)	The	 YabA1-58	
tetramer	buries	a	large	percentage	of	the	available	surface	area:	YabA1-58	tetramer	rendered	with	a	
partially	transparent	surface:	chain	A	is	in	blue,	chain	B	in	green,	chain	A’	in	yellow,	and	B’	in	coral.		
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Table	4.8:	Data	and	refinement	statistics	for	YabA1-58	
	 YabA1-58	
Data	Collection	 	
X-ray	source	 DLS,	i04	
Wavelength	(Å)	 0.9795	
Resolution	Range	(Å)	 56.70	-	2.0	
Space	Group	 I222	
Unit	Cell	Parameters	 	
a	b	c		(Å)	 49.08,	73.77,	88.64	
α	β	γ	(°)	 90,	90,	90	
No.	of	reflections	o	 72719/5336	
Completeness	(%)	a	 100/100	
Redundancy	a	 6.5/6.6	
I/σ(I)	a	 19.1/2.5	
Rmerge
p	(%)	a	 4.5/62.7	
	 	
Refinement	and	Model	Statistics	 	
Resolution	Range	(Å)	 56.7-2.0	
R-factorq	(Rfree
r)	 24.2	(28.2)	
Reflections	(working/Rfree)	 10629/593	
Outer-shell/High	Res	range	 2.00-2.05	
Outer-shells/High	Res	R-factorc	(Rfree)
d	 30.1/32.9	
Outer-shell/High	Res	Reflections	(working/free)	 774/37	
Molecules	per	asymmetric	unit	 2	
rmsd	from	ideal	geometryt	 	
Bond	Lengths	(Å)	 0.033	
Bond	Angles	(°)	 2.7	
Average	B-factor	(Å2)	 38.3	
Ramachandran	Plotug	 97.0/2.0/1.0	
																																								 																				
o	.	The	first	number	refers	to	the	overall	data	set,	the	second	refers	the	outer	resolution	shell	(2.05-2.00).	
p	.	Rmerge=∑hkl∑i|Ii−	<	I	>	|/∑hkl	∑i	<	I	>	where	Ii		is	the	intensity	of	the	ith	measurement	of	a	reflection	with	
indexes	hkl	and	<	I	>	is	the	statistically	weighted	average	reflection	intensity.		
q	.	R-factor	=∑||Fo|	−	|Fc||/∑|Fo	|	where	Fo	and	Fc	are	the	observed	and	calculated	structure	factor	amplitudes	
respectively.	
r	.	R-free	is	the	R-factor	calculated	with	5%	of	the	reflections	chosen	at	random	and	omitted	from	refinement.	
s	.	Outer	shell	for	refinement	corresponds	to	2.05-2.00	Å.		
t	.	Root-mean-square	deviation	of	bond	lengths	and	bond	angles	from	ideal	geometry.	
u	.	Percentage	of	residues	in	most-favoured/disallowed/allowed	regions	of	the	Ramachandran	plot.	
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The	 helical	 pairs	 extend	 away	 from	 one	 another	 in	 the	 tetramer,	 with	 2	 C-terminal	
extensions	located	at	either	end.	The	4-stranded	antiparallel	coiled-coil	region	is	formed	by	
the	N-termini	of	 each	 chain	 (residues	1-31)	 and	 the	extended	 regions	 span	 from	 residue	
32-54.	 The	 YabA	 helical	 bundle	 has	 a	 buried	 interface	 of	 8672	 A2	 of	 solvent	 accessible	
surface	area	-	a	large	proportion	of	the	overall	available	area	(21606	A2)	(Fig.	4.11,	C).			
Coiled-coiled	 proteins	 are	 composed	 of	 α-helices	 which	 contain	 a	 seven	 amino	 acid	
'heptad'	repeat	sequence	(a-g)n	,	each	of	which	spans	2	helical	turns.	The	first	(a)	and	fourth	
(d)	 residues	 of	 each	 repeat	 are	 predominantly	 hydrophobic	 and	 help	 to	 define	 the	
architecture	 of	 the	 fold.	 Three	 types	 of	 anti-parallel	 tetrameric	 coiled-coil	 architecture	
have	been	previously	reported,	defined	by	the	interacting	residues	between	chains	within	
the	heptadic	repeat;	these	are	either	a-d	core,	a-d-e	core	or	a-d-g	core	(Fig.	4.12)	223,224.	
	
Figure	 4.12:	 Possible	 core	 structures	 of	 4-stranded	 antiparallel	 coiled-coil	 proteins	 :	A)	 a-d	 core	
structure;	 side	 chains	 from	 residues	 a	 and	 d	 contribute	 to	 the	 core	 packing	 of	 the	 4-stranded	
antiparallel	 coiled-coil	 structure.	 B)	 a-d-e	 core	 structure;	 side	 chains	 from	 residues	 a,	 d	 and	 e	
contribute	 to	 the	 core	 packing	 of	 the	 4-stranded	 antiparallel	 coiled-coil	 structure.	 C)	 a-d-g	 core	
structure;	 side	 chains	 from	 residues	 a,	 d	 	 and	 g	 contribute	 to	 the	 core	 packing	of	 the	 4-stranded	
antiparallel	coiled-coil	structure.	
	
YabA	displays	an	a-d	core	structure,	with	a-a	and	d-d	inter-chain	interactions	(Fig.	4.12,	A).	
Leucine	residues	6,	13,	20	and	27	 in	the	d	position	form	a	classical	 leucine	zipper,	where	
the	 side	 chains	between	chains	A	and	A'	or	B	and	B'	display	a	 typical	 "knobs	 into	holes"	
style	 packing	 (Fig.	 4.12,	 B	 and	 D).	 Val	 10,	 Ile	 17	 and	 31	 and	 Leu	 24	 residues	 in	 the	 a	
positions	display	a	similar	side	chain	"knobs	into	holes"	packing	between	chain	A	and	chain	
B	(Fig.	4.13,	C	and	D).		
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Figure	4.13:	Hydrophobic	packing	 in	YabA1-58	 by	 side	 chains	of	 residues	 at	 a	 and	d	positions:	A)	
Helical	wheel	representation	of	the	4-stranded	anti-parallel	packing	in	YabA1-58;	B)	Leucine	residues	
6,	13,	20	and	27	in	the	d	positions	of	chain	B	(green)	and	A’	(yellow)	form	a	leucine	zipper	motif.	C)	
Val	10,	Ile	17	and	31	and	Leu	24	residues	in	a	positions	display	a	"knobs	into	holes"	packing	between	
chain	A	and	chain	B.	D)	Stereo	 image	of	the	YabA	tetramer	showing	 ‘d’	Leu	residues	(dark	green),	
and	‘a’	Ile,	Val	and	Leu	residues	(light	green);	chain	A	is	in	blue,	chain	B	in	green,	chain	A’	in	yellow,	
and	B’	in	coral.	
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In	this	a-d	core	type	structure,	residues	at	the	g	position	lie	above	those	in	the	d	position,	
partially	 buried	 and	partially	 solvent	 exposed.	 Similarly,	 residues	 at	 e	 positions	 lie	 above	
those	 in	 position	 a	 (Fig.	 4.14,	 A).	 	 In	 YabA1-58	 several	 stabilising	 hydrogen	 bonds	 can	 be	
observed	between	residues	at	g	positions	(Gln	16	and	Gln	23	from	bonds	between	chains	A	
and	B'	and	B	and	A')	and	e	positions	(Glu	14	forms	a	bond	with	Lys	28	between	chains	A	
and	A'	and	B	and	B')	(Fig.	4.14,	A	and	B).		Residues	in	positions	b,	c	and	f	are	predominantly	
solvent	exposed.		
	
Figure	4.14:	Stabilising	inter-chain	interactions	form	between	e	and	g	residues	on	YabA1-58:	Chain	
A	is	shown	in	blue,	chain	B	in	green,	chain	A’	in	yellow,	and	B’	in	coral.	A)	Stereo	image	showing	side	
chain	 packing	 of	 core	 a	 residues	 (carbon	 atoms	 in	 light	 green),	 d	 residues	 (carbon	 atoms	 in	 dark	
green),	 e	 residues	 (carbon	 atoms	 in	 purple,	 oxygen	 atoms	 in	 red,	 nitrogen	 atoms	 in	 blue)	 and	 g	
residues	(carbon	atoms	in	pink,	oxygen	atoms	in	red	and	nitrogen	atoms	in	blue).	B)	Stereo	image	of	
stabilising	 hydrogen	 bond	 interactions	 between	 YabA-58	 chains:	 hydrogen	 bonds	 occur	 between	
residues	Gln	16	and	Gln	23	(chains	A’	to	B	and	B’	to	A);	and	between	residues	Glu	14	and	Lys	28,	(A	
to	A’	and	B	to	B’).		
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4.5.16:	Discussion	
The	structure	of	YabA1-58	reveals	a	four-stranded	anti-parallel	coiled-coil	domain	with	an	‘a-
d’	 core	 packing,	 in	 agreement	 with	 the	 YabA1-62	 structure	 solved	 by	 collaborators	 L.	
Terradot,	 M.	 Cherrier	 and	 A.	 Bazin.	 	 These	 structures	 confirm	 that	 the	 tetramerisation	
determinants	of	YabA	reside	in	the	N-terminal	domain,	in	agreement	with	the	SEC-MALLS	
data	presented	in	Chapter	3	(see	section	3.5.10)	and	that	the	tetramerisation	determinants	
specifically	lie	in	residues	1-31	of	YabA.		
YabA	 has	 been	 shown	 to	 interact	 with	 DnaA	 and	 DnaN	 via	 its	 C-terminal	 domain,	 thus	
structural	 information	 about	 the	 C-terminal	 domain	 and	 the	 full-length	 structure	 in	
addition	 to	 the	 N-terminal	 domain	 structure	 are	 of	 value	 for	 understanding	 how	 YabA	
regulates	the	initiation	of	replication.	To	address	this	question,	our	collaborators	P.	Roblin,	
M-F.	 Noirot-Grios,	 and	 L.	 Terradot	 used	 small	 angle	 X-ray	 scattering	 (SAXS)	 to	 obtain	
structural	 information	 about	 full-length	 YabA.	 SAXS	 can	 be	 used	 to	 determine	 low-
resolution	structures	of	proteins	in	solution.	The	analysis	of	YabA	by	SAXS	revealed	that	it	
has	a	radius	of	gyration	of	63.5	Å	and	maximum	dimension	(Dmax)	of	250	Å.	These	values	
are	surprisingly	high	for	a	low	molecular	weight	protein,	even	accounting	for	the	fact	that	
YabA	forms	tetramers.	Analysis	of	the	data	in	the	form	of	a	Kratky	plot,	which	assesses	the	
likelihood	of	unfolded	regions	within	the	protein,	indicated	flexibility	between	the	domains	
of	 YabA.	 	 Ab	 initio	 modelling	 with	 an	 imposed	 P22	 symmetry	 (as	 seen	 in	 the	 YabA1-62	
structure)	 generated	 a	 cylindrical	model	with	pairs	 of	 elongated	 arms	 at	 either	 end	 (Fig.	
4.15,	A).	Altogether,	these	results	suggest	that	full-length	YabA	adopts	an	elongated	form	
with	flexibility	between	domains.	
To	generate	a	more	accurate	model	of	full-length	YabA,	a	model	was	created	using	the	N-
terminal	 YabA1-62	 crystal	 structure	 and	 a	 truncated	 version	 of	 the	 in	 silico	 YabA	 model	
(presented	in	section	3.1)	containing	only	the	C-terminal	domain	of	YabA	from	residue	76	
to	119	 (Fig.	4.15,	B).	 	The	 intermediate	 residues	62-76	were	modelled	as	a	 flexible	 linker	
between	 the	 N-	 and	 C-terminal	 domains	 to	 account	 for	 the	 large	 maximum	 dimension	
described	above.	The	resultant	model	(Fig.	4.15,	C)	fits	the	experimental	scattering	pattern	
and	shows	a	similar	domain	organisation	to	the	ab	initio	model.	Several	C-terminal	domain	
positions	within	the	model	were	found	to	fit	the	data	with	equal	agreement	(Fig.	4.15,	D);	
this	verifies	an	 intrinsic	flexibility	 in	the	 linker	between	the	N-	and	C-terminal	domains	of	
YabA.		These	results	define	a	full-length	structure	of	YabA,	where	the	N-terminal	domains	
form	a	 tetrameric	helical	 ‘core’	 structure	which	 is	 flanked	on	either	end	by	 two	pseudo-
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monomeric	 C-terminal	 domains,	 one	 attached	 to	 each	 N-terminal	 domain	 via	 a	 flexible	
linker	region.		
	
	
Figure	4.15:	Low	resolution	full-length	YabA	structure	defined	by	SAXS	:	A)	Ab	initio	model	of	YabA	
generated	from	SAXS	data	with	an	imposed	P22	symmetry.	B)	In	silico	model	of	the	YabA	C-terminal	
domain.	C)	Full-length	YabA	model	in	agreement	with	SAXS	scattering.	D)	Alternative	YabA	models	
which	agree	equally	with	SAXS	scattering	data,	confirming	flexibility	in	the	linker	region	between	the	
N-	and	C-terminal	domains	of	YabA.	
	
The	C-terminal	domain	of	YabA	has	previously	been	shown	to	carry	 the	determinants	on	
YabA	 for	 interacting	 with	 DnaA	 and	 DnaN163	 and	 full	 length	 YabA	 can	 form	 a	 ternary	
complex	 with	 DnaA	 and	 DnaN	 as	 judged	 by	 their	 interaction	 in	 a	 yeast	 three-hybrid	
assay162.	As	the	C-terminal	domain	has	been	characterised	to	be	spatially	 independent	of	
the	N-terminal	domain,	this	posed	the	question	of	whether	or	not	it	was	also	functionally	
independent.	 Experiments	were	 carried	out	 to	 assess	whether	or	not	 an	 independent	C-
terminal	domain	could	form	interactions	with	DnaA	and	DnaN,	or	if	the	N-terminal	domain	
was	also	required	for	binding.	M-F	Noirot	Gros,	T.	Garcia	and	M.	Ventroux	carried	out	yeast	
two	and	three-hybrid	experiments	which	assess	the	 interaction	of	 the	C-terminal	domain	
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(residues	62-119)	with	DnaA	and	DnaN.	These	reveal	that	the	C-terminal	domain	alone	can	
interact	with	DnaA	or	DnaN,	but	that	it	 is	unable	to	form	a	simultaneous	interaction	with	
both	 DnaA	 and	 DnaN	 in	 vivo.	 In	 contrast,	 full-length	 YabA	 can	 from	 a	 simultaneous	
interaction	with	DnaA	and	DnaN.	These	 results	 therefore	determine	a	 functional	 role	 for	
the	N-terminal	domain	of	YabA	which	appears	to	provide	a	structural	'hub'	from	which	the	
C-terminal	domains	can	extend	to	form	interactions	with	both	DnaA	and	DnaN	on	separate	
domains.		
M-F.	Noirot	Gros	and	colleagues	have	also	mapped	the	DnaA	and	DnaN	binding	residues	of	
YabA	 onto	 the	 C-terminal	 in	 silico	 model	 and	 identified	 additional	 residues	 involved	 in	
interactions	 with	 YabA	 using	 yeast	 two-hybrid	 screening.	 These	 results	 delineate	 two	
partially	overlapping	surfaces	on	the	YabA	C-terminal	domain	for	binding	DnaA	and	DnaN.	
Furthermore,	 introduction	 of	 these	 mutations	 into	 YabA	 affects	 its	 localisation	 in	 vivo.	
YabA	 has	 previously	 been	 shown	 to	 form	 foci	 at	 the	mid-cell	 for	most	 of	 the	 cell-cycle,	
indicating	 localisation	 with	 the	 replication	machinery.	Mutations	 of	 YabA	which	 cause	 a	
loss	 of	 interaction	 with	 either	 DnaA	 or	 DnaN	 have	 been	 shown	 to	 affect	 localisation	 of	
YabA	and	also	 loss	of	 initiation	control.	Remarkably,	 complementation	of	a	YabA	mutant	
which	 cannot	 interact	 with	 DnaN	with	 a	 YabA	mutant	 which	 cannot	 interact	 with	 DnaA	
restores	 the	 formation	 of	 YabA	 foci	 at	 the	 mid-cell;	 this	 provides	 evidence	 for	 the	
physiological	 role	 of	 a	 DnaA-YabA-DnaN	 complex,	 and	 highlights	 the	 requirement	 of	 the	
tetrameriation	determinants	of	YabA	to	allow	interaction	with	multiple	partners	in	vivo.	
	
YabA	Function	
YabA	has	 been	 suggested	 to	 function	by	 inhibiting	 co-ooperative	 binding	of	DnaA	 at	 the	
origin34,	 and	 also	 by	 tethering	 DnaA	 to	 the	 replication	machinery	 via	 a	 ternary	 complex	
with	 DnaN164.	 How	 YabA	 is	 able	 to	 coordinate	 these	 activities	 and	 regulate	 replication	
initiation	 is	 currently	 poorly	 understood	 and	 knowledge	of	 the	 structural	 organisation	of	
YabA	 and	 its	 interactions	 with	 DnaA	 and	 DnaN	 are	 vital	 to	 our	 understanding	 of	 its	
mechanism.	 The	 work	 described	 here	 and	 in	 Chapter	 3,	 along	 with	 SAXS	 and	 in	 silico	
experiments	carried	out	by	our	collaborators,	defines	the	structural	architecture	of	YabA.	
In	 vivo	 experiments	 carried	 out	 by	 M-F.	 Noirot-Gros	 and	 colleagues	 strongly	 suggest	 a	
mode	of	 interaction	where	 YabA	binds	DnaA	and/or	DnaN	 via	 separate	 'independent'	 C-
terminal	domains	at	either	end	of	a	 tetrameric	core.	The	existence	of	 several	 interaction	
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modules	within	 YabA	 provides	 the	 protein	with	 the	 opportunity	 to	 interact	with	 several	
DnaA	(or	DnaN)	molecules	simultaneously,	enabling	its	function.		For	example,	YabA	could	
inhibit	co-operative	binding	of	DnaA	at	oriC	by	binding	several	DnaA	molecules	(Fig.	4.16,	
A),	 or	 interact	with	DnaA	 and	DnaN	 at	 opposite	 ends	 of	 the	 tetramer	 to	 form	 a	 ternary	
complex	 at	 the	 replication	 machinery	 (Fig.	 4.16,	 B).	 	 Further	 study	 is	 required	 to	
understand	 the	 nature	 and	 stoichiometry	 of	 the	 interactions	 YabA	 forms	with	DnaA	 and	
DnaN.	The	structure	of	YabA	presented	here	provides	a	framework	for	understanding	how	
YabA	 interacts	 with	 multiple	 protein	 partners	 during	 the	 regulation	 of	 DNA	 replication	
initiation.		
	
	
Figure	 4.16:	 Theoretical	 modes	 of	 interaction	 of	 YabA	 with	 DnaA	 and	 DnaN:A)	 YabA	 binding	
multiple	DnaA	molecules	at	oriC.	B)	YabA	forming	a	ternary	complex	with	DnaA	and	DnaN	
at	the	replication	machinery.		
	
Structural	Similarity	to	Geminin	
YabA	shares	structural	similarity	to	the	protein	Geminin225,	an	 inhibitor	of	origin	 licencing	
in	eukaryotes.	Origin	licencing	is	the	term	given	to	the	strict	spatial	and	temporal	control	of	
DNA	replication	 in	eukaryotes	and	 involves	 the	assembly	of	a	pre-replicative	complex	on	
chromatin	 before	 DNA	 replication	 can	 commence.	 A	 protein	 called	 Cdt1	 is	 a	 crucial	
regulator	of	pre-replicative	complex	assembly	as	 it	 recruits	 the	 replicative	helicase,	mini-
chromosome	 maintenance	 (MCM)	 complex,	 the	 final	 step	 in	 pre-replicative	 complex	
assembly226.	 The	 activity	 of	 Cdt1	 is	 in	 turn	 inhibited	 by	 Geminin	 during	 parts	 of	 the	 cell	
cycle	 as	 a	 method	 of	 control	 over	 origin	 licencing.	 However,	 there	 appear	 to	 be	 some	
significant	 differences	 in	 the	 oligomerisation	 states	 and	 mechanisms	 of	 Geminin	 and	
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YabA226.	Geminin	is	a	three	domain	protein	whose	central	domain	forms	a	dimeric	parallel	
coiled	 coil	 (this	 is	 somewhat	 reminiscent	 of	 the	 asymmetric	 unit	 observed	 for	 YabA).	
However,	unlike	YabA,	Geminin’s	other	domains	are	believed	to	be	unstructured	and	the	
functional	 (inhibitory)	amino	acids	 lie	at	the	C-terminal	end	of	 its	coiled-coil	domain227.	 It	
forms	a	‘permissive’	heterotrimeric	complex	with	one	molecule	of	Cdt1,	and	two	of	these	
heterotrimers	 are	 thought	 to	 form	 an	 inhibitory	 heterohexameric	 Geminin-Cdt1	 4:2	
complex227.	The	 interaction	between	 two	Geminin	dimers	 in	 this	 complex	 is	mediated	by	
two	 Cdt1	 molecules	 and	 does	 not	 at	 all	 resemble	 the	 four-stranded	 anti-parallel	 helix	
observed	 in	 YabA1-58.	 Furthermore,	 the	 functional	 determinants	 of	 YabA	 –	 i.e.	 residues	
which	 interact	with	DnaN	and	DnaA,	 have	been	mapped	 to	 its	C-terminal	 domain	 (away	
from	the	coiled-coil),	suggesting	that	YabA’s	function	must	be	differently	mediated	to	that	
of	Geminin227.	Thus,	 it	 seems	unlikely	 that	 the	structural	 similarity	between	Geminin	and	
YabA	has	 any	bearing	on	 their	 functional	 activities.	 It	 is	more	 likely	 to	be	a	 result	 of	 the	
diversity	 in	 structure	 and	 function	 observed	 in	 coiled-coil	 domains.	 Nevertheless,	 it	 is	
interesting	to	observe	the	presence	of	a	similar	structural	motif	acting	as	a	DNA	replication	
inhibitor	 in	 both	 eukaryotes	 and	 prokaryotes,	 and	 it	 will	 be	 of	 interest	 to	 understand	 if	
there	are	any	similarities	in	their	mechanisms.			
	
Antiparallel	Coiled-Coil	Domains	
Coincidentally,	the	structure	of	YabA1-58	may	be	of	interest	to	protein	scientists	who	study	
coiled-coil	 domains	 with	 the	 goal	 of	 understanding	 the	 relationship	 between	 primary	
sequence	 and	 tertiary	 structure,	 ultimately	 aiding	 rational	 protein	 design.	 Coiled-coil	
domains	have	been	extensively	studied	for	this	purpose	due	to	their	ability	to	form	a	wide	
range	of	oligomers	and	topologies223,228.	Strikingly,	changes	as	small	as	a	single	amino	acid	
substitution	have	been	shown	to	induce	a	tetrameric	coiled-coil	domain	topology	to	switch	
from	parallel	 to	anti-parallel229.	Therefore	the	ability	to	accurately	predict	the	quaternary	
state	 of	 coiled-coil	 domains	 is	 an	 attractive	 goal.	 Given	 the	 large	 number	 of	 elucidated	
coiled-coil	structures,	surprisingly	few	anti-parallel	tetramers	have	been	solved	compared	
to	parallel	tetramers.	Although	modelling	capabilities	are	improving,	with	programs	being	
developed	 which	 can	 predict	 parallel	 and	 anti-parallel	 topology230,	 YabA1-58	 may	 be	 of	
interest	in	the	validation	of	these	programs.		
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Chapter	5 :	Conclusions	and	Future	Perspectives	
The	 regulators	 of	 DNA	 replication,	 YabA	 and	 SirA,	 form	 direct	 interactions	 with	 the	
replication	 initiator	 protein	 DnaA,	 to	 negatively	 regulate	 replication	 initiation.	 Although	
both	 have	 been	 predicted	 to	 act	 by	 preventing	 the	 binding	 of	 DnaA	 at	 the	 replication	
origin,	 the	 proteins	 interact	 with	 different	 domains	 of	 DnaA	 and	 appear	 to	 orchestrate	
replication	 control	 by	 different	 mechanisms.	 This	 is	 not	 surprising	 as	 YabA	 controls	
replication	initiation	during	vegetative	growth,	where	replication	control	must	be	dynamic	
to	 allow	 the	 cell	 to	 reinitiate	 replication	 when	 required,	 whilst	 SirA	 regulates	 DNA	
replication	during	 sporulation;	a	 situation	 in	which	 the	 cell	does	not	need	 to	 initiate	any	
further	replication	events.	
	
Perspectives	from	SirA	
The	structure	of	SirA	in	complex	with	domain	I	of	DnaA	presented	in	Chapter	2	delineates	
the	 interaction	 interface	 between	 the	 proteins.	 This	 work	 was	 supported	 by	 in	 vivo	
functional	 studies	performed	by	N.	Rostami	and	H.	Murray	which	demonstrated	 that	 the	
SirA-DnaADI	 interface	 identified	 in	 the	 crystal	 structure	 was	 functionally	 relevant.		
Intriguingly,	 the	 SirA	 interaction	 determinants	 on	 DnaADI	 where	 found	 to	 be	 at	 a	
structurally	equivalent	site	to	those	for	two	positive	regulators	of	initiation,	DiaA	in	E.	coli	
and	 HobA	 in	H.pylori,	 despite	 their	 differing	 effects	 on	 replication	 initiation73,157,214.	 The	
relevance	of	this	binding	site	may	extend	further	as	two	other	known	interaction	partners	
of	DnaADI,	the	E.	coli	DNA	replication	regulator	Hda	and	the	E.	coli	helicase,	have	also	been	
shown	to	interact	with	specific	residues	within	a	structurally	equivalent	surface	of	DnaADI	
26,82.	Furthermore,	our	inability	to	produce	alanine	mutations	at	residues	Thr	26,	Trp	27	and	
Phe	49	on	DnaA	at	the	SirA-DnaADI	 interface	implies	that	B.	subtilis	DnaA	may	ultilise	this	
site	 in	 an	 essential	 interaction	 with	 another	 component	 of	 the	 initiation	 machinery	 –	
perhaps	an,	as	yet,	unidentified	interaction	partner	at	this	site.		Significantly,	no	interaction	
partner	of	DnaADI	has	been	found	to	interact	with	any	other	location	on	DnaADI.	This	poses	
the	 question	 of	what	makes	 this	 site	 on	DnaADI	 a	 prime	 location	 for	 its	 interaction	with	
protein	 partners,	 and	 how,	 if	 at	 all,	 it	 relates	 to	 the	 role	 of	 DnaADI	 during	 replication	
initiation?	
Despite	its	many	interaction	partners,	the	role	of	DnaADI	during	the	initiation	process	is	not	
well	established.	DnaADI	has	a	KH-domain	fold	commonly	found	in	ssDNA	binding	proteins,	
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and	one	study	has	suggested	that	it	has	a	weak	but	specific	affinity	for	single	stranded	oriC	
DNA26.	However,	it	is	not	known	if	this	ssDNA	binding	plays	a	functional	role	in	vivo.		In	E.	
coli,	DnaADI	has	long	been	thought	to	play	a	role	in	the	oligomerisation	of	DnaA	molecules	
at	oriC	231.This	is	based	on	the	observation	that	it	can	functionally	replace	the	dimerisation	
domain	of	the	bacteriophage	λ	CI	repressor	in	a	“one-hybrid-system”	231	(i.e.	a	chimeric	λ	
CI-DnaADI	protein	is	able	to	inhibit	λ	replication	as	efficiently	as	λ	cI)	and	because	it	affects	
DnaA	 oligomerisation	 in	 a	 gluteraldehyde	 cross-linking	 assay76	 (removal	 of	 domain	 I	
reduces	the	amount	of	observed	cross-linking).	
Based	 mainly	 on	 the	 observation	 that	 other	 KH-domains	 can	 form	 dimers,	 it	 has	 been	
suggested	 that	 DnaADI	 may	 also	 form	 dimers26.	 In	 E.	 coli	 DnaADI,	 it	 is	 proposed	 that	
dimerisation	 is	mediated	by	an	essential	 tryptophan	at	position	6	 (and	other	 residues	of	
the	same	helix)75,76	on	one	surface	of	the	domain.	This	helix	is	located	on	the	opposite	face	
of	DnaADI	to	the	binding	site	of	the	interaction	partners	of	DnaADI	(Fig.	5.1).	However,	the	
assignment	of	this	surface	as	a	site	for	self-interaction	must	be	treated	cautiously	because	
it	 is	unclear	 if	mutations	at	 these	residues	specifically	 interfere	with	oligomerisation	or	 if	
they	could	also	affect	the	fold	of	the	protein.	In	the	B.	subtilis	DnaADI	structure	presented	
in	Chapter	2,	which	has	an	equivalent	tryptophan	at	position	8	(Fig.	5.1,	A),	the	tryptophan	
side	 chain	 is	 completely	 buried	 in	 the	 protein	 core,	 forming	 significant	 interactions	with	
side	chains	of	residues	 in	adjacent	helices;	 including	those	 involved	 in	binding	 interaction	
partners	of	DnaADI.	In	the	NMR	structure	of	E.	coli	26	DnaADI,	this	tryptophan	is	also	partially	
buried	(Fig.	5.1,	B).	Thus,	a	mutation	of	this	residue	is	likely	to	cause	movement	of	helices	
adjacent	 to	 the	 tryptophan	 side	 chain	 and	 destabilisation	 of	 the	 DnaADI	 structure.	 This	
would	 inevitably	disrupt	the	 interactions	of	DnaADI	with	 its	binding	partners	-	such	as	the	
helicase,	 which	 interacts	 with	 the	 residue	 Glu	 2126	 (Fig.	 5.1,	 B).	 Helicase	 loading	 is	 an	
essential	step	in	the	initiation	of	replication	and	therefore	blocking	loading	of	the	helicase	
is	inhibitory	to	replication	events.	Thus,	loss	of	the	DnaA-helicase	interaction	could	account	
for	the	 in	vivo	effects	seen	with	an	E.	coli	Trp6Ala	mutant;	where	Trp	6	was	judged	to	be	
essential	for	DNA	replication	based	on	the	fact	that	cells	harbouring	the	Ala	substitution	at	
Trp	 6	 are	 unable	 to	 form	 colonies	 in	 a	 plating	 assay75.	 As	 demonstrated	 by	 the	 DnaADI	
Ala50Val	mutation	which	prevents	the	binding	of	SirA	to	DnaA83,	even	small	perturbations	
of	 the	 protein	 core	 can	 have	 significant	 effects	 on	 the	 binding	 ability	 of	 DnaADI.	 Thus,	
interpretation	 of	 the	 results	 with	 regards	 to	 a	 self-interaction	 between	 two	 N-terminal	
domains	of	DnaA	must	be	made	cautiously.		
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Nevertheless,	 self-interaction	may	 provide	 an	 explanation	 for	 a	 common	 binding	 site	 on	
DnaADI;	 this	 may	 be	 the	 only	 accessible	 surface	 of	 domain	 I	 during	 initiation	 if	 other	
surfaces	are	obscured	due	to	a	self-interaction.	A	related	theory	is	that	the	orientation	of	
domain	 I	with	respect	to	the	rest	of	DnaA	is	somehow	important	for	 initiation.	Given	the	
flexible	nature	of	DnaA	Domain	II,	 it	 is	unclear	how	this	could	be	orchestrated	other	than	
by	self-interaction.	Nevertheless,	orientation	could	also	play	a	role	in	dictating	the	surface	
of	 DnaADI	 available	 to	 bind	 interaction	 partners,	 and	 provides	 a	 mechanism	 by	 which	
positive	 regulators	 such	as	HobA/DiaA	 could	promote	 replication	 initiation	by	promoting	
the	correct	orientation	of	domain	I,	and	negative	regulators	such	as	SirA	could	inhibit	the	
correct	orientation	of	domain	I.		
	
	
Figure	5.1:	Structures	of	DnaADI	from	B.	subtilis	and	E.	coli:	A)	Crystal	structure	of	B.	subtilis	DnaADI	
displaying	 the	 location	of	 the	buried	 tryptophan	 residue	at	position	6,	 and	 the	 close	proximity	 to	
other	 buried	 side	 chains	 on	 adjacent	 helices.	 The	 SirA	 interaction	 site	 is	 displayed	 as	 a	 surface	
representation	in	lilac,	as	an	example	of	the	location	of	interaction	for	various	partners	of	DnaADI.	B)	
NMR	structure	of	E.	coli	DnaADI	displaying	Trp	6	and	Glu	21.	The	partially	buried	tryptophan	6	has	
been	 implicated	 in	 self-interaction	 of	 domain	 I,	 and	 Glu	 21	 has	 been	 shown	 to	 be	 important	 for	
DnaB	helicase	binding.			
	
Regardless,	the	SirA-DnaADI	structure	highlights	the	importance	of	understanding	the	role	
of	DanADI	during	replication	initiation,	and	may	signal	additional	essential	interactions	with	
DnaADI	 which	 have	 not	 yet	 been	 found	 in	 B.	 subtilis.	 Ultimately,	 to	 further	 our	
understanding	of	the	initiation	process	and	elucidate	the	mechanism	of	not	only	SirA,	but	
of	many	other	 interaction	partners	of	DnaA,	more	must	be	understood	about	the	role	of	
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the	N-terminal	domain	of	DnaA	and	how	 it	orchestrates	 its	 function	with	 the	 rest	of	 the	
initiator.	
	
Perspectives	from	YabA	
The	 structural	 and	 biophysical	 characterisation	 of	 YabA	 described	 in	 Chapters	 3	 and	 4,	
together	with	the	results	of	our	collaborators,	delineates	the	overall	architecture	of	YabA	
and	 provides	 insights	 into	 the	mode	 of	 interaction	 between	 YabA,	 DnaA	 and	DnaN.	 The	
architecture	 of	 the	 YabA	 tetramer	 comprises	 a	 four-helix	 anti-parallel	 coiled-coil	 core,	
flanked	at	either	end	by	two	‘independent’	pseudo-monomeric	C-terminal	domains	which	
are	 tethered	 to	 the	N-terminal	 helices	 via	 a	 flexible	 linker.	 YabA	 is	 able	 to	 interact	with	
DnaA	 and	 DnaN	 via	 the	 distal	 C-terminal	 domains	 in	 a	 manner	 which	 allows	 multiple	
interactions	 to	 take	 place	 simultaneously.	 However,	 to	 further	 elucidate	 how	 YabA	
regulates	initiation,	it	 is	essential	to	know	more	about	the	stoichiometry	and	architecture	
of	the	complex(es)	it	forms	with	DnaA	and	DnaN.	These	questions	could	be	addressed	by	a	
number	of	additional	structural	and	biophysical	experiments	as	outlined	below.	
	
Although	we	have	defined	 the	overall	 architecture	 of	 YabA,	 our	 understanding	of	 the	C-
terminal	 domain	 interaction	with	DnaA	 and	DnaN	 is	 still	 somewhat	 limited.	 The	 in	 silico	
model	 used	 for	 low-resolution	 structure	 determination	 by	 SAXS	 is	 not	 based	 on	 a	 direct	
homolog	of	YabA,	but	on	proteins	carrying	similar	Zn-binding	motifs.	This	means	that	high-
resolution	 structural	 information	 (e.g.	 locations	 of	 side	 chains)	 cannot	 be	 inferred.	
Elucidation	of	 a	 high-resolution	 structure	 of	 the	C-terminal	 domain	of	 YabA	would	 allow	
greater	 understanding	 of	 the	 interaction	 determinants	 on	 YabA	 for	 binding	 DnaA	 and	
DnaN,	through	mapping	of	identified	loss	of	interaction	residues.		
	
The	 YabA	 C-terminal	 domain	 construct	 produced	 here,	 YabA70-119,	 was	 not	 readily	
crystallisable.	However,	it	is	not	immediately	obvious	where	the	secondary	structure	of	the	
C-terminal	 domain	 begins,	 meaning	 this	 construct	 may	 contain	 residues	 of	 the	 flexible	
linker	(between	the	N-	and	C-terminal	domains	of	YabA)	that	are	inhibiting	crystallisation.	
As	 the	 C-terminal	 domain	 has	 a	 low	 molecular	 weight	 and	 appears	 as	 a	 monomer	 in	
solution,	 it	 is	an	 ideal	candidate	 for	NMR	spectroscopy232.	Even	obtaining	a	simple	 1H	1D	
spectrum	 would	 provide	 information	 about	 the	 level	 of	 structure	 present	 within	 the	
construct233.	A	full	assignment	could	also	be	undertaken	to	elucidate	the	structure	by	NMR	
156	
	
and/or	 identify	 all	 unstructured	 regions	 within	 the	 C-terminal	 domain232.	 This	 would	
provide	information	for	making	a	more	'crystallisable'	construct;	which	could	then	be	used	
in	 co-crystallisation	 trials	 with	 DnaA	 or	 DnaN.	 Formation	 of	 a	 complex	 of	 the	 YabA	 C-
terminal	domain	with	DnaA	or	DnaN	may	be	facilitated	by	co-expression.	
	
A	crystal	structure	of	full-length	YabA	is	likely	to	be	unobtainable.	Crystallisation	attempts	
with	 full-length	protein	described	 in	 section	4.5.1,	by	M.	Fogg	 in	York	and	by	L.	Terradot	
and	 colleagues	 in	 Lyon,	 all	 resulted	 in	 crystals	 containing	 only	 the	N-terminal	 domain	 of	
YabA	 following	 in	 situ	 proteolysis.	 This	 highlights	 the	 sensitivity	 of	 the	 protein	 to	
proteolysis.	Furthermore,	the	flexible	linker	between	the	N-	and	C-terminal	domains	is	also	
likely	 to	 inhibit	 crystallisation	 of	 a	 full-length	 construct.	 Thus	 any	 future	 crystallisation	
studies	carried	out	with	YabA	should	include	only	the	C-terminal	domain	or	a	construct	of	
YabA	which	has	the	flexible	linker	removed.	
	
Study	of	the	interactions	of	YabA	with	DnaA	and	DnaN	could	also	be	undertaken	with	SAXS,	
or	 by	 AUC;	 if	 the	 proteins	 form	 stable	 complexes	 in	 solution.	 This	 could	 allow	 the	
stoichiometry	 of	 the	 complexes	 to	 be	 determined.	 Ultimately,	 if	 co-crystal	 structures	 of	
YabA	C-terminal	domain	with	DnaA	or	DnaN	are	possible,	analysis	of	the	ternary	complex	
by	SAXS	could	allow	a	low	resolution	structural	envelope	to	be	generated,	 into	which	the	
co-crystal	structures	could	be	fitted.	This	would	provide	significant	insight	into	the	nature	
of	 the	DnaA-YabA-DnaN	complex,	and	ultimately	 the	molecular	mechanism	YabA	uses	 to	
regulate	replication	initiation.		
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List	of	Abbreviations	
Å	 	 	 	 Angstrom	
βME	 	 	 	 β-Mercaptoethanol	/	2-Mercaptoethanol
µg	 	 	 	 Microgram	 	
µl	 	 	 	 Microlitre	
Ala	 	 	 	 Alanine	
ADP	 	 	 	 Adenosine	diphosphate	
Asn	 	 	 	 Asparagine	
Asp	 	 	 	 Aspartic	Acid	
ATP	 	 	 	 Adenosine	triphosphate	
B.	anthracis	 Bacillus	anthracis	
Bis-Tris	Propane	 2,2'-(Propane-1,3-diyldiimino)bis-
[2(hydroxymethyl)propane-1,3-diol]	
B.	subtilis	 Bacillus	subtilis	
C	 Celsius	
C.	crescentus	 Caulobacter	crescentus	
C.	difficile	 Clostridium	difficile	
CDP	 Cytosine	diphosphate	
Da	 	 	 	 Dalton	
DARS	 	 	 	 DnaA	reactivating	sequence	
DDBH1	 	 	 	 DnaD	DnaB	homology	domain	1	
DDBH2	 	 	 	 DnaD	DnaB	homology	domain	2	
DLS	 	 	 	 Diamond	Light	Source	
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Dmax	 	 	 	 Maximum	dimension	
DNA	 	 	 	 Deoxyribonucleic	acid	 	
DnaADI	 	 	 	 Domain	I	of	DnaA	
dsDNA	 	 	 	 Double-stranded	DNA	
DUE	 	 	 	 DNA	unwinding	element	
E.	coli	 	 	 	 Escherichia	coli	
EDTA	 	 	 	 Ethylenediaminetetraacetic	acid	
ESI	 	 	 	 Electrospray	ionisation	
Glu	 	 	 	 Glutamic	acid	
Gln	 	 	 	 Glutamine	
GFP	 	 	 	 Green	fluorescent	protein	
HEPES	 	 	 	 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic	acid	
His	 	 	 	 Histidine	
H.	pylori	 	 	 Helicobacter	pylori	
Ile	 	 	 	 Isoleucine	
IPTG	 	 	 	 Isopropyl-β-D-1-thiogalactoside	
Kan	 	 	 	 Kanamycin	
KCl	 	 	 	 Potassium	chloride	
kDa	 	 	 	 Kilo-Dalton	
KH	 	 	 	 K-homology	
l	 	 	 	 Litre	
LB	 	 	 	 Lysogeny	Broth	
Leu	 	 	 	 Leucine	
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MCM	 	 	 	 Mini-chromosome	maintenance	
MES	 	 	 	 2-ethanesulfonic	acid	
Met	 	 	 	 Methionine	
mg	 	 	 	 Milligram	
Min	 	 	 	 Minutes	
ml	 	 	 	 Millilitre	 	
mM	 	 	 	 Micromolar	 	
MS	 	 	 	 Mass	Spectrometry	
ng	 	 	 	 Nanogram	
OD600	 	 	 	 Optical	density	at	a	wavelength	of	600	nm		
NMR	 	 	 	 Nuclear	Magnetic	Resonance	
PAGE	 	 	 	 Polyacrylamide	gel	electrophoresis	 	
PCR	 	 	 	 Polymerase	Chain	Reaction	
PDB	 	 	 	 Protein	databank	
PEG	 	 	 	 Polyethylene	glycol	
Phe	 	 	 	 Phenylalanine	
Pro	 	 	 	 Proline	
RMSD	 	 	 	 Root-mean-square	deviation	
rpm	 	 	 	 Revolutions	per	minute	
SAD	 	 	 	 Single	anomalous	dispersion	
SAXS	 	 	 	 Small	angle	x-ray	scattering	
SDS	 	 	 	 Sodium	dodecyl	sulphate	
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SEC-MALLS	 Size	exclusion	chromatography	–	multi-angle	laser	light	
scattering	
SeMet	 Selenomethionine	
Ser	 Serine	
ssDNA	 Single-stranded	DNA	
Thr	 Threonine	
Tris	 2-Amino-2-hydroxymethyl-propane-1,3-diol	
Trp	 Tryptophan	
Tyr	 Tyrosine	
Val	 Valine	
Zn	 Zinc	
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